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Abstract
Objective The anterior skull base region can
be reached through different surgical
approaches. The most frequently used are the
pterional, bifrontal, and orbitozygomatic
approaches. No previous reports describe the
microsurgical technique when treating
olfactory groove meningiomas (OGMs),
anterior clinoidal meningiomas (ACMs), and
tuberculum sellae meningiomas (TSMs)
through the small lateral supraorbital (LSO)
approach. The purpose here was to assess the
reliability and safety of the LSO for the
treatment of vascular and neoplastic lesions
of  the  anterior  skull  base.  The
neuroanesthesia method when using this
small approach is also presented. When
needed, anterior clinoidectomy, intradurally
or extradurally, is also possible through the
LSO approach.
Patients and Methods Between September
1997 and August 2010, we analyzed the
clinical data, radiological findings, surgical
treatment, anesthesiological procedure,
histology, outcome, and long-term follow-up
of 66 OGMs, 73 ACMs, 52 TSMs
consecutive patients treated by the senior
author (J.H.) through the LSO approach.
Anterior clinoidectomy technique through
the LSO is presented after reviewing 82
patients who underwent surgery for vascular
and neoplastic lesions between June 2007
and January 2011. Altogether 273 patients of
a total of 3000 LSO approaches were
analyzed, and 15 videos were selected to
show the approach and the microsurgical
techniques used.
Results Olfactory groove meningiomas:
There was no surgical mortality. Six patients
(9%) had CSF leakage, four (6%) had wound
infections and cotton granulomas, and one
(2%) had postoperative hematoma. The
median Karnofsky score at discharge was 80
(range, 40-100). Six patients had residual
tumors: three were re-operated on after an
average of 21 (range, 1-41) months, one was
treated with radiosurgery, and two were
followed up. During the median follow-up of
45 (range, 2-128) months there were four
recurrences (6%) diagnosed on average 32
(range, 17-59) months after surgery.
Anterior clinoidal meningiomas: At three
months after discharge, 60 patients (82%)
had a good recovery, nine (12%) were
moderately disabled, one (1%) presented
with  severe  disability,  and  three  (4%)  died
due to surgery-related complications. Sixteen
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patients  (22%)  had  residual  tumors,  six  of
which required re-operation. Of 39 patients,
pre-existing visual deficit improved in 11
(28%), worsened in four (5%), and three
(4%) had de novo visual deficit. During the
median follow-up of 36 (range, 3-146)
months tumor recurred in three patients: two
were followed up and one was reoperated.
Tuberculum sellae meningiomas: At three
months postdischarge, 47 patients (90%) had
a good recovery, four (8%) were moderately
disabled, and one (2%) died 40 days after
surgery of unexplained cardiac arrest. Of 42
patients, pre-existing visual deficit improved
in 22 (42%), remained the same in 13 (25%),
and worsened in seven (13%), and de novo
visual deficit occurred in one patient (2%).
Seven patients (13%) had minimal residual
tumors, two of which required re-operation.
During the median follow-up of 59 (range, 1-
133)  months  tumor  recurred  in  one  of  the
patients who had received a second
operation.
Anesthesia: Surgical conditions with slack
brain were good in 154 meningioma patients.
Slack brain was achieved by a head position
elevated 20 cm above cardiac level in all
patients; administering mannitol
preoperatively in medium or large
meningiomas (60 cases); propofol infusion
(46 cases) or volatile anesthetics (107 cases)
also in patients with large tumor (37 cases);
and controlling intraoperative
hemodynamics. The mean systolic blood
pressure was 95-110 mmHg during surgery.
The median intraoperative blood loss was
200 (range, 0-2000) ml and 9% of patients
had red blood cell transfusion. One-hundred
and fifty-seven patients (84%) were
extubated on the day of the surgery. The
median (25th/75th percentiles) time to
extubation after surgery was 18 (8/105) min.
Anterior clinoidectomy: Eighty-two patients
underwent anterior clinoidectomy: 45
patients (55%) were treated for aneurysms,
35 patients (43%) were treated for
intraorbital, parasellar, and suprasellar
tumors, and two patients (2%) presented with
carotid-cavernous fistula. Intradural anterior
clinoidectomy was performed in 67 cases
(82%); in 15 cases (18%), an extradural
approach was used. We performed a tailored
anterior clinoidectomy: in five patients (6%),
only the medial tip of the anterior clinoid
process (ACP) was removed, in eight (10%)
the head of the ACP, in 18 (22%) the body of
the ACP, and in 51 (62%) the entire ACP.
Four patients (5%) had new postoperative
visual deficits and 12 (15%) improved their
preoperative visual deficits after intradural
anterior clinoidectomy. Extradural anterior
clinoidectomy and use of ultrasonic bone
device  (Sonopet)  may  increase  the  risk  of
postoperative visual deficits. There was no
mortality in the series.
Conclusions The LSO approach can be used
safely  for  OGMs,  ACMs,  and  TSMs  of  all
sizes, with a low mortality and a relatively
11
low morbidity. Anterior clinoidectomy can
be performed through the LSO approach.
However, it is required only in selected cases
and we prefer the intradural route.
A slack brain is mandatory when performing
the small LSO approach and can be achieved
by patient positioning, propofol or inhaled
anesthetics, preoperative mannitol, and
optimizing cerebral perfusion pressure.
With advancements in the neurosurgical
field, the skull opening should be simple and
as minimally invasive as possible. Surgical
results with the simple, clean, and fast LSO
approach are comparable with those
achieved with more extensive, complex, and
time-consuming approaches. We highly
recommend  the  use  of  LSO  for  removal  of
vascular and neoplastic lesions of the
anterior skull base.
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1  Introduction
The surgical opening of the skull is one of
the most fascinating practices in human
history. Since the first skull trepanation dates
back to the Neolithic period ca. 8000 BC,
enormous efforts have been made to refine
this surgical procedure (247). Over the
centuries, especially during the last one, the
procedure has undergone important
developments. This progression is due to the
parallel evolution of the neuroradiological
field, essential for optimal understanding of
the anatomy and neurovascular relationship
of the lesion, and improvement of
neurosurgical techniques with the
introduction of the microscope and
microsurgical techniques.
According to the location and anatomical
features of the intracranial lesion, several
surgical approaches have been developed,
particularly in the last fifty years.
We focused our study on the surgical
approach to reach the anterior skull base
(ASB). This is the endocranial surface of the
skull bordered posteriorly by the sphenoid
ridge and joined medially by the chiasmatic
sulcus. This region is particularly difficult to
reach because of the complex neurovascular
structures present.
Several surgical approaches are described to
reach the ASB. Those most frequently used
are the pterional, frontolateral, bifrontal, and
fronto-orbitozygomatic approaches.
The aim of this study was to demonstrate the
reliability and safety of the lateral
supraorbital (LSO) approach in the treatment
of the most frequent neoplastic and vascular
lesions of the ASB.
More specifically, the microsurgical
technique, long-term follow-up, and
neuroanesthesia procedures were carefully
examined  to  demonstrate  the  efficacy  of  the
LSO approach for treating olfactory groove
meningiomas (OGMs), anterior clinoidal
meningiomas (ACMs), and tuberculum
sellae meningiomas (TSMs). The results
were then compared with those obtained
utilizing pterional, orbitozygomatic, bifrontal
approaches that are more invasive and time-
consuming approaches. Furthermore, the
skull base approach with both extradural or
intradural anterior clinoidectomy, for the
treatment of vascular and neoplastic lesions,
was studied through the LSO approach.
All patients analyzed and described in this
study were treated by a single neurosurgeon,
the senior author (J.H.), at the Department of
Neurosurgery, Helsinki University Central
Hospital, Finland.
2  Review of the Literature
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2  Review of the Literature
History of Craniotomy
Pre-Historic and Classic Eras
Neolithic Era (8000 BC)
The primitive technique to open the skull
was trephination, performed in the Neolithic
era (8000-5000 BC) in different locations
around the world (Africa, South America,
and Melanesia, one of the regions of
Oceania). The first archeological findings
related to perforation of the skull date back
to the Neolithic period and were made in
France in the Neolithic site of Ensisheim in
1685 (217).
The word “trepanation” is derived from the
Greek and it means auger (hand tool for
boring holes). The word “trephination”, by
contrast, refers to an opening made by a
circular saw of any type. Skull opening
through trepanation was practiced in Europe,
Asia, New Zealand, Pacific Islands, and
North America.
Trephination or trepanation consisted of
removing  a  piece  of  the  skull  (frontal,
parietal, or occipital bones) from a living
patient to expose the dura mater. In the pre-
anesthesia and pre-antisepsis era, patient
survival improved if the dura mater remained
intact  when  opening  the  skull.  While  the
operation was performed on men, woman,
and  children,  the  patients  were  most  often
adult males. Two-thirds of the skulls found
and examined reveal various degrees of
healing, providing evidence of survival and
indicating great skill of the surgeon
considering the number of potential
complications (e.g. bleedings, infections,
edema).
Neolithic trepanation and trephination have
been the subject of speculation since the first
specimens were discovered in the nineteenth
century. Archaeologists speculate that it was
performed to allow evil or unwanted spirits
to escape. More reasonable is a therapeutic
treatment of headaches, fractures, localized
cranial deformities, mental changes,
infections, or convulsions. Another
explanation is a religious one, to acquire the
2  Review of the Literature
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rondelles (the disks of bone obtained from
the  cutting  of  circular  holes  in  the  skulls)
used as amulets or talismans. The findings of
skull fracture suggested also that the
procedure was performed to relieve
intracranial pressure. Three surgical
techniques were used: scraping, drilling, and
cutting (Figure 1). The Neolithic Age
occurred before the introduction of
metallurgy. The holes were made with a
sharp-edged flint scraper or knife, deeper and
deeper until penetration to the dura mater
was accomplished. In ancient Peru, people
used knives of bronze or obsidian. The
wound was covered with a shell, a gourd, or
even  a  piece  of  gold  or  silver.  The  most
common  tool  used  was  the  bow  drill.  The
bow was made of springy wood and had a
leather thong wound around the drill several
times. To perform the procedure, the
operator positioned the drill tip against the
head and bored through the bone. Drilled
holes were usually roughly circular. Holes
made by a knife were typically more square.
A few skulls have had up to five holes, the
longest of which measures two inches across
(205, 217, 247).
Figure 1: Schematic drawing
showing the different skull
trepanation techniques during
the Neolithic era (8000 BC).
(A) The intersecting incisions
to remove a rectangular piece of
skull; (B) Boring and cutting;
(C) Grooving;
(D) Scraping.
Classic Era
Edwin Smith was an American Egyptologist
who bought an ancient papyrus from
Mustapha Aga, a consular agent in Luxor in
1862 (223). Smith died in 1906 and his
daughter gave the papyrus to the New York
Historical Society in 1920. The papyrus was
2  Review of the Literature
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translated in 1922 by James H. Breasted, an
American Egyptologist, and published in two
volumes in 1930. The translation of Edwin
Smith's papyrus is the only medical treatise
of the Pharaonic era, and it reveals how
advanced medical care, especially trauma
surgery, was in ancient Egypt. Edwin Smith's
papyrus describes for the first time cranial
sutures, meninges, the external surface of the
brain, and the cerebrospinal fluid (CSF).
Forty-eight different pathological cases are
presented  with  details  of  the  examination,
diagnosis, treatment, and prognosis. Trauma
cases with neurological symptoms are very
well described; for example, cervical
vertebral dislocation was considered to be
the cause of such symptoms as quadriplegia
and urinary incontinence. Trepanation is not
mentioned in the papyrus (20, 223, 247).
The codification of craniotomy performed
for head injury was first done by Hippocrates
in  5th century BC. The Corpus
Hippocraticum is a systematic review of the
head trauma treatment performed by ancient
physicians. The book describes guidelines
for the treatment of head trauma with
symptoms, techniques, and complications.
The Corpus Hippocraticum remained valid
for 2000 years. Hippocrates advised
performing the craniotomy without delay,
within the first three days of the trauma in
severe contusions. In skull fractures, he
advised removal of the embedded fragments
without lacerating the meninx (217).
Hippocrates was the first to demonstrate that
the  specific  location  of  injury  of  the  skull
was important. Trauma at bregma was
associated with a higher risk of brain injury
than a lesion in the temporal region, which in
turn  was  associated  with  a  higher  risk  of
brain injury than a lesion in the occipital
region. Simple concepts of head injury
location and its prognosis were applied by
the Hippocrates school and were valid for
many centuries.
Celsus was a counselor to the emperors
Tiberius and Caligula. He was not a surgeon
or physician, but a patrician intellectual who
wrote a series of books entitled: De Re
Medicina. Book VIII, Chapter 4 describes an
epidural hematoma. Celsus advised operating
on the patient on the side of greater pain and
placing the trephine where the pain is best
localized. This is the first observation of dura
innervation and its sensitivity to pressure.
Celsus first described how a craniotomy is
performed:  making  a  number  of  holes  and
then connecting them with a hammer and
chisel. Regarding the trephination operation,
Celsus considered it the “ultimum refugium”,
to be applied only when conservative
methods failed.
Galen of Pergamon (AD 129-210) lived
under  the  reign  of  Marcus  Aurelius  (reign
AD 161-180), one of the most powerful and
important emperors of the Roman Empire.
Galen  was  the  physician  of  the  gladiators,
allowing him to treat traumatic injuries. He
2  Review of the Literature
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made important contributions to
neuroanatomical knowledge and
neurosurgical techniques. He was the first to
differentiate between pia and dura mater, and
he provided descriptions of many anatomical
structures, including the corpus callosum,
pineal and pituitary glands, cranial nerves
(he identified seven), and ventricular
systems. Besides neuroanatomical studies, he
provided an extensive description of how the
trephination is performed without lacerating
the dura (85).
Medieval Period
During this period the leading medical
school was in Salerno, Italy. A prominent
leader of this school was Constantinus
Africanus (ca. 1015-1087), known as
“magister orientis et occidentis”. He was
credited for introducing Arabic medicine to
all of Europe. In contrast to the pre-historic
and classic Greek-Roman period, when the
craniotomy was quite frequently performed,
in the Middle Ages this was an exceptional
procedure for Byzantine, Arabic, and Eastern
surgeons. The only procedure performed and
only rarely was trephination (217).
Renaissance and the 18th Century
During  the  Renaissance  the  craniotomy  was
again performed frequently, especially to
treat traumatic head injuries. In the 16th
century,  the  indications  and  surgical
techniques for craniotomy were described in
the most important surgical books. These
books included “Tractatus de fractura calvae
sive cranei” written by Giacomo Berengari
from Carpi, Italy, “Dix Livres de la
Chirugie” by Ambroise Pare’, and “Cirugia
Universale” by Giovanni Andrea Dalla
Croce.  Knowledge  of  the  anatomy  of  the
brain progressively increased, especially in
the  second  half  of  the  17th century with the
studies of Malpighi and Willis (217). During
the 18th century the craniotomy procedure
was performed only in exceptional cases
because of the high incidence of
complications such as infections.
19th Century and the Osteoplastic Craniotomy
In the second half of the 19th century, with
the introduction of general anesthesia, the
introduction of asepsis by Lister, and greater
knowledge of neuroanatomy and
neurophysiology, the craniotomy was not
only performed for trauma cases but also to
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treat intracranial expansive lesions. At the
end of the 19th century, the first operations of
brain tumors are described. Sir William
Macewen (1848-1924) in Glasgow pioneered
the  treatment  of  the  brain  abscess  and  also
other lesions. On July 27, 1879, he removed
a tumor, a meningioma, from the left
olfactory groove. The patient had a good
recovery and was able to return to work in a
few months (7).
In 1894 and 1895, Chipault A.M.J.N, a
French anatomist and assistant of surgery a
la Salpêtrière, Paris, published the
Chirurgie Operatoire du Systeme Nerveux in
two volumes. In the first volume, the history
of cranio-cerebral surgery from the pre-
historic era was reported. The importance of
a small skull opening over the suspected
tumor area was emphasized. The osteoplastic
craniotomy was described. This method was
needed to expose a large area of the brain in
order to localize the neurological disease
without leaving the patient with a big hole in
the skull. Before this, the trepanation
technique was the only one performed and
the small area of bone removed was not
reinserted (145, 245).
The osteoplastic craniotomy was described
in the Chipault volume, but it was first
applied by Wilhelm Wagner (1848-1900), a
chief general surgeon from a small hospital
in Königshütte (Germany) interested in
cranial and spinal injuries (23, 24, 145, 246).
He was a brilliant surgeon who developed,
based on cadaveric dissection, a technique of
elevating the bone flap attached to the
temporal muscle. Wagner met Julies Wolff,
who created and published in 1863 an
experimental work where the osteoplastic
techniques were possible. Julies Wolff
(1836-1902) was an orthopedic surgeon who
graduated from the University of Berlin and
investigated bone remodeling, later inspiring
Wagner (248). Wagner was the first to
perform the osteoplastic craniotomy on a
patient by cutting the bone with a chisel. At
the same time, the Gigli saw by Leonardo
Gigli from Florence (1863-1908) was
introduced and popularized. The Gigli saw
was initially used for cutting the symphysis
pubis and later for performing the
craniotomy (246).
Fedor Krause and the Unilateral Frontal Osteoplastic Craniotomy
Fedor Krause (1857-1937), the chairman of
the surgical department of Augusta Hospital
in Berlin, was the first surgeon in Germany
to  treat  epilepsy.  He  also  was  known  for
innovative skull openings and surgical
approaches. In 1900, he removed a revolver
bullet from the region of the clinoid process
by performing a frontal osteoplastic
craniotomy. Krause was the first to perform a
unilateral subfrontal approach without
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removal of the orbital rim, recommending
this approach to reach pituitary adenomas.
Neurosurgeons worldwide remember Krause
for his famous infratentorial supracerebellar
approach in 1913, but even before this he
was credited with first using the unilateral
frontal osteoplastic craniotomy. He
published his surgical experiences in “Die
Chirurgie des Gehirns und Rückenmarks
nach eigenen Erfahrungen” (Surgery of the
Brain and Spine), in two volumes appearing
in 1908 and 1911 and translated into English,
French, and Spanish (23).
Sir Victor Horsley: From the Transfrontal Route to the Subtemporal Approach
In 1889, Sir Victor Horsley (1857-1916)
performed in London the first pituitary
adenoma operation through a transfrontal
route, sacrificing the frontal veins draining
into the superior sagittal sinus (SSS). The
patient presented with a frontal infarction
documented at autopsy a few years later.
Horsley subsequently abandoned the
transfrontal route for the temporal
craniotomy, reaching the lateral aspect of the
pituitary gland through a subtemporal route.
Once during pituitary surgery by a
subtemporal route, Horsley was forced to
ligate the internal carotid artery (ICA) to
gain access to the tumor (132). Cushing
spent a short time with Horsley in London
and after visiting him stated that:“the
refinements of neurological surgery could
not be learned from Horsley” (86).
Francesco Durante: The First Olfactory Groove Meningioma Surgery through Unilateral
Frontal Osteoplastic Craniotomy
In Rome in 1885, Durante described the first
operation of meningioma removal. Durante
was born in Messina (Sicily) and educated in
Florence, Paris (with Ranvier) and in Berlin
(with Virchow) (88). In the surgical report of
the operation, Durante wrote the following:
“With a chisel and a hammer, layer by layer
a portion of the frontal bone, a part of the
superior internal margin of the orbit was
removed, and an opening about 5 cm2 was
made. In the base I found the inner table to
be  destroyed  up  to  the  external  table.  From
the inner table in the frontal region I
gradually extirpated the tumor with much
care. After having removed the greater part I
found the point of attachment to the dura
mater.  It  was  then  easy  to  remove  all  of  the
extensions of the tumor. These included the
left cranial base of the anterior fossa and part
of the right anterior fossa. I finally arrived at
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the anterior clinoid tubercle of the sella
turcica. In the region of the lamina cribrosa
of  the  left  ethmoid  sinus  there  was  a
prolongation of the tumor that descended
into the ethmoidal cells. After excising the
tumor that was emplanted on the dura mater,
one could observe that the orbital roof was
depressed, but not broken. The left frontal
lobe was replaced by a tumor the size of an
apple. After hemostasis was established and
the  soft  tissues  were  closed  a  drain  was
inserted from the cranial cavity into the left
nasal cavity. The operation lasted about one
hour. The loss of blood was not great. The
patient withstood the chloroform anesthesia
very well. Later she responded and was able
to speak. On the third day after the operation
she had recovered” (63).
Durante utilized the hypophysectomy
method with a pharyngeal approach (64). He
was also instrumental in building the
Policlinico of Rome (88). The end of the 19th
century is the period in which many
neurosurgeons performed brain operations
with poor results (217).
20th Century and the Macrosurgical Period
Cushing and “The Special Field of Neurological Surgery”
Harvey Cushing (1869-1939) spent one year
in Europe (July 1900- August 1901) at the
beginning of his career. He was in Berne,
Switzerland, for five months with
physiologist Hugo Kronecker researching
brainstem control of blood pressure during a
rise in intracranial pressure (Cushing
response). He spent two months in Turin,
Italy, with physiologist Angelo Mosso
studying the same topic, and finally three
months in Liverpool, England, with
physiologist Charles S. Sherrington studying
the motor cortex mapping of anthropoid apes
(86). Returning to USA, Cushing became an
Associate Professor of Surgery at John
Hopkins University, and in 1905 published
in the hospital Bulletin a report entitled “The
Special Field of Neurological Surgery”. The
report includes the following three sections:
The Brain and its Envelopes, The Spinal
Cord, and The Peripheral Nerves. In The
Brain and its Envelopes, he wrote: “ For the
first time aseptic processes had permitted
surgeons to perform craniotomies with a
certain assurance... of operative safety... Not
only has the localization of the more
approachable parts of the cortex –after a long
series of researches culminating in Flechsig’s
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anatomical observations and in the
experimental researches of Sherrington and
his coworkers; -been put on a working basis
for us, but also through the enormous strides
in operative technique, particularly through
Wagner’s osteoplastic method of resection,
we are now able to bring under observation
extensive portions of the cerebral surface”
(43). In the same article, Cushing wrote that
a properly trained neurosurgeon must be his
own clinical and experimental neuroscientist.
Besides general surgical skills, a knowledge
of clinical neurology, neuropathology, and
experimental neurophysiology is essential
not only for proper treatment of the patient
but also to achieve progress in the
neurosurgical field (43). These statements
after almost 100 years remain true. One of
Cushing's  great  contributions  was  to  utilize
the transsphenoidal approach for a pituitary
adenoma in 1909 (86, 132). Cushing
performed the head opening to reach the
ASB through an osteoplastic craniotomy.
Regarding meningioma surgery, he wrote in
1922: “There is today nothing in the whole
realm of surgery more gratifying than the
successful removal of a meningioma with
subsequent perfect functional recovery,
especially should a correct pathological
diagnosis have been previously made” (41).
Cushing was a leader in the development of
neurosurgical procedures, and many
neurosurgeons from around the world
learned from him. In 1910, he wrote another
article “The Special Field of Neurological
Surgery: five years later” where he reported
the following: “Neurological surgery is
fascinating and will long continue an
important and profitable field for intense
cultivation, partly because it has been largely
unworked from an operative standpoint,
partly because it deals with one of the two
most important systems of the body -
nervous and circulatory. It is gratifying to see
that a number of young men are fitting
themselves to specialize in it, with a
preparation which makes envious one who
has wriggled into the subject and, like the
proverbial squid, has left little but a trail of
ink behind him” (42).
Ludvig Puusepp and the First School of Surgical Neurology
Ludwig Puusepp (1875-1942) was born in
Kiev, Ukraine, on December 3, 1875. He
graduated in St. Petersburg, where he
undertook his neurological training with
neurologist Professor Vladimir Bechterew,
who established a special operating room for
the surgical treatment of his patients. The
neurosurgical results were poor and
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Bechterew said: “If today’s neurologists
must still request the help of surgeons, then
the coming generation will no longer need to
do so, for they have sized the scalpel to
perform what legitimately belongs to their
realm”. These words inspired Puusepp to
become a neurologist and surgeon in a new
speciality. He performed his first operation
in 1899. At that time, Puusepp wrote:
“...Today nobody is surprised at the
gynecologist performing operations in his
own field, the ophthalmologist in his own:
only the neurologist is still at the sidelines...
if an operation in his field is necessary, the
neurologist asks for the assistance of a
general surgeon... if nobody asks a surgeon
to remove a cataract from as small an organ
as the eye, how can we then insist on the
surgeon having detailed knowledge of so
complicated a structure as the nervous
system?”
During the year between 1904 and 1905,
Puusepp served as a surgeon in the Russo-
Japanese war, operating on traumatic
injuries. In 1907, he became an Assistant
Professor  at  the  Department  of  Nervous  and
Mental Diseases of the St. Petersburg
Military Medical Academy. In 1907 in St.
Petersburg,  a  Chair  of  Surgical  Neurology
was established, and Puusepp accepted this
post in 1910. This resulted in Puusepp being
the first Professor of Surgical Neurology
worldwide to emerge from a neurological
background. After World War I and the
October Revolution in 1920, Puusepp moved
to his father’s native country (Estonia),
where he was appointed Professor of
Neurology at Tartu University. Until 1940,
Puusepp’s clinic in Tartu was the only center
specialized in neurology and neurosurgery.
Puusepp had a great influence on the Russian
neurosurgical school. In 1917, he wrote the
textbook “Principles of Surgical Neurology”
in Russian. Puusepp is recognized worldwide
as the first neurological surgeon (192).
Otto George Theobald Kiliani and the Bifrontal Osteoplastic Craniotomy
In 1903 in New York, Kiliani operated on a
patient with pituitary apoplexy with an acute
intratumoral hemorrhage. The lesion was
reached through a bifrontal osteoplastic
craniotomy and a subfrontal approach (132).
Louis Linn McArthur and Charles Frazier and the First Fronto-Orbital Osteoplastic
Craniotomy
In 1908, McArthur, in Chicago, performed
the first frontal craniotomy with resection of
the  orbital  rim.  The  approach  to  reach  the
pituitary gland was epidural, with a dura
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opening of 0.5 cm proximal to the chiasmatic
sulcus (155). Charles Frazier (1870-1936), in
Philadelphia, used a frontal extradural
approach and later changed to a frontobasal
intradural approach with resection of the
supraorbital rim and part of the orbital roof,
as previously described by McArthur. This
approach was used to remove large pituitary
adenomas (74) .
Walter Dandy and the Frontotemporal Craniotomy
In 1914, based on a cadaveric study, George
Heuer (1882-1950) of Baltimore, suggested a
new approach to the pituitary region through
the sylvian fissure. This approach differed
from the approach of Krause or Frazier, and
it  was  first  applied  to  a  living  patient  by
Walter Dandy (1886-1946), who was one of
Cushing’s residents. Dandy spent his entire
career at the Johns Hopkins Hospital in
Baltimore and made important contributions
to the fields of pathophysiology and
neuroradiology. The relationship between
Cushing and Dandy was strained, the main
cause  being  Dandy’s  talent.  Dandy
discovered ventriculography and conducted
an important study in cerebrospinal fluid
physiology. He also made important findings
in the treatment of acustic neurinoma and
was the first to perform hemispherectomy to
eradicate an infiltrating glioma in the
nondominant hemisphere (86). He developed
craniotomy techniques, performing the
frontotemporal approach, a large flap used to
treat vascular and neoplastic lesions. Dandy
was credited with performing vascular
surgery with the principle of selective
obliteration of the aneurysm, sparing the
parent artery, and in March 1937 he was the
first to apply a silver clip to the neck of a
posterior communicating artery (PComA)
aneurysm (Figure 2) (45). Dott in 1931 used
the frontotemporal approach for the surgical
treatment of an intracranial aneurysm by
wrapping it with a piece of muscle, but this
approach became popular with Dandy (73).
The frontotemporal approach was used by
Dandy at the beginning of his surgical career
to reach the pituitary region and later to treat
vascular and tumoral lesions.
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Figure 2: Schematic drawing showing the osteoplastic frontotemporal craniotomy performed by Dandy to treat a
PComA aneurysm in 1937 (45).
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The Leadership of Herbert Olivecrona
Herbert Olivecrona (1891-1980) is
considered the father of the European School
of  Neurosurgery  and  one  of  the  founders  of
modern neurosurgery. He started his career
at the Serafimerlasarettet in Stockholm in
1918. One year later, he went to Baltimore to
learn brain tumor surgery with Cushing, and
in 1922 he performed his first tumor
operation. A few years later, in 1927, he
published his early experience in the
treatment of brain tumors (Die Chirurgische
Behandlung der Gehirntumoren: The
Surgical Treatment of Brain Tumors), where
he thoroughly analyzed the possible causes
of surgical complications. In 1935, he
became a Professor of Neurosurgery at the
Karolinska Institute. In 1940 the Karolinska
Hospital was opened, later becoming the
foremost European neurosurgical school
hospital (Figures 3 and 4).
Figure 3: Olivecrona performing an operation at the Karolinska Institute (Courtesy of Professor Lars Kihlström from
the Department of Neurosurgery of Karolinska Institute).
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Figure 4: Neuroanesthesia for posterior cranial fossa surgery (Courtesy of Professor Lars Kihlström from the
Department of Neurosurgery of Karolinska Institute).
The contributions of Olivecrona to the
development of neurosurgical techniques are
several. He emphasized the importance of a
precise preoperative diagnosis of intracranial
lesions. The surgical technique was
performed while taking care to minimize
trauma to the surrounding normal brain, and
he considered perfect hemostasis mandatory
for successful intracranial surgery. In 1930,
Olivecrona introduced use of hydrogen
peroxide solution to stop bleeding from small
vessels in tumor cavities. Olivecrona was a
pioneer in vascular neurosurgery and was the
first to perform the arterio-venous
malformation (AVM) operation (142). In
1935, he published a book entitled
“Parasagittal meningiomas (Die
parasagittalen Meningeome)”. In 1936, he
published his early experience in AVM
surgery in the Gefässmissbildungen und
Gefässgeschwülste des Gehirns (Vascular
Malformations and Vascular Tumors of the
Brain) (107). Olivecrona removed OGM
through an unilateral frontal approach with a
partial lobectomy (174), and in 1946 he
already  had  a  total  experience  of  46  cases
(27). Olivecrona also performed the
osteoplastic craniotomy, especially to reach
lesions of the temporal region (107, 148).
In 1951, Olivecrona wrote down his thoughts
about the development of neurosurgery. He
emphasized advancements in psychiatric
neurosurgery by Egas Moniz and also in
functional neurosurgery. Moreover, he
established the basis for neurosurgical
training, predicting subspecialization by
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subspecialists, which he referred to as
“super-neurosurgeons”. He first posed the
question of whether a neurosurgeon trained
in a specialized field, such as pediatric
neurosurgery, should be allowed to perform
vascular or spinal surgeries (176). This
question is today a pressing reality.
Olivecrona’s pupils became the founders of
European neurosurgery (Figure 5). Early on,
he understood the importance of
collaboration with the departments of
neurology, neuroradiology, and
neurophysiology. In his view, this was the
key to success, and it remains at the basis of
the organizational structure of the Karolinska
University Hospital. In this environment,
Lars  Leksell,  a  pupil  of  Olivecrona's,
developed his stereotactic system for
functional neurosurgery and radiosurgery,
the Leksell Gamma Knife (142).
Figure 5: Olivecrona and his pupils. European directors. First sitting on the right Lars Leksell (1907-1986) and first
on the left Gösta Norlén (1906-1992) (Courtesy of Professor Lars Kihlström from the Department of Neurosurgery of
Karolinska Institute).
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Aarno Snellman and the Craniotomy in Finland
Aarno Snellman (1893-1964) (Figure 6) is
considered the founder of neurosurgery in
Finland. He was a general surgeon at the
beginning  of  the  career,  working  with  Simo
A. Brofeldt (1892-1942), the head of the
Helsinki Surgical Department. Other
surgeons before him who were interested in
neurosurgery included Ali Krogius, Richard
Faltin, and A.J. Palmen. The Ph.D. thesis of
the latter in 1914 was entitled “Features of
Intervertebral Tumor”. Another person
contributing to the field of neurosurgery in
Finland was F. Langenskiöld, who was a
student of Cushing in 1929 (233-235).
Neurosurgical operations were performed in
1932 at the Red Cross Hospital (today Töölö
Hospital) founded by General C.G.E.
Mannerheim (Figures 6-8). His sister Sophie
Mannerheim, a head nurse, founded in
Helsinki the school of nursing at Kirurginen
Hospital.
Figure 6: Aarno Snellmann (in the centre) with the head of the nurse Berrit Kihlman at the Christmas party of the Red
Cross Hospital in 1942. Serious faces: there was a war on, and the previous driving chief surgeon Simo A. Brofeldt
(1892-1942) had died.
Figure 7: Marshal Mannerheim cheering a patient at the Red Cross Hospital in 1942.
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Figure 8: The Red Cross Hospital (later Töölö Hospital) in 1932.
In spring 1935, Snellman went to the
Serafimer Hospital of Karolinska Institute,
Stockholm, Sweden, to study with
Olivecrona for almost six months. When he
returned to Finland, he performed the first
neurosurgical operation (September 18,
1935). Thus, the neurosurgical department
was launched at the Red Cross Hospital, and
it was the only neurosurgical department in
Finland until 1967. After Snellman, S.G.L. af
Björkesten (1912-1974), a talented and
brilliant neurosurgeon, became the chairman
of the Helsinki Department of Neurosurgery
on February 1, 1963. He spent six months
with Olivecrona in 1952. After af Björkesten,
Henry Troupp (1932- ) became the chairman
of the Helsinki Department of Neurosurgery
in 1976 (233-235). The craniotomy used by
Snellman  and  later  by  af  Björkesten  and
Troupp  for  vascular  or  neoplastic  lesions  of
the anterior skull base was a large
frontotemporal craniotomy (Figures 9-13).
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Figure 9: On the left Professor Snellman washing the head of a patient in 1953; the anesthetist was Mirja Tappura.
She was the first anesthetist of Töölö Hospital and became the first head of anesthesiology of the hospital. In 1964
she moved to Tampere. On the right af Björkesten (assistant) and Snellman together performing a neurosurgical
operation in 1953.
Figure 10: On the left: sister Laina (Moisio), Professors Snellman and af Björkesten performing a neurosurgical
operation. Notice the basic equipment for keeping warm the saline solution for flushing the wound. On the right
Professors Troupp (assistant, left), af Björkesten (surgeon, centre) and Snellman (spectator, right) during a
neurosurgical operation.
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Figure 11: Left picture: Professor af Björkesten in 1960. He became Professor in 1963. Right picture: Professor
Troupp, young medical student, suturing a patient wound in 1955, twenty-one years before his Professorship. In the
picture sister Maire (Reuna) assisting from the outpatient clinic ward .
Figure 12: Anterior-posterior conventional angiography (left) and lateral (right) view showing a large right frontal
craniotomy (arrows) for aneurysm surgery.
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Figure 13: Transcript of the operation report for an aneurysm surgery performed by Professor af Björkesten on
August 12, 1957.
Present state. General condition. No heart or pulmonary problems. RR 110/70. No gastric problems. Teeth cared for.
Neurologic status:
5.8.-57 (af Björkesten) Verified subarachnoidal bleeding, symptom-free, except for headache more on the right side
of the head. Routine examinations.
6.8.57. Image of the skull: no obvious abnormalities.
            EEG: Arrhythmia not classified (labilitas functionis).
           Angiography (Left internal carotid) No pathology.
12.8.57. Ligatura aneurysmatis
      af Björkesten (1st operator) – Troupp (assistant) – Valtonen (assistant) – Kerttu (instrument nurse)
      Intubation + hypotension Virkkala (anesthetist)
Right side Dandy modified skin incision. Bone removed in an osteoplastic flap. Intracranially, pressure reduced well
when the lumbar drainage was opened. Dura was opened medially. Under the right frontal lobe are exposed the optic
nerve and internal carotid. After opening the arachnoid on the lateral side of the carotid artery is exposed the base of
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the aneurysm, which is located in the central part of the bifurcation. Without major complications, I sutured below the
central part of the aneurysm, but the suture slipped away from the aneurysm base, making the operation more
difficult. Also close to the aneurysm and below but more on the medial side was a second vessel (choroid artery?),
which could not be dissected from the neck. It would have been mandatory to close both vessels at the same time,
hiding the carotid from everything. Thus, the suture attempt was abandoned. I prepared a small opening in the
aneurysm base and at the periphery of the angle between the carotid and the opening. A different silver staple was
applied on the neck of the aneurysm. This was done without bleeding; the clip was located well, and if it would be
seen all the aneurysm neck bridging compressed.
There was no bleeding. Dura suture with silk, suture of the periosteum with silk, and the central suture of the bone
with flax. The bone was fixed with two metallic sutures. Muscles, galea, and skin suture.
The patient woke up after the operation. Condition was good, no paresis.
20th Century and the Microsurgical Leadership of Yaargil
The microsurgical era in neurosurgery
started with the use of the operative
microscope. In the 1950s, Theodore Kurze
(1922-2002), a neurosurgeon of the
University  of  Southern  California,  Los
Angeles, recognized the surgical microscope
as an important instrument in acoustic
neurinoma surgery. In 1957, he performed
the first craniotomy on a human being under
the microscope (61). Thereafter, the use of
the microscope became increasingly frequent
worldwide.
Microneurosurgical techniques introduced by
Yaargil (1925- ) revolutionized the
neurosurgical field.  Yaargil worked at the
University Hospital of Zurich for 40 years.
He started his training in 1953 with Hugo
Krayenbühl (1902-1985). At the beginning
of his career, between 1958 and 1965,
Yaargil was active in the field of cerebral
angiography and functional neurosurgery.
In  1965,  he  went  to  learn  the
microneurosurgical techniques at the
University of Vermont, Burlington,
Vermont, where Jacobson and Donaghy
established the first microvascular training
laboratory in 1958. During his training he
learned how to perform microsutures on
animal vessels and how to use bipolar
coagulation. Upon using bipolar forceps,
Yaargil was certain that microsurgical
techniques were possible (258). He returned
to Zurich, where he developed his own
microneurosurgical instruments between
1967 and 1993. The routine use of
microneurosurgery began on January 18,
1967, and on October 30, 1967 the first
extracranial-intracranial bypass was
performed. Milestone microneurosurgical
principles of Yaargil were based on
cisternal approaches and on the knowledge
of bipolar coagulation techniques (257).
Zurich became the world center for learning
microneurosurgical techniques; more than
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3000 foreign neurosurgeons traveled here to
learn these techniques, among them the
present Professor and Chairman of Helsinki
Neurosurgery Department, Juha
Hernesniemi. Yaargil wrote in his
biography that all visiting colleagues from
abroad were stimulating with their criticism,
improving the microneurosurgical techniques
(258). After his retirement in 1993, Yaargil
analyzed the data collected during his years
in  Zurich  and  wrote  volumes  IVA  and  IVB
of Microneurosurgery, where he described
the microsurgical principles for performing
anterior skull base meningioma surgery
through pterional craniotomy and the
transsylvian approach (258); his
microsurgical techniques are still used today,
routinely applied worldwide.
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Microsurgical Anatomy of Anterior Skull Base
Bone Structures
Anterior Cranial Fossa
The skull is divided into the cranium and the
facial skeleton. The cranium is further
divided into the calvarium and the cranial
base (194). The calvarium or calvaria (from
latin calva: bald, plural calvariae) is the
upper part of the cranium and surrounds the
cranial cavity containing the brain. The
calvarium is formed by the following bones:
frontal, parietal, temporal, and occipital. The
cranial base has an exocranial and
endocranial surface. Both of these surfaces
are divided into three regions: anterior,
middle, and posterior.
The anterior cranial fossa (ACF) is the
endocranial surface of the skull, bordered
posteriorly by the sphenoid ridge and joined
medially by the chiasmatic sulcus.
Lamina Cribrosa of the Ethmoid Bone
The  floor  of  the  ACF  is  formed  by  the
frontal, ethmoid, and sphenoid bones. Frontal
and sphenoid bones roof the orbits. At the
midline anterior to the ethmoid, a ridge: the
frontal crest, is formed by the frontal bones
(134). Located between the frontal bones, at
the ACF, is the ethmoid bone, including the
crista  galli  and  the  cribriform  plate.  The
crista galli and the frontal ridge are the
anterior attachment of the falx cerebri (134,
194).
The ACF is not flat, and this is important for
surgery. The lowest part is the cribriform
plate; this is part of the nasal cavity roof and
contains olfactory bulbs and the anterior and
posterior ethmoidal foramens. Through these
two foramens run the anterior and posterior
ethmoidal arteries and veins. Many holes are
present in the cribriform plate for the
filaments of the olfactory nerve; they are
covered by dura mater and arachnoid
membrane.
Between the frontal ridge and the crista galli
is a small hole: the foramen cecum, where a
small vein comes from the nasal cavity
reaching the SSS. The chiasmatic sulcus and
the  sphenoid  ridge  separate  the  anterior
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cranial fossa from the middle cranial fossa.
The distance from the foramen cecum to the
frontosphenoidal suture is about 3 cm, and
this is the area where OGMs originate (134,
209).
Olfactory Fossa
Olfactory epithelium is located at the roof of
the nasal cavity, in the superior nasal
conchae, and in the nasal septum. The nerve
fibers pierce the cribriform plate to synapse
in the olfactory bulb, which appears as an
ovoid structure located in the olfactory
groove of the cribriform plate. The olfactory
groove is covered by dura mater and
averages 15 mm in length and 5 mm in
width. The olfactory bulb averages 12 mm in
length and 5 mm in width. The olfactory
tract averages 3 cm in length (26).
The posterior part of the olfactory tract has a
triangular section with three crests: internal,
external, and superior. Right and left
olfactory tracts run under the surface of the
inferior frontal lobes, extending to the
olfactory areas (26, 133, 177). Approaches to
the anterior cranial base can involve the
transection of the nerves to gain access to the
posterior part of the anterior skull base; an
osteotomy around the cribriform plate
includes all of the olfactory nerves that exit
the skull base (47). Nerve fibers piercing the
cribriform plate are very fragile and often are
injured by the slightest manipulation.
Sphenoid Bone
The central portion of the sphenoid bone is
the pituitary fossa, which is limited by the
tuberculum  sellae  anteriorly,  the  dorsum
sellae posteriorly, and the diaphragma sellae
superiorly. This is the dura covering the
pituitary gland with a small central opening
for  the  pituitary  stalk  (195).  This  layer  of
dura extends from the posterior clinoid
processes to the tuberculum sellae. The
tuberculum sellae is an osseous protuberance
between the chiasmatic sulcus and the
anterosuperior limit of the pituitary fossa
(Figure 14). The chiasmatic sulcus is a
shallow depression between the optic
foramina, bounded posteriorly by the
tuberculum sellae and anteriorly by the
planum sphenoidalis. It is located anterior to
the optic chiasm, explaining the early
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diagnosis of TSM due to a visual deficit. The
limbus sphenoidalis is the small area
between the planum sphenoidalis and the
chiasmatic sulcus. The planum sphenoidalis
is the smooth surface of the medial portion of
the lesser sphenoid wings that is in contact
with olfactory tracts, the gyrus rectus, and
the posterior portion of the frontal lobe. The
dura maters of the planum sphenoidalis,
limbus sphenoidalis, chiasmatic sulcus,
tuberculum sellae, and diaphragma sellae are
all  sphenoidal  structures  from which  a  TSM
can originate (133). Except for the dura of
the diaphragma sellae, all other dura
locations can be removed, achieving
Simpson grade 1.
Figure 14: The planum sphenoidalis, chiasmatic sulcus, tuberculum sellae, sella turcica, and dorsum sellae of a skull
specimen.
Superior Orbital Fissure
The superior orbital fissure (SOF) is located
between the less and greater sphenoid wings.
Passing through this foramen are the
oculomotor, trochlear, abducens, and
ophthalmic nerves and the ophthalmic veins.
The SOF is located laterally and inferiorly to
the  anterior  clinoid  process  (ACP),  and  it  is
opened to expose the cavernous sinus
structures (194).
Anterior Clinoid Process
The ACP is the medial part of the lesser
sphenoid wing and covers the lateral part of
the optic canal (194). Together with the
orbital part of the frontal bone, the ACP
covers the orbital roof and the lateral part of
the optic canal. The ACP is an important
zone  of  dural  attachment  for  the  falciform
ligament, extending from the ACP to the
planum sphenoidale and covering the roof of
the optic canal. The orbital roof and the ACP
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can be pneumatized from the extension of
ethmoidal and sphenoid sinuses, and this
must be borne in mind when removing the
ACP (209).
Vascular and Dural Structures
Ophthalmic Segment of the ICA and Dural Rings
The ICAs are located on both sides of the
sphenoid bone, whereas the basilar artery
(BA) lies against the posterior surface of the
sphenoid bone. Both ICAs, their perforators,
and all arteries forming the circle of Willis
may be encased or dislocated by a
meningioma originating from the ACF.
The  ICA  coming  from  the  cavernous  sinus
makes the extradural and extracavernous
anterior loop (C3 segment) between the
proximal and distal rings inferomedial to the
ACP.
The lateral wall of the cavernous sinus is
formed by the superficial and inner dural
layers. These two layers separate at the
anterior portion of the cavernous sinus: the
inner layer running inferior to the ACP and
surrounding  the  C3  segment  of  the  ICA
forms the proximal ring, which is the roof of
the anterior cavernous sinus; the superficial
layer covering the superior surface of the
ACP  envelops  the  ICA  and  forms  the  distal
ring. Anterior clinoidectomy is necessary to
expose this segment of the ICA. Intradural
segments of the ICA begin from the distal
ring:  the  C2  segment  consists  of  the  ICA
between the distal ring and origin of the
PComA and is also called the ophthalmic
segment  of  the  ICA  (52);  the  C1  segment
arises  from  the  origin  of  the  PComA  and
extends to the ICA bifurcation (253). The
ophthalmic segment of the ICA presents
several branches. The largest is the
ophthalmic artery (OA) arising from the
dorsal or dorsomedial surface of the ICA just
as it penetrates the intradural space. The OA
originates below the optic nerve and extends
to the optic canal. Anterior clinoidectomy is
mandatory for proper exposure of the OA
and ophthalmic segment of the ICA. The
superior hypophyseal artery is another
important perforator arising from the medial
or inferomedial surface of the ophthalmic
segment of the ICA just before the origin of
the PComA (52). This perforator may have a
horizontal direction or may ascend or
descend; it supplies the optic nerve and
chiasm, the superior aspect of the pituitary
gland and stalk, and the dura around the
cavernous sinus (Figure 15) (52, 195).
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Figure 15: Schematic drawing showing the internal carotid arteries, ophthalmic arteries and superior hypophyseal
arteries.
Arterial Supply to the Dura Mater of the Anterior Cranial Fossa
The dura of the ACF has many invaginations
and is rather thick everywhere except in the
region of the cribriform plates. The medial
part of the dura is supplied by branches of
the ethmoidal arteries, and the lateral parts
by frontal branches of the middle meningeal
artery.
Anterior and posterior ethmoidal arteries
(AEAs; PEAs) originate from the OA, are
the predominant vascular support of the ACF
dura  and  of  the  olfactory  bulb  and  tract  and
form the main supply to the OGM.
The anterior skull base receives vascular
supply from the ethmoidal arteries, and
consequently their coagulation, necessary
during  the  removal  of  OGM,  results  in
ischemic damage to the olfactory nerve. The
external carotid artery (ECA) and ICA
anastomose via the frontal branch of the
middle meningeal artery (MMA), which
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connects the ethmoidal branches of the OA (47, 67, 134, 194).
Arterial Supply to the Dura of the Anterior Clinoid Process
The ACP is the medial part of the lesser
wing of the sphenoid bone. With the orbital
part of the frontal bone, the ACP covers the
orbital roof and the lateral part of the optic
canal. Important dural attachments to the
ACP are a) the anteromedial portion of the
tentorium with the anterior and posterior
petroclinoid folds and the interclinoid folds
and b) the falciform ligament extending from
the ACP to the planum sphenoidale covering
the roof of the optic canal. These dural
structures receive their main vascular supply
from the OA and from its branches, the
ethmoidal arteries (194).
The optic nerve proximal to its entrance to
the optic canal may be covered by the
falciform ligament for a length varying
between 1 mm and 1 cm (195). The main
vascular supply for the optic nerve comes
from the superior hypophyseal arteries, and
care should be taken to avoid damaging
them,  as  this  may  lead  to  ischemia  of  the
optic nerve (241).
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“… non ragioniam di lor, ma guarda e passa”.
Dante, The Divine Comedy, Inferno Canto III: 51
Classical Approaches to Anterior Skull Base
Pterional Approach
The frontotemporal approach applied by
Dandy and Dott was later popularized by
Yaargil. In Microneurosurgery volume I,
Yaargil described the technique of the
interfascial pterional craniotomy. The head
of the patient is elevated slightly, rotated
about 30° to the contralateral side, with the
direction of the head around 20° vertex
down.  The  frontal  lobe  falls  away  from  the
orbital roof and the sphenoid ridge is
directed vertically in the operating field. The
skin incision begins 1 cm superior to the
anterior aspect of the auricle extending to the
temporal crest in a direction perpendicular to
the zygoma. Retraction of the temporal
muscle and fascia is done through an
interfascial approach. Burr holes are located
1) superior to the frontal zygomatic suture
under the linea temporalis; 2) at the frontal
bone 3-4 cm superior to the first burr hole
and 1-2 cm above the orbital rim, avoiding
the frontal sinus; 3) along the linea
temporalis; and 4) in the squamous temporal
bone (Figure 16). The sphenoid ridge is
flattened with a drill,  and the purpose of the
approach is to have the sylvian fissure in the
middle of the opening. Advantages of the
pterional  approach  are  to  spare  the  SSS and
frontal cortical veins, to avoid compressing
the frontal lobes, and simultaneously to
allow  the  surgeon  to  visualize  the  anterior
circulation, the basal feeders, and the optic
nerve and chiasm. This approach was used
by Yaargil to treat aneurysms of the anterior
circulation and upper basilar region and all
tumors  of  the  sellar  and  parasellar  regions
(256).
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Figure 16: 3D-CT skull reconstruction and schematic drawing showing the pterional craniotomy described by
Yaargil (256).
Fronto-Orbital and Fronto-Orbitozygomatic Approaches
Jane in 1982 (114) described a modification
of the frontal craniotomy applied first by
McArthur in 1912 and Frazier in 1913 to
reach the pituitary region (74, 155). The
technique consisted in a bicoronal skin
incision to expose the supraorbital nerve and
artery,  which  are  often  sacrificed.  Two  burr
holes are made: one at the midline, at the
level of the orbital ridge, and the other just
behind the arch of the zygomatic process
(Figure 17). Both burr holes are connected
by using a Gigli saw, nowadays replaced by
a high-speed drill, including the superior
orbital rim and part of the orbital roof. Three
or four centimeters of the orbital roof can be
removed by using rongeurs. Through this
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approach, the brain retraction to reach the
sella turcica or the anterior cerebral artery
(ACA) complex is minimal. Jane's approach
removes  the  frontal  and  orbital  rim  in  one
bone fragment; the disadvantage of the
technique with frequent opening of the
frontal sinus is often the sacrifice of the
supraorbital nerve and artery with CSF
leakage and disappearance of the frontal
wrinkles .
This approach is recommended by Al-Mefty
and  Sekhar  when  treating  OGM,  ACM,  and
TSM (3-6, 208, 209). Al-Mefty stresses the
following advantages: 1) minimal brain
retraction; 2) access to the tumor via
different routes (subfrontal, subtemporal,
transsylvian);  3)  ability  to  enter  the
cavernous sinus if needed; and 4) possibility
for early interruption of the tumor blood
supply through the sphenoid ridge for ACM
and TSM (3, 5, 6). Haddad and Al-Mefty
recommend using spinal drainage to achieve
a slack brain (91). Sekhar recommend a CSF
drain or the direct opening of the basal
cisterns to release CSF during subfrontal
dissection; furosemide or mannitol can be
used if necessary (210). Sade and Lee
recommend a cranio-orbital approach
associated with extradural clinoidectomy and
opening of the falciform ligament before
ACM removal to decompress the optic nerve
even if the meningioma is not in the optic
canal (203). Risi et al. reported a series of 34
ACM patients with complete removal of the
sphenoid wing, including the anterior clinoid
and part of the planum sphenoidalis, with
early devascularization of the tumor and
minimal brain retraction when resecting the
zygomatic arch (196).
Figure 17: 3D-CT skull
reconstruction and schematic
drawing showing the cranio-
orbitozygomatic approach
(114).
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Bifrontal Approach
The bifrontal craniotomy allows the access to
the ASB through an interhemispheric
approach. The technique consists in a
bicoronal  skin  incision,  the  burr  holes  are
located behind the arch of the zygomatic
process and frontally paramedian and
anterior to the coronal suture (Figure 18).
The advantage of the interhemispheric route
is early access to the anterior cerebral
arteries and the optic nerves without opening
the frontal sinus, but care must be taken to
preserve the SSS and the bridging veins
(154). The frontal sinus is always opened
through this approach and can be sealed with
a flap of pericranial tissue. To completely
remove the tumor, the dura of the skull base
should be accessed with opening of the
ethmoid sinus, and reconstruction of the
cribriform  plate  is  covered  with  a  graft  of
pericranial tissue and Gelfoam to prevent a
CSF leak.
In the microsurgical technique of Sugita, the
bifrontal craniotomy is preferred for TSM
surgery  to  avoid  brain  retraction.  After
craniotomy, the anterior portion of the tumor
is removed, and after partial removal the
attachment to the optic nerves can be
dissected. Following the arachnoidal plane,
the tumor is removed and a small piece can
be left attached to the optic nerve to prevent
visual function worsening. Sugita affirmed
that large TSMs can be removed also
through a unilateral frontal craniotomy, but
the bilateral approach is preferred because of
the larger operating field and less brain
retraction (220).
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Figure 18: 3D-CT skull reconstruction and schematic drawing showing the bifrontal craniotomy.
Frontolateral Approach
Al-Mefty and Babu recommended a
unilateral frontal craniotomy with orbital
osteotomy to prevent bifrontal retraction,
leading to possible mental changes (4, 5). A
recent anatomical study compares surgical
exposure of the pterional, orbitozygomatic,
and minisupraorbital approaches. The
authors concluded that the minisupraorbital
approach with removal of the orbital rim
gives a similar surgical view as the pterional
and orbitozygomatic approaches. Inclusion
of orbital osteotomy is not necessary or
beneficial to reach and remove the ASB (71).
A recent cadaveric study compares the
pterional approach with the lateral
supraorbital approach; the authors concluded
that both approaches provide similar
exposure  to  the  sellar,  suprasellar,  and
anterior communicating artery (AComA)
areas (204). The authors further concluded
that the pterional approach gives better
exposure  of  the  retrosellar  area.  In  our
opinion, the LSO approach also gives good
exposure to this region.
Samii after extensive skull base surgery
experience came to the conclusion that the
frontolateral approach (without orbital
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inclusion) is sufficient to reach and properly treat ACF lesions (159, 161).
Meningiomas: General Concepts
Meningioma is a term first used by Cushing
in 1922 to describe a benign tumor
originating from the meninges of the central
nervous system. Meningiomas are derived
from the neuroectoderm and arise from
arachnoidal cap cells. Meningiomas account
for 10-15% of all brain tumors (7). They are
the most frequent brain tumors originating
from non-neuroepithelial progenitor cells.
Usually, they are benign and completely
resectable. Although they can potentially
occur at any site in the meninges, certain
intracranial locations are more common than
others; parasagittal, attached to the falx, over
the cerebral convexities, in the olfactory
groove, on the tuberculum sellae, along the
sphenoid ridge, in the cerebellopontine
angle, along the clivus, and at the foramen
magnum. Most meningiomas are well-
demarcated, round or oval, frequently
lobulated attached to the dura. In a minority
of meningiomas a dural attachment cannot be
shown. The benign meningioma tend to
compress the brain but not invade it (219).
Approximately 15 % of meningiomas have
atypical features. Aggressive or malignant
meningiomas are characterized by abundant
mitosis and invasion into brain tissue. Less
than 0.1% of meningiomas can metastatize to
extracranial sites such as the lung, liver,
pleura, and lymph nodes. Their etiology
remains unknown and may be multifactorial,
environmental (head trauma, viruses,
radiation) or genetic (chromosome 22
deletions, neurofibromatosis type 2) (19,
189).
General Principles of Meningioma Surgery
The treatment options of meningiomas are
surgery, radiotherapy or a combination of the
two. The goal of surgery depends upon
meningioma location and the patient's
clinical condition. Complete resection
involves removal of the dura and the bone
from which the tumor originates. The
surgical approaches are selected according to
the tumor location. Especially for ASB
meningioma, a small approach can be
enough to completely remove the lesion. The
major vascular supply of meningiomas
comes from the dural attachment, but in
larger meningiomas there can be also feeders
from  the  surrounding  arteries.  The  first  step
in meningioma surgery is to devascularize
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the tumor with high power coagulation and
after that to debulk it. A large meningioma is
debulked with the help of ultrasonic aspirator
and after that it is gradually dissected from
the surrounding cerebrovascular structures;
small meningioma can be removed en-block
after dura coagulation (137). Simpson in
1957 (212) established four grades of
meningioma resection grade I: complete
meningioma resection with the dura and
underlying bone; grade II: complete
meningioma removal with coagulation of the
dural attachment; grade III: complete
meningioma removal without resection or
coagulation of dural attachments; grade IV:
subtotal resection. This classification is very
useful  in  evaluating  tumor  recurrence.  In
Simpson’s series, grades I through IV had
recurrence rates of 9%, 19%, 29%, and 40%,
respectively, at 10 years. Jääskeläinen et al.
(111) analyzed 657 meningioma patients
over a 20-year period; the overall recurrence
rate was 19%. Risk factors for recurrence
were simple coagulation of the tumor base,
invasion of bone, and soft tumor consistency.
Mirimanoff et al. (156) reviewed 225
patients operated on from 1962 to 1980 and
found that the degree of resection is the most
important factor in recurrence. After subtotal
resection, 37% of tumors had progressed in 5
years, 55% in 10 years, and 91% in 15 years.
Radiation therapy can arrest the growth of
some meningiomas. The indication for their
use includes: residual tumor after surgery,
tumor recurrence, meningioma that could not
be treated surgically and malignant lesions
(172).
Clinical Characteristics of Olfactory Groove, Anterior Clinoidal, and
Tuberculum Sellae Meningiomas
OGMs account for 8-13% of all intracranial
meningiomas (159). They arise at the
cribriform plate of the ethmoid bone and at
the frontosphenoidal suture at the midline of
the ACF (37, 209, 236). They are usually
diagnosed when they reach a large size
(173). The most frequent symptom of
patients with OGMs is mental change,
followed by headache, visual deficit, hypo-
anosmia, and epileptic seizures (14, 159,
173).
ACMs are frequently attached to, or even
encasing, adjacent neurovascular structures
of the anterior skull base, making the
complete  removal  challenge  (5).  ACMs
account for less than 10% of supratentorial
meningiomas and they were first described
by Frotscher and Becker in 1910 in an
autopsy of a 72-year-old man (75). In the
past, they were often included in the group of
sphenoidal meningiomas, masking their true
surgical and clinical outcome (179). Medial
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sphenoid wing meningiomas form a different
group of meningiomas, growing mainly
towards the temporal lobe in the medial
cranial fossa and frequently infiltrating the
cavernous sinus. We consider ACMs to be
meningiomas that originate from the dura of
the inferior, superior, and lateral aspects of
the ACP and grow cranially or into the optic
foramen. A recent report defines clinoidal
meningiomas as those that have the epicenter
of  the  tumor  base  on  the  ACP  and  grow
upwards, forming a small peduncle (179).
However, in large meningiomas, invasion to
such surrounding structures as the sellar
region,  cavernous  sinus,  and  the  temporal
portion of the medial sphenoid ridge makes it
difficult to define origin before resection. In
these cases, typical tumor shape and location
of ACP in the center of the lesion usually
reveal that the tumor belongs to the ACM
group.
TSMs comprise 5-10% of intracranial
meningiomas (40, 161, 214). Their location
is challenging because of adjacency to
neurovascular structures of the anterior skull
base. Despite this, their microsurgical
treatment today shows favorable results
because visual field deficits usually lead to
diagnosis at a stage when the tumor is still
small (151). Cushing and Eisenhardt (1938),
in describing their series of 28 suprasellar
meningiomas, wrote: “... Few promise in the
future to be easily recognized while still of
small size” (40). However, with improved
imaging and the introduction of
microsurgical techniques, the outcome is
good. TSMs form a subgroup of
meningiomas often contained within the
group of suprasellar meningiomas, which
also includes anterior and posterior clinoid
process, planum sphenoidalis, olfactory
groove, optic foramen, and diaphragma
sellae meningiomas (40, 112, 115, 161).
Cushing and Eisenhardt, in their first
classification, did not differentiate between
TSMs and diaphragma sellae meningiomas.
This differentiation was introduced by Kinjo
et al. in 1995 (125), when they reported 12
cases of diaphragma sellae meningiomas.
However, from the microsurgical point of
view,  we do  not  consider  diaphragma sellae
meningiomas to form a clearly different
entity and include them as TSMs, defined as
those meningiomas originating from the dura
of the tuberculum sellae, prechiasmal sulcus,
diaphragma sellae, limbus sphenoidalis, and
planum sphenoidalis and growing upwards
with the main location over the sella (117).
In large meningiomas, invasion to the
surrounding structures, anterior clinoid
processes, cavernous sinus, and the temporal
portion of the medial sphenoid ridge makes it
difficult to define origin before resection. In
these  cases,  typical  tumor  shape  and  main
location over the sella reveal that the
meningioma belongs to the TSMs.
Contrary to OGMs, which are diagnosed
when large-sized, ACMs and TSMs, because
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of their close relationship to the optic nerve
and chiasm, are diagnosed when they are
small, and the most frequent symptom is
visual impairment, followed by headache,
epileptic seizures, and endocrinological
symptoms (16, 173). A report written in
1959 by neurosurgeon Olli Heiskanen of the
Helsinki Neurosurgical Department
describes 14 anterior clinoidal meningioma
cases; 11 presented with headache, eight
with visual deficit, six with epilepsy, four
with exophtalmus, and two with diplopia
(98).
Microsurgical Treatment of OGM, ACM, and TSM through Classical Surgical
Approaches
Olfactory Groove Meningiomas
Italian surgeons were pioneers in treating
intracranial meningiomas, and the first
successful surgical removal of an intracranial
meningioma was performed in 1835 by
Pecchioli, a Professor of Surgery at the
University of Siena (80). The first surgical
report of an OGM comes from Francesco
Durante in Rome (88). In 1885, he
performed a resection of an olfactory
meningioma through a left subfrontal
approach; the patient had a good outcome
(63, 64). Harvey Cushing published in 1938
his lifetime experience of 29 patients with
OGMs operated on via a unilateral frontal
craniotomy  (40).  In  the  same  year,  Dandy
published a bifrontal approach to treat OGMs
with partial bilateral lobectomy (44). In
1935, Olivecrona operated on an OGM
through a unilateral frontal craniotomy and
partial frontal lobectomy (174). Tönnis
reported in 1938 a bifrontal approach with
closure of the anterior portion of the SSS, but
preservation of the frontal lobe (232). Kempe
proposed a unilateral approach by pterional
route, allowing dissection of the posterior
part of the lesion, thereby preserving
neurovascular structures and avoiding brain
retraction and opening of the frontal sinus
(122). The bifrontal craniotomy with orbital
removal/transbasal extension was defined by
Derome in 1972 (56). In the same year,
Bakay  reported  a  personal  series  of  25
olfactory meningiomas: 12 cases were
treated by using a unilateral frontal approach
and 13 cases by using bifrontal craniotomy
(13).
After these important initial surgical reports,
several authors have published their
operative experience, macro- or
microsurgical, in the management of OGMs
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using unilateral (12, 57, 96, 97, 122, 159,
169, 184, 206, 214, 216, 236-238, 254, 255)
or bilateral approaches (12, 14, 55, 65, 79,
94, 96, 97, 99, 120, 122, 131, 146, 147, 150,
154, 157, 159, 162, 173, 184, 187, 200, 206,
211, 214, 216, 229).
Table 1. Macro- and microsurgical series of OGM surgeries through different approaches.
Author(s), year  (reference) Approach
Death or morbidity/operations
(mortality or morbidity)
Macrosurgery
Durante F., 1885 (63) unilateral subfrontal 0/1 (no mortality)
Dandy W., 1938 (44) bifrontal with bifrontal polar
lobectomy
NA
Cushing H. and Eisenhardt L., 1938
(40)
unilateral frontal with partial bifrontal
lobectomy
8/29 (mortality)
Tönnis W., 1938 (232) bifrontal without frontal
lobectomy
0/3 (no mortality)
Olivecrona H., 1946 (27) unilateral frontal NA/46
Bakay L. and Cares H.L., 1972 (13) unilateral frontal
bifrontal
1/12 (mortality)
2/13 (mortality)
Microsurgery
Yaargil M.G., 1996 (255) pterional-transsylvian 0/14 (no mortality)
Yamashita J. et al., 1980 (250) NA 6/30 (mortality)
Rubin G. et al., 1995 (200) bifrontal; pterional; unilateral frontal 6/67 (mortality)
Ojemann R.G., 1996 (172) bifrontal 1/19 (mortality)
Gerber M. et al., 1998 (79) bifrontal 0/1 (no mortality)
Paterniti S. et al., 1999 (184) pterional 2/20 (mortality)
Turazzi S. et al., 1999 (238) pterional 1/37 (mortality)
Tuna M. et al., 1999 (237) NA 0/15 (no mortality)
D’Avella D. et al., 1999 (57) pterional 0/6 (no mortality)
El Gindi S., 2000 (65) bifrontal 0/25 (no mortality)
Couldwell W.T. and Weiss M.H.,
2000 (37)
bifrontal NA
Hallacq P. et al., 2001 (94) transsinusal bifrontal osteoplastic 0/6 (no mortality)
Wei C.P. et al., 2002 (243) bifrontal 0/1 (no mortality)
Obeid F. and Al-Mefty O., 2003
(169)
supraorbital subfrontal (uni-bilateral)   0/15 (no mortality)
Dolenc V.V., 2003 (59) pterional 7/157 (morbidity)
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Hentschel S.J. et al., 2003 (99) bifrontal 0/13 (no mortality)
Tuna H. et al., 2004 (236) bifrontal
pterional
0/19 (no mortality)
0/6 (no mortality)
Spektor S. et al., 2005 (216) bifrontal
unilateral subfrontal
pterional
fronto-orbital
subcranial
1/35 (mortality)
0/9 (no mortality)
0/18 (no mortality)
0/7 (no mortality)
0/12 (no mortality)
Reisch R. and Perneczky A. at al.,
2005 (193)
supraorbital subfrontal 0/21 (no mortality)
Tella Jr. O.I. et al., 2006 (229) uni-bifrontal 1/13 (mortality)
Bassiouni H. et al., 2007 (14) bifrontal
pterional
unilateral frontal
supraorbital
3/36 (mortality)
0/13 (no mortality)
0/4  (no mortality)
0/3  (no mortality)
Kanno T., 2007 (120) bifrontal NA
O’Brien D. et al., 2007 (168) frontal craniotomy 0/1 (no mortality)
Welge-Luessen A. et al., 2007 (244) bifrontal and frontal 0/12 (no mortality)
Colli B.O. et al. 2007 (34) bifrontal-uniorbital 2/17 (mortality)
Nakamura M. et al., 2007 (159) bifrontal
frontolateral
pterional
3/46 (mortality)
0/34 (no mortality)
0/2 (no mortality)
Gazzeri R. et al., 2008 (78) bifrontal 0/36 (no mortality)
El-Bahy K. et al., 2009 (66) frontolateral 1/18 (mortality)
Warren L.W. and Grant G.A., 2009
(242)
fronto-orbitozygomatic 0/4 (no mortality)
For OGM surgery, Yaargil recommended
understanding the relationship between the
posterior surface of the tumor and the ACA
and optic nerves. The tumor must be
debulked  from  its  lateral  portion  and
devascularized from its base. The ACA can
be dissected along the lamina terminalis
cistern (254, 255).
Hassler  and  Zenter  first  reported  in  1989  a
series of 11 olfactory meningiomas treated
using the pterional approach (97). Many
authors have subsequently reported this
approach for OGMs (14, 26, 34, 57, 59, 96,
183, 184, 216, 238). Both pterional or
minipterional approaches have the sylvian
fissure in the center of the craniotomy, with
partial exposure of the frontal and temporal
lobes (70, 254, 255). No previous report
describes the microsurgical treatment of
OGMs through a minipterional approach.
Dolenc affirmed that complete opening of
the sylvian fissure is mandatory when
dealing with an OGM or TSM (59). Turazzi
et al. reported their surgical experience of 37
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OGMs through the pterional approach and
emphasized the importance of opening the
basal  cisterns  for  CSF  release  and  to  get
more space to visualize the necessary
neurovascular structures. The author
recommend that the opening of the sylvian
fissure be only partial. In large meningiomas,
debulking of the tumor enables dissection of
the A2 branches and the posterior part of the
tumor (238).
In 1996, Ojemann published 19 cases of
OGM treated through bifrontal craniotomy.
This approach is associated with less
retraction of the frontal lobe with direct
access to all sides of the tumor and allows
the debulking of the tumor and simultaneous
access to the base from which its vascular
support is derived (172).
Colli et al. in 2007 published their series of
17 OGM cases treated through a bifrontal
approach with unilateral orbitotomy (34).
Mayfrank and Gilsbach reported 18 cases of
OGM treated through unilateral frontal
craniotomy and an interhemispheric route
(154).
Nakamura et al. compared the outcome and
recurrences of OGM when treated through
pterional, bifrontal, and frontolateral
approaches. Similar results were obtained in
the pterional and frontolateral groups. The
authors recommended the use of the
frontolateral approach instead of the bifrontal
approach (161).
Anterior Clinoidal Meningiomas
The two most frequently described surgical approaches to remove ACMs are pterional (16, 82,
135, 160, 179, 188, 201, 255) and orbitozygomatic (4, 5, 91, 196, 209, 210).
Table 2. Macro- and microsurgical series of ACM surgeries through different approaches.
Author(s), year (reference) Approach
Death or morbidity/operations
 (mortality or morbidity)
Macrosurgery
Cushing H. and Eisenhardt L., 1938
(39)
unilateral frontal with partial
lobectomy
1/11 ( mortality)
Uihlein A. and Weyand R.D., 1953
(240)
NA 17/52 (mortality)
Holub K., 1956 (106) NA 9/19 (mortality)
Heiskanen O., 1959 (98) NA NA/14
Olivecrona H., 1967 (175) unilateral frontal 11/47 (mortality)
2  Review of the Literature
54
Guyot J.F., 1967 (90) NA NA/13
Cook A.W., 1971 (35) pterional 2/11 (mortality)
Fischer G., 1973 (72) NA 2/6 (mortality)
Ugrumov V.M. et al., 1979 (239) NA 3/17 (mortality)
Cophignon J. et al., 1979 (36) NA 0/6 (no mortality)
Symon L. and Jakubowki J.,1979
(225)
unilateral frontal 1/30 (mortality)
McCarty C.S. and Taylor W.F.,
1979 (147)
NA NA/47
Microsurgery
Yaargil M.G., 1996 (255) pterional-transsylvian 0/9 (no mortality)
Konovalov A.N. et al., 1979 (129) NA 11/92 (mortality)
Bonnal J. et al., 1980 (21) pterional 3/9 (mortality)
Pompili A. et al., 1981 (186) frontotemporal 1/10 (mortality)
Hakuba A. et al., 1981 (93) orbitozygomatic 0/7 (no mortality)
Sugita K., 1985 (220) pterional 0/7 (no mortality)
Jan M. et al., 1986 (113) NA 6/19 (mortality)
Jääskeläinen J., 1986 (111) NA NA/79
Al-Mefty O., 1991 (5) fronto-orbitozygomatic 2/24 (mortality)
Ojemann R.G. and Swann K.W.,
1991 (173)
frontotemporal 0/18 (no mortality)
Risi P. et al., 1994 (196) fronto-orbitozygomatic 2/34 (mortality)
Rubin G. et al., 1995 (200) bifrontal; pterional; unilateral frontal 6/67 (mortality)
Benjamin V. and McCormack B.,
1995 (18)
pterional 0/20
Haddad G.F. et al., 1996 (91) orbitozygomatic NA
Ojemann R. G., 1996 (172) frontotemporal 1/17 (morbidity)
Puzzilli F. et al., 1999 (188) pterional 5/33 (mortality)
Tuna M. et al., 1999 (237) NA 0/2 (no mortality)
Tobias S. et al., 2003 (231) pterional 0/25
Chatterjee P.R. et al., 2004 (31) NA 0/1 (no mortality)
Tao C.S. et al. 2005 (227) supraorbital-orbitozygomatic 1/12 (morbidity)
Reisch  R.  and  Perneczky  A.  at  al.
2005 (193)
supraorbital subfrontal 0/18 (no mortality)
Cui H. et al., 2007 (38) pterional-extended pterional 0/26 (no mortality)
Pamir M.N. et al., 2008 (179) pterional 0/43 (no mortality)
Sade B. and Lee H.J., 2008 (203) fronto-orbital 0/52 (no mortality)
Bassiouni H. et al., 2009 (16) pterional
fronto-orbitozygomatic
2/104 (mortality)
0/2 (no mortality)
Yang Y.M. et al., 2010 (251) pterional; frontotemporal; 1/53 (morbidity)
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orbitozygomatic
Yaargil reported only nine cases of medial
sphenoid wing meningioma through a
transsylvian approach and recommended not
removing the part infiltrating the cavernous
sinus in order to prevent cranial nerve palsy
after surgery (255). In 2008, Pamir et al.
described a consecutive series of 43 ACMs
treated through a pterional approach. After
craniotomy, the sylvian fissure was widely
opened and the CSF removed to achieve a
slack brain. The MCA was followed to the
ICA and the tumor dissected following the
arachnoidal plane. The dura of the ACP was
removed in all 43 cases (179). Bassiouni
reported a multicenter series of 106 ACMs,
104 treated using a pterional transsylvian
craniotomy (in only two cases an
orbitozygomatic approach was applied). The
tumor was removed via a unilateral
subfrontal route. Intradural clinoidectomy
was performed in 16 cases where the tumor
was inside the orbit and in an additional
seven cases to relieve optic nerve
compression and avoid its further damage
during tumor removal (16). Ojemann
reported a series of 17 ACMs through a
frontotemporal craniotomy and a subfrontal
route. After initial exposure, the medial
portion of the sylvian fissure can be opened,
followed by tumor debulking. It is important
to dissect the MCA and follow it medially to
the ICA. The author recommended an
intradural clinoidectomy when the tumor is
inside the optic canal (173).
Al-Mefty advised a fronto-orbitozygomatic
approach to remove ACMs. After
craniotomy, brain relaxation is achieved
through lumbar drainage and opening of the
basal cisterns. Elevation of the frontal lobe
should be minimal (1.5 cm) to avoid harming
the olfactory tract. The sylvian fissure is
opened and the tumor if large can be
debulked by an ultrasonic aspirator, after
which the MCA branches can be visualized.
With microdissection, the tumor capsule is
removed from the vessels. The dissection
follows all of the vessels (ICA and ACA),
becoming easier in the proximity of the
PComA and anterior choroidal artery
(AChA),  i.e.  along  the  arachnoidal  plane.
The optic nerve also has an arachnoidal
membrane to facilitate the dissection (5). Al-
Mefty advised intradural removal of the
anterior clinoid process if the ACM or TSM
is inside the optic canal or orbit. The
pituitary stalk can be recognized by its color
and vascular network. It is usually displaced
backwards and to the opposite side and can
be dissected following its arachnoidal plane
(5, 149).
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Tuberculum Sellae Meningiomas
The anatomical region from which the TSM
originates is  one of the most complex of the
brain for both transcranial and
transsphenoidal routes. The neural and
vascular relationships with the sphenoid
bone are key when treating TSMs. ICA and
its branches, optich chiasm and nerves, and
pituitary stalk can be attached, dislocated,
and encased by a TSM making challenge a
complete tumor removal. We consider the
transcranial route preferable than the
transsphenoidal one to achieve a complete
tumor removal and to preserve the
neurovascular structures. The most frequent
microsurgical approaches to remove TSMs
are pterional (6, 15, 17, 68, 81, 95, 112, 124-
126, 151, 161, 171, 178, 180, 202, 207, 214,
222, 224, 254, 255), fronto-orbital, fronto-
orbitozygomatic (3, 6, 9, 10, 81, 114, 117,
124, 125, 141, 149, 208) frontolateral (76,
81, 124, 141, 161) and bifrontal (6, 10, 15,
76, 77, 81, 115, 125, 161, 171, 222, 224,
230).
Table 3. Macro- and microsurgical series of TSM surgeries through different approaches.
Author(s), year (reference) Approach
Death or morbidity/operations
 (mortality or morbidity)
Macrosurgery
Cushing H. and Eisenhardt L., 1938 (40) unilateral subfrontal 3/24 (mortality)
Olivecrona H., 1946 (27) unilateral frontal NA/42
Hänsel G. and Seeger W., 1977 (95) pterional 0/5 (no mortality)
Jefferson A. and Azzam N., 1979 (115) bifrontal 1/19 (mortality)
Ugrumov V.M. et al., 1979 (239) NA 4/17 (mortality)
Kadis G.N. et al., 1979 (118) bifrontal 13/105 (mortality)
Microsurgery
Yaargil M.G., 1996 (255) pterional-transsylvian 1/112 (mortality)
Konovalov A.N. et al., 1979 (129) NA 5/68 (mortality)
Bonnal J. et al., 1980 (21) frontotemporal NA/12
Yamashita H., 1980 (250) NA 6/39 (mortality)
Solero C.L. et al.,1983 (214) unilateral frontal craniotomy with
frontal lobectomy
13/55 (mortality)
Chan R.C. and Thompson G.B., 1984
(28)
NA 2/12 (mortality)
Symon L. and Rosenstein J., 1984 (224) unilateral frontal osteoplastic
bifrontal osteoplastic
6/92 (mortality)
0/4 (no mortality)
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Al-Mefty O. et al., 1985 (6) bifrontal (11 cases); pterional (4
cases); subfrontal (2 cases)
3/17 (mortality)
Sugita K., 1985 (220) bifrontal 1/9 (mortality)
Jääskeläinen J., 1986 (111) NA NA/64
Grisoli F. et al., 1986 (87) pterional 0/28 (no mortality)
Andrews B.T. and Wilson C.B., 1988 (9) fronto-orbital 2/38 (mortality)
Al-Mefty O. and Smith R.R., 1991 (3) cranio-orbitozygomatic 0/35 (no mortality)
Ojemann R.G. and Swann K.W., 1991
(173)
frontotemporal 0/20 (no mortality)
Benjamin V. and McCormack B., 1995
(18)
pterional 1/9 (mortality)
Rubin G. et al., 1995 (200) bifrontal; pterional; unilateral
frontal
6/67 (mortality)
Kinjo T. et al., 1995 (125) pterional (5 cases); bifrontal (3
cases); unifrontal (1 case); fronto-
orbital (2 cases)
0/11 (no mortality)
Ojemann R.G., 1996 (172) pterional 3/21 (morbidity)
Tuna M. et al., 1999 (237) NA 2/10 (mortality)
Raco A. et al., 1999 (190) NA 5/69 (mortality)
Arai  H. et al. 2000 (10) bifrontal + orbital rim 0/21 (no mortality)
Ciric I. and Rosenblatt S., 2001 (33) pterional; orbitozygomatic 0/24 (no mortality)
Zevgaridis D. et al., 2001 (262) frontobasal/frontotemporal 0/34 (no mortality)
Ohta K. et al., 2002 (171) pterional (15 cases); fronto-
orbitozygomatic/fronto-orbital (10
cases); bifrontal  (6 cases); others
(2 cases)
0/33 (no mortality)
Goel A. et al., 2002 (81) unifrontal
orbitofrontal
bifrontal
orbitozygomatic
2/60 (mortality)
0/3 (no mortality)
0/4 (no mortality)
0/2 (no mortality)
Fahlbusch R. and Schott W., 2002 (68) pterional 0/47 (no mortality)
Jallo G.I. and Benjamin V., 2002 (112) pterional 2/23 (mortality)
Dolenc V.V., 2003 (58) frontotemporal 0/49 (no mortality)
Chi J.H. and McDermott M.W., 2003 (32) bifrontal (11 cases); unilateral
subfrontal (8 cases);
pterional (1 case)
0/20 (no mortality)
Takahashi J.A. et al., 2004 (226) pterional 0/3 (no mortality)
Benjamin V. and Russell S.M., 2005 (17) pterional NA
Reisch R. and Perneczky A. at al. 2005
(193)
supraorbital subfrontal 0/16 (no mortality)
Pamir M.N. et al., 2005 (180) pterional 1/42 (mortality)
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Schick U. and Hassler W., 2005 (207) pterional 2/53 (mortality)
Bassiouni H. et al., 2006 (15) pterional (49 cases); bifrontal (7
cases); unilateral subfrontal (4
cases); supraorbital (2 cases)
10/62 (morbidity)
Nakamura M. et al., 2006 (161) pterional-frontotemporal
bifrontal
frontolateral
0/21 (no mortality)
2/21 (mortality)
0/30 (no mortality)
Park C.K. et al., 2006 (181) pterional
bifrontal
0/26 (no mortality)
0/4 (no mortality)
Otani N. et al., 2006 (178) pterional 0/32 (no mortality)
Kitano M. et al., 2007 (126) pterional 0/12 (no mortality)
Li X. et al., 2007 (140) unifrontal
pterional
NA/24
NA/19
Kanno T., 2007 (119) bifrontal NA
de Divitiis E. et al., 2008 (54) pterional
unilateral subfrontal
bifrontal
0/36 (no mortality)
0/4 (no mortality)
0/4 (no mortality)
Nozaki K. et al., 2008 (166) frontotemporal 0/22 (no mortality)
Kim T.W. et al., 2008  (123) unilateral frontal (20 cases);
pterional (5 cases); fronto-orbital
(2 cases)
0/27 (no mortality)
Suri A. et al., 2008 (222) pterional; bifrontal; fronto-orbito-
zygomatic
0/18 (no mortality)
Ganna A. et al., 2009 (77) bifrontal 0/24 (no mortality)
Sade B. and Lee H.J., 2009 (202) pterional 0/31 (no mortality)
Jung H.W. and Park C.K., 2009 (117) fronto-orbitozygomatic NA
Warren L.W. and Grant G.A., 2009  (242) fronto-orbitozygomatic 0/10 (no mortality)
Fatemi N. et al., 2009 (69) supraorbital keyhole 0/7 (no mortality)
Galal A. et al., 2010 (76) frontolateral (18 cases); bifrontal
(3 cases)
1/21 (mortality)
Mahmoud M. et al., 2010 (149) unilateral fronto-orbital 1/58 (mortality)
Xu Y.M. et al., 2010 (249) bifrontal 0/11 (no mortality)
Bowers C.A. et al., 2011 (22) pterional 0/22 (no mortality)
Terasaka S. et al., 2011 (230) bifrontal 3/9 (morbidity)
The largest series of TSMs, comprising 112
cases, comes from Yaargil (255). Yaargil's
protocol involves opening the sylvian fissure,
as  in  OGM  and  ACM  surgeries,  and
following the MCA to the ICA bifurcation. A
window should be made in the prechiasmatic
area to devascularize the tumor. Debulking
of the tumor provides space to allow
dissection of the optic nerves, optic chiasm,
circle of Willis, pituitary stalk, and
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oculomotor nerve. The tumor capsule is
dissected from the pituitary stalk and can be
removed. If the tumor extends into the optic
canal, this can be drilled for a few
millimeters, allowing mobilization of the
optic nerve and the ophthalmic artery.
Attention must be paid, however, to avoid
entering the sinuses. Yaargil stated that
complete removal of TSMs is more often
possible  than  removal  of  other  skull  base
meningiomas (255). The surgical technique
described by Yaargil was applied by other
authors (172, 173).
Jung and Parker reported a surgical
technique to remove TSMs through a fronto-
orbitozygomatic approach and extradural
clinoidectomy. Lumbar drainage is used to
achieve a slack brain. The sylvian fissure is
opened and the frontal lobe gently retracted.
The first step is to devascularize the tumor
from the planum sphenoidalis to reduce
intraoperative bleeding. Debulking of the
tumor is done with suction and an ultrasonic
aspirator or bipolar and microscissors. Under
high magnification, the neurovascular
structures are dissected. The ACA and MCA
are freed from the tumor. The arterial supply
to the inferior surface of the optic apparatus
from the superior hypophyseal artery should
be preserved by following the arachnoidal
plane during the sharp microdissection. After
tumor removal, its origin is coagulated (117).
Ganna  reported  24  TSMs  where  the
interhemispheric approach allowed an early
tumor devascularization, and after central
debulking  of  the  tumor,  both  ICAs  were
identified. The optic nerves and chiasm are
not retracted because if the tumor is inside
the  optic  canal  it  can  be  unroofed.  The
tuberculum sellae hyperostosis can be
drilled, paying attention to reconstruct the
skull base and avoid a CSF fistula (77).
Nakamura reviewed the surgical experience
of  Samii  when  treating  TSMs  through
pterional, frontolateral, and bifrontal
approaches, and emphasized the importance
of the frontolateral approach (161).
Outcome  of  OGM,  ACM,  and  TSM  through  Pterional,  Orbitozygomatic,  and
Bifrontal Approaches
Olfactory Groove Meningiomas
Surgical complications in OGMs treatment
are: CSF fistula, frontal syndrome, hypo-
anosmia, hemiparesis, visual worsening,
postoperative hematoma, hydrocephalus,
infections, seizures and mortality (159, 238).
Dolenc in 2003 published his personal
experience of 157 OGMs treated through the
pterional approach. After surgery,
improvement was seen in 112 patients, no
change in 38 patients, and worsened
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condition in seven patients. In all cases, the
tumor was completely removed. In 25 cases,
reconstruction of the floor of the ACF was
required, and in all of these cases lumbar
drainage  was  used  for  one  week  after
reconstruction of the skull base. No mortality
occurred in the series (59). Ojemann in 1996
published his experience of 19 OGMs,
advising treatment through bifrontal
craniotomy. One patient presented with CSF
leakage, requiring repair of the skull base,
one patient had a wound infection, and one
patient required a subdural-peritoneal shunt
for a subdural hygroma. Preoperative visual
symptoms and disturbance of mental
function were completely alleviated (172).
Colli reported a series of 17 OGM patients
treated through bifrontal craniotomy and
unilateral orbitotomy. Two patients died,
four had local infections, two presented with
epilepsy, one had postoperative edema, and
one had transient ptosis (34). Spektor in a
series of 80 OGM patients treated through
different surgical approaches reported CSF
leakage in 10 patients (12.5%), eight
resolved with lumbar drainage and two
underwent skull base sealing. Five of their 10
patients underwent bifrontal craniotomy, and
one patient of the bifrontal group died. No
mortality was found in the patients
undergoing unilateral subfrontal, pterional,
or fronto-orbital craniotomy (216). Tuna et
al. reported 25 OGMs treated through
bifrontal and pterional approaches. No
patient died, but four had CSF leakage, one
had epilepsy, and three developed frontal
lobe edema (236). Nakamura compared the
treatment of OGM through bifrontal,
pterional, and frontolateral approaches; four
patients died in the bifrontal group, whereas
no mortality occurred in patients treated
through the frontolateral or pterional route
(159).
Anterior Clinoidal Meningiomas
The  close  relationship  of  ACM  with  ICA,
optic nerve and other neurovascular
structures make their total removal challenge
and associated with postoperative
complications (CSF leakage, visual
worsening, hemiparesis, aphasia,
hydrocephalus, endocrinological symptoms,
hematoma, infections) and mortality (16,
179). Pamir reported a series of 43 ACMs
treated through pterional approach. Eight
patients presented with surgical
complications (three meningitis,
postoperative hematoma, one hydrocephalus,
one hemiparesis for venous infarction, one
epilepsy, one pneumonia). No mortality was
reported (179).
Of 24 patients treated by Sade and Lee
through a skull base approach with fronto-
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orbital craniotomy and extradural anterior
clinoidectomy, preoperative visual deficit
improved in 17 cases. No patients died (203).
In  the  multicenter  series  of  106  ACM  cases
reported by Bassiouni et al. through pterional
craniotomy (104 cases) or an
orbitozygomatic approach (two cases),
postoperative complications included aphasia
(eight cases), transient hemiparesis (four
cases), and CSF leakage (four cases) treated
by lumbar drainage. Two patients died. Of
52 patients with preoperative visual deficits,
21 improved and 7 worsened (16). Ojemann
described one patient treated through
frontotemporal approach; this patient had
permanent morbidity with dysphasia and
hemiparesis. The author was uncertain of
total tumor removal because of complicated
attachment to vessels (172).
Puzzilli reported a series of 33 ACMs treated
through pterional craniotomy. Four patients
died after surgery. At the end of the follow-
up of 19 patients for a mean of 53.7 (range
12-108) months, there were five recurrences
(188). In the Risi series treated by
orbitozygomatic approach, three patients had
CSF leakage, two patients died, and three
patients had permanent morbidity. Of the 20
patients with preoperative visual deficit, 13
improved, one remained unchanged, and six
worsened (196). Al-Mefty treated 24
meningioma cases through a fronto-
orbitozygomatic approach and reported two
deaths. Furthermore, one patient became
blind, one had permanent 3rd nerve  palsy,
one had CSF leakage, and three had diabetes
insipidus (two transitory and one permanent)
(5).
Tuberculum Sellae Meningiomas
Although the relation of the optic chiasm to
the sellar region frequently affects the visual
outcome, other complications can occur after
TSM surgery. The most common
complications are: CSF leakage,
endocrinological disturbances, infections;
less frequent complications are: hematoma,
hemiparesis, and mortality (6, 68, 81).
Yaargil reported through a pterional
transsylvian approach 104 patients with good
outcome, seven with moderate disability, and
one with undetected rhinorrhea and
meningitis who subsequently died. Forty-five
patients had improvement of visual function,
29 unchanged, and 11 impaired (255).
Ojemann described a series of 21 cases
operated on through a pterional approach; 18
had good outcome, one had mild frontal lobe
syndrome and worsening of visual function,
one had severe frontal lobe syndrome, and
one had already undergone four earlier
operations. No patients died. Visual function
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worsened in two cases (172). Nakamura
compared the simple frontolateral approach
(very similar to our LSO approach) with the
bifrontal approach in microsurgery of TSMs,
and two patients in the bifrontal group died
due to postoperative brain edema. No deaths
occurred in the frontolateral or pterional
groups. The authors concluded that the
anterior third of the SSS should be preserved
during OGM surgery, and this is better
achieved with the frontolateral approach. The
visual improvement rate was significantly
better in patients who underwent
frontolateral tumor resection compared with
the bifrontal group (161).
Mahmoud reported 58 cases; no mortalities
occurred and three patients presented with a
worsening of visual function, four had CSF
leakage with one requiring reoperation, three
had unilateral olfactory tract damage with
anosmia, seven had postoperative hyposmia,
one had infection, and one died due to
pulmonary embolism (149). With the
bifrontal approach, the most frequent
complication is anosmia, reported in seven
TSM  patients  by  Ganna  et  al.,  only  one
patient had visual worsening after surgery
(77).
Recurrences of OGM, ACM, and TSM when Using Classical Approaches
In the series of OGMs reported by Ojemann,
no patients who underwent scans (13/19
patients) had a recurrence during a mean
follow-up of 4.4 years (172). Snyder et al.
reported four OGM recurrences after a mean
of 6 years (213). An extensive review of the
literature on meningiomas by Black
unearthed a 10-year recurrence rate of 9-20%
for totally resected meningiomas (19). Chan
and Thompson reviewed their experience of
257 meningiomas, including 20 OGMs and
12 TSMs, noting recurrences in three and
two  patients,  respectively,  over  a  mean
follow-up of 9 years (range 6 months-22
years) (28). The surgical approach was not
specified in their series. Snyder et al.
reported four late OGM recurrences; one of
the patients was treated through bifrontal
craniotomy and for the other three the
approach was not specified. In three of these
patients, the dura was coagulated (without
removal), and in one a subtotal tumor
resection was achieved. No recurrences
occurred in a series of 20 (total 25) OGMs
treated through bifrontal and pterional
approaches during a mean follow-up of 58.4
(range, 14-112) months (213). Nakamura
reported OGM and TSM resection through
different surgical approaches and concluded
that the rate of total tumor removal (Simpson
grade 1 or 2) did not differ significantly
among the approaches. It was 92.7% in the
frontolateral group and 93.5% in the
bifrontal group, and the overall recurrence
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was 4.9% during a mean follow-up of 5.3
years (2.9% in the frontolateral group and
6.5% in the bifrontal group) (159, 161). The
recurrence rate was 0 in 15 OGM patients
treated by Obeid and Al-Mefty through a
supraorbital subfrontal approach (unilateral
or bilateral) (169). In a series of 106 ACM
patients treated through pterional (104 cases)
and orbitozygomatic approaches (two cases),
10 patients experienced a recurrence during
the mean follow-up of 4.8 (range, 2-8) years.
Two had Simpson grade I and eight Simpson
grade II removals. Three of these patients
underwent a second surgery and three
fractionated radiotherapy for a high cellular
proliferative index (16). Of the 17 ACM
cases treated by Ojemann, three had a
recurrent tumor with two requiring
reoperation and radiotherapy (172). Al-
Mefty reported one ACM recurrence in a
series of 24 cases followed up for 57 months
(5).
None of the 112 patients operated on by
Yaargil had a recurrence during a 10-year
follow-up (255). In Nakamura's TSM series,
the recurrence rate was 2.8% (2/72 patients)
during a mean follow-up of 45.3 (range, 4-
238) months (161). In Mahmoud's series, one
recurrence was recorded over a mean follow-
up of 23 months (149).
Anterior Clinoidectomy
The medial portion of the lesser wing of the
sphenoid bone is the ACP (109). Its
anatomical location is extremely important
for the relationship to the optic nerves, ICA,
and other parasellar neurovascular structures.
Anterior clinoidectomy allows the exposure
and safe mobilization of the optic nerve at its
proximal entrance to the optic canal and the
ICA in its transitional segment from the
cavernous to the intradural space (226);
anterior clinoidectomy is a key microsurgical
step for the successful and safe management
of paraclinoid aneurysms and parasellar
neoplastic lesions (52, 60, 261). Drake
reported performing an anterior
clinoidectomy in 1968 when treating carotid-
ophthalmic aneurysms, although he later
claimed it was unnecessary (62). A few years
later, Guidetti (89), Yaargil (259), and
Sundt (221) described the microsurgical
technique of intradural anterior
clinoidectomy for the treatment of carotid-
ophthalmic aneurysms.
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Table 4. Anterior clinoidectomy through different surgical approaches.
Author(s), year (reference) Approach (lesions)
Intradural/Extradural
Clinoidectomy
(number of cases)
Drake C.G. et al., 1968 (62) pterional (carotid-ophthalmic
aneurysms)
intradural (14 cases)
Guidetti B. and La Torre E., 1975 (89) frontotemporal (carotid-
ophthalmic aneurysms)
intradural (26 cases)
Yaargil M.G. et al., 1977 (259) pterional (carotid-ophthalmic
aneurysms)
intradural (30 cases)
Iwabuchi T. et al., 1978 (110) unilateral frontal (carotid-
ophthalmic aneurysms)
intradural (6 cases)
Sundt T.M. and Piepgras D.G., 1979 (221) pterional (giant aneurysms) intradural (80 cases)
Heros R.C. et al., 1983 (105) pterional (paraclinoid
aneurysms)
extradural (34 cases)
Dolenc V.V., 1985 (60) pterional (carotid-ophthalmic
aneurysms)
extradural (14 cases)
Perneczky A. et al., 1985 (185) pterional (infraclinoid
aneurysms)
intradural (NA)
Knosp E. et al., 1988 (127) pterional (paraclinoid
aneurysms)
intradural (NA)
Nutik S. L., 1988 (167) NA intradural (NA)
Kobayashi S. et al., 1989 (128) pterional (carotid cave
aneurysms)
intradural (32 cases)
Ohmoto T. et al., 1991 (170) pterional (intracavernous
aneurysms)
intradural (7 cases)
Korosue K. and Heros R.C., 1992 (130) pterional (carotid aneurysm) intradural (1 case)
Day J.D. et al., 1994 (53) orbitozygomatic (upper basilar
and infrachiasmatic lesions)
extradural (22 cases)
Yonekawa Y. et al., 1997 (261) pterional (parasellar lesions) extradural (40 cases)
Tobias S. et al., 2003 (231) pterional (ACMs) extradural (23 cases)
Huynh-Le P. et al., 2004 (109) NA extradural (NA)
Takahashi J.A. et al., 2004 (226) pterional (ICA aneurysms,
TSMs)
intradural en-bloc (37
cases)
Avci E. et al., 2005 (11) frontotemporal intradural (NA)
extradural (NA)
Benjamin V. and Russel S.M., 2005 (17) pterional (TSMs) intradural (NA)
Noguchi A. et al., 2005 (165) orbitozygomatic (40
aneurysms and 20 tumors)
extradural (60 cases)
Chang H.S. et al., 2006 (30) frontotemporal (parasellar extradural (8 cases)
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tumors)
Otani N. et al., 2006 (178) pterional (TSMs) extradural (32 cases)
Andaluz N. et al., 2006 (8) pterional intradural (NA)
Gonzalez-Darder J.M., 2007 (84) pterional (paraclinoid
aneurysms)
intradural (NA)
Sade B. and Lee J.H., 2008 (203) pterional (ACMs) extradural (52 cases)
Nozaki K. et al., 2008 (166) frontotemporal (TSMs) intradural (20 cases)
Jung H.W. and Park C.K., 2009 (117) fronto-orbitozygomatic
(TSMs)
extradural (NA)
Chang D.J. et al., 2009 (29) pterional (NA) extradural (45 cases)
Sade B. and Lee J.H., 2009 (202) pterional (TSMs) extradural (28 cases)
Bassiouni H. et al., 2009 (16) pterional (ACMs) intradural (23 cases)
Park S.K. et al., 2009 (182) NA (PComA aneurysms) intradural (6 cases)
Li-Hua C. et al., 2010 (141) fronto-orbital; frontolateral
(TSMs)
intradural (27 cases)
Son H.E. et al., 2010 (215) pterional (paraclinoid
aneurysms)
extradural (22 cases)
Golshani K. et al., 2010 (83) NA (PComA aneurysms) intradural (NA)
Nanda A. and Javalkar V., 2011 (163) pterional (carotid-ophthalmic
aneurysms)
intradural (86 cases)
The milestone description of extradural
anterior clinoidectomy by Dolenc for the
treatment of carotid-ophthalmic aneurysms
appeared in 1985 (60). All of these reports
describe the anterior clinoidectomy through
pterional or orbitozygomatic approaches (52,
60, 89, 226, 259, 261).
Anterior Clinoidectomy through Pterional or Orbitozygomatic Approach
A few recent reports describe surgical
techniques to remove the ACP. Takahashi
reported intradural en-bloc removal of the
ACP through a pterional approach (226).
After dura incision and its removal
posteriorly, a diamond drill (diameter 1 mm)
is used starting at the posterior edge of the
optic canal to 1 cm anterior of the medial
margin of the optic canal. Drilling continues
until the deeper side of the cortical bone is
reached. With a small rongeur, the ACP is
ruptured and removed en-bloc.
Understanding the relationship between the
ACP and the ICA or optic nerve is crucial
(226). A similar technique and the same
pterional approach but through an extradural
route are described by Yonekawa (261). He
also advised en-bloc removal of the ACP;
2  Review of the Literature
66
however, if en-bloc is not possible, a small
piece can be removed by drilling and by
microrongeur (261). Otani reported 32 cases
of TSM treated through pterional craniotomy
and 20 underwent extradural clinoidectomy.
The ACP was removed by using a diamond
drill under microscope (178).
Noguchi reported a microsurgical technique
to extradurally remove the ACP and SOF
through an orbitozygomatic craniotomy.
First the sphenoid ridge is flattened, the dura
dissected, and the SOF opened. The lesser
wing of the sphenoid over the SOF and also
the  greater  wing  are  then  opened  to  expose
the  inferior  margin  of  the  SOF.  The  dura
over  the  ACP  is  dissected  and  the  ACP
removed. A 2-mm diamond drill is used
during the procedure (165). Chang described
an interesting technique to perform anterior
clinoidectomy extradurally and through a
pterional approach without the use of a high-
speed drill but only microrongeurs of
different sizes (29).
Anesthesiological Procedures
Anesthetic management can significantly
affect the prognosis of a patient undergoing
removal  of  an  anterior  skull  base
meningioma (164). No previous reports
describe neuroanesthesia procedures for
different  ASB  approaches;  only  general
principles in dealing supratentorial
procedures have been published (1, 25, 164,
191). General principles of neuroanesthesia
for supratentorial procedures include: 1)
optimize brain oxygenation; 2) maximize
venous drainage ensuring adequate head
position (15-30° tilt); 3) reduce oxygen
metabolism: deepen anesthesia, bolus
intravenous of anesthetic agents or lidocaine;
4) reduce extracellular fluid volume with
mannitol or hypertonic saline, 5) consider
hypocapnia or an anticonvulsant in some
cases (25, 191).
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3 Aims of the Study
I-III: To describe the microneurosurgical technique and assess the effectiveness and safety of the
lateral supraorbital (LSO) approach in removing:
I:   Olfactory Groove Meningiomas
II:  Anterior Clinoidal Meningiomas
III: Tuberculum Sellae Meningiomas.
IV: To assess the principles of neuroanesthesia in achieving a slack brain when removing
meningiomas of the anterior cranial fossa through the LSO approach.
V and VI: To describe the microneurosurgical technique and assess the effectiveness and safety of
the LSO approach when performing extradural or intradural anterior clinoidectomy for the
treatment of vascular and neoplastic lesions.
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4 Patients and Methods
This study is based on retrospective data and
the analysis of operative videos of 66 OGM,
73 ACM, and 52 TSM patients treated
through the LSO approach between
September 1997 and August 2010.
Anesthesiological data of these 191
consecutive patients were analyzed to
determine the principles necessary to achieve
a slack brain when treating OGMs, ACMs,
and TSMs through an LSO approach.
The microsurgical technique and outcome of
82 consecutive patients undergoing an
anterior clinoidectomy through the LSO
approach between June 2007 and January
2011 were retrospectively analyzed. All
patients were treated at the Department of
Neurosurgery of Helsinki University Central
Hospital between September 1997 and
January 2011 by a single neurosurgeon
(J.H.).
Treatment of OGM, ACM, TSM through LSO Approach
(Publications I-IV)
Patients and Imaging
The publications I-III are based on 191
consecutive meningioma patients (66 OGMs,
73 ACMs and 52 TSMs) operated on
between September 1997 and August 2010 at
the Department of Neurosurgery, Helsinki
University Central Hospital, Finland, by the
senior  author  (J.H.),  with  a  total  personal
series of meningiomas exceeding 1200 cases.
The Table 5 reports the demographics and
clinical findings of the patients. Clinical
conditions, preoperative and postoperative,
were expressed by the Karnofsky
performance score (121), and Glasgow
outcome score (GOS) was used to express
the postoperative clinical outcome (116).
4  Patients and Methods
69
Table 5. Demographic data of 191 patients.
Men; 57
Woman; 134
Age (years); mean (range) 59 (range, 14-87)
Karnofsky score; mean (range) 82 (range, 40-100)
Edema 86
Brain shift 79
Sellar infiltration 58
Duration of surgery; median (minutes) 115 (range, 35-442)
Computed tomography (CT) or magnetic
resonance imaging (MRI) of the brain was
performed prior to surgery. For 13 OGM, 21
ACM, and 19 TSM patients, magnetic
resonance angiography (MRA) was also
performed to evaluate the tumor's vascular
supply and relation to the ACAs. Possible
tumor-related pathological changes of the
ICA, AComA, and middle (MCA) and ACA
were investigated (Figure 19). CT
angiography (CTA) was performed in three
ACM and TSM cases, and digital subtraction
angiography (DSA) was performed in four
ACM, one OGM, and one TSM case.
Preoperative tumor embolization was not
performed on any of the patients. When
treating  OGM,  ACM,  and  TSM  the  main
blood  supply  comes  from  the  AEAs  and
PEAs, which originate from the OA and they
are difficult to close endovascularly (67, 134,
194). The preoperative images were
evaluated for tumor size and lateralization,
brain shift, edema, possible calcifications,
signs of sellar and ethmoidal hyperostosis,
erosion and infiltration; intraorbital,
cavernous sinus, anterior clinoid, and planum
sphenoidalis involvement; attachment,
dislocation,  or  encasement  of  ACA,  MCA,
ICA, and BA; involvement of optic nerves
and  the  optic  chiasm;  and  pituitary  stalk
lateralization. An immediate postoperative
CT scan was performed on 55 OGM patients
and 37 TSM patients. An immediate
postoperative  MRI  scan  was  performed  on
55 ACM patients, a CT scan only was
performed on 17 ACM  and 12 TSM
patients. One ACM patient died of a cardiac
infarction before the postoperative
radiological examination. An early
postoperative MRI with gadolinium
enhancement was done when a tumor
remnant was suspected.
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Figure 19: Large OGM as seen on preoperative MRI. A, MRA showing ACAs attached to the posterior part of the
tumor (arrows). B, T2-weighted MRI showing lateral dislocation of the ACAs (arrow).
Intraoperative Videos
The videos of all operations were analyzed
and selected to show the microsurgical
technique used when treating OGMs
(Supplementary videos 2-5), ACMs
(Supplementary videos 6-9), and TSMs
(Supplementary videos 10-12) of different
sizes and consistencies through a LSO
approach.
Anesthesia Records
The anesthesia methods of 64 OGMs, 71
ACMs, and 52 TSMs were analyzed. Data
collection included duration of anesthesia
and surgery, anesthetic agents and their
doses, total amount of administered
vasoactive agents (phenylephrine, ephedrine,
dopamine, or atropine), total amount of
administered crystalloids (Ringer´s acetate),
colloids (hydroxyethyl starch solution, HES,
or albumin), mannitol, red blood cell
concentrates, fresh frozen plasma, or platelet
concentrates. Heart rate and non-invasive
blood pressure was recorded before
anesthesia. Intraoperatively invasive arterial
blood pressures (arterial transducer set to
zero  at  the  level  of  the  foramen  Monroe)
were registered at 5-min intervals for 40 min
and thereafter at 10-min intervals until the
end of surgery. Hypertension (systolic
arterial pressure, SAP > 160 mmHg) was
scrutinized during the immediate
postoperative  phase.  The  evaluation  of  the
surgical conditions during craniotomy was
based on surgical charts and was classified as
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good, satisfactory, or poor retrospectively.
Patients’ preoperative medical comorbidities,
such  as  hypertension,  and  the  use  of  any
medication were registered.
Follow-up
The patients were periodically seen at the
outpatient clinic, first at three months after
discharge and then at 1- to 2-year intervals
for up to seven years depending on the grade
and extent of removal. Patients with a known
postoperative residual tumor usually had a
clinical examination and MRI follow-up
once a year.
Statistical Analysis
Data were analyzed with the statistical
software package SPSS (SPSS Inc., Chicago,
IL, USA). Categorical variables were
compared with the Fisher exact two-tailed
test or the Pearson 2 test and the Kruskall
Wallis test, and continuous variables
between two groups with the Mann-Whitney
U-test. Univariate association of continuous
variables was tested with Spearman rank
correlation coefficients. Univariate and
multivariate odds ratios (ORs) with 95%
confidence intervals (CIs) were estimated
using unconditional logistic regression to
determine factors predicting good clinical
outcome  (GOS=5)  at  the  end  of  follow-up,
good neurosurgical condition, and extubation
time. The tested variables included age,
preoperative symptoms of anosmia, visual
deficit, size of meningiomas, peritumoral
edema, duration of preoperative visual
deficits, memory impairment, preoperative
Karnofsky score, and method of anesthesia.
Tumor  size,  consistency,  attachment  to
ACAs, ICA, MCA, AComA, or the optic
nerve or chiasm, and infiltration into the
paranasal sinuses were also analyzed in the
OGM group. The maximum likelihood
stepwise forward and backward elimination
procedures were used with selection of
variables based on the magnitude of their
probability values (P<0.1). A two-tailed
probability value of less than 0.05 was
considered significant.
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Anterior Clinoidectomy through LSO Approach (Publications V and
VI)
Patients and Imaging
Between June 2007 and January 2011, a total
of 82 patients underwent anterior
clinoidectomy through an LSO approach for
vascular and neoplastic lesions. The lesions
and clinical data of these patients are
presented in Table 6. Preoperative clinical
conditions were expressed on the Karnofsky
performance score (121) for neoplastic
lesions.  The Hunt-Hess (HH) scale (108)
was used for vascular patients. The GOS
(116) was used to reflect the postoperative
clinical outcome of vascular and neoplastic
patients.
Table 6. Patients and lesions.
Demographic data
Men; n 21
Woman; n 61
Age [years]; median (range) 54 (range, 22-82)
Preoperative condition
Karnofsky score of 35 tumor patients;
median (range)
90 (range, 60-90)
Hunt-Hess (n. of vascular patients) Grade   0 (3)
             1 (28)
             2 (5)
             3 (4)
             4 (3)
             5 (4)
Visual impairment 27
Duration of preoperative visual deficit
          < 6 months
          6-12 months
           >12 months
10
  2
15
Frontal syndrome-memory deficit   5
Oculomotor nerve deficit 10
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Seizures   1
Headache 17
Hemiparesis   2
Abducens paresis
Exophtalmus
Trigeminal hypoestesia
  1
  5
  1
Location of the lesions
Vascular cases
Carotid-ophthalmic aneurysms
Other carotid aneurysms
Basilar bifurcation aneurysm
Carotid cavernous fistulas
47
21
23
  1
  2
Tumor cases 35
Meningiomas 26
Other lesions   9
All  tumor  patients  underwent  MRI  before
surgery. All patients with aneurysms,
ruptured or unruptured, underwent CT and
CTA before surgery. Postoperative 3D
reconstructions of CT or CTA imaging were
analyzed to evaluate the extent of removal of
the ACP in all cases.
Intraoperative Videos
Intraoperative videos of 82 patients were
analyzed for nuances of the anterior
clinoidectomy technique, and illustrative
cases were selected to show extradural and
intradural clinoidectomy for vascular and
neoplastic lesions (Supplementary videos 13-
15).
Follow-up
We reported early clinical outcome at
discharge and at three months in the
outpatient clinic with special attention
focused on visual outcome.
Statistical Analysis
The statistical analysis was performed using
SPSS 18.0 software (SPSS Inc., Chicago, IL,
USA). Groups were compared using Mann-
Whitney U-test or Pearson’s 2 test. P-values
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of less than 0.05 were considered significant.
Risk factors (aneurysms, high score of HH,
opening of the superior orbital fissure,
extradural clinoidectomy, and use of
ultrasonic bone device) with P-values of less
than 1.0 in the univariate analysis were
included in the binary logistic regression
analysis used for multivariate comparison of
potential risk factors for postoperative visual
deficits. P-values of less than 0.05 were
considered significant.
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“There is nothing more difficult, more dangerous nor more least likely to succeed than to initiate
a new order of things”.
Niccolo’ Machiavelli, The Prince (1469-1527)
Microsurgical Techniques (Publications I-VI)
Lateral Supraorbital Approach
Patient Position
The patient is in supine position (Figure 20
A). The head fixed to the head frame is a)
elevated around 20 cm or more above
cardiac level; b) rotated 20º to 30º towards
the contralateral side of the tumor or
aneurysm; and c) the neck is slightly flexed
and tilted laterally to obtain a better view of
the anterior part of the anterior fossa,
enabling optimal venous return. It is our
practice also to adjust the position of the
fixed head and body during the operation as
needed, but the frequency of this maneuver
could not be assessed retrospectively. No
local anesthetics are infiltrated for pins of
Sugita frame. A bolus of remifentanil is
given to prevent hypertension.
Craniotomy
After minimal shaving and injection of a
vasoconstrictive agent, an 8- to 10-cm skin
incision is made behind the hairline (Figure
20 B). Following an oblique frontotemporal
skin incision, behind the hairline a one-layer
skin-muscle flap is retracted frontally with
spring hooks, and the superior orbital rim
and the anterior zygomatic arch are exposed
(Figure 20 C). The upper part of the temporal
muscle is split and retracted towards the
zygomatic arch. The extent of craniotomy
depends  on  lateralization  and  size  of  the
ACM  or  TSM.  Usually,  a  classic  LSO
craniotomy is all that is necessary. A single
burr hole is placed just under the temporal
line of the bone, i.e. the superior insertion of
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the temporal muscle (Figure 20 D). A bone
flap of 4 x 3 cm is detached mostly by side-
cutting drill, and the basal part can be drilled
before lifting (Figure 20 E). The dura is
incised curvilinearly with the base
sphenoidally and elevated by multiple
stitches extended over the craniotomy
dressings (Figures 20 F and 21). From this
point onwards, all surgery, including skin
closure, is performed under the operating
microscope.
Figure 20: (A) Position when performing the LSO approach, (B) skin incision, (C) muscle detachment, (D) burr hole,
(E) size of craniotomy, and (F) brain exposed after an LSO approach (199).
Figure 21: Exposure of the right ICA and optic nerve after performing a
right  LSO  in  a  cadaveric  specimen  (Courtesy  of  Dr.  Asem  Salma  of
Columbus University, Ohio) (204).
LSO Approach with Minimal Temporal Exposure (Publications II and V)
In the classic LSO, the sylvian fissure
remains at the inferior border of the dural
opening, and, if needed, it can be easily
opened, as our large experience on anterior
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and even posterior circulation aneurysms
demonstrates (48-51, 100, 102, 138, 139,
198, 199). In 20 ACM cases and in 20
patients who underwent anterior
clinoidectomy, we performed an LSO
approach with temporal extension, i.e. the
classic LSO with additional lateral extension
towards the middle cranial fossa for minimal
temporal exposure. This means extending the
exposure for approximately one centimeter
or so to the temporal side of the sylvian
fissure (Figures 22 and 23). The head
position is the same as in a classic LSO
approach, with a more caudal and posterior
skin-muscle cut. Size of the tumor or
aneurysm with a significant temporal
component is the only indication for
temporal extension of the LSO approach.
Figure 22: (A) A CT-3D skull base reconstruction showing the classic LSO (continuous black line) and the minimal
temporal extension (dotted line). (B) The origin of the OGM (dotted circle, small); ACM (continuous circle) and
TSM (dotted circle, large) of the anterior skull base reached through an LSO approach.
Figure 23: The
brain exposed
(A) after a left
LSO with
minimal
temporal
extension and
(B) after a right
classic LSO.
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Removal of OGM, ACM, TSM through LSO Approach (Publications I-III)
Neuroanesthesia is mandatory to achieve a
slack brain (191). The floor of the ASB is
followed towards the ipsilateral optic nerve
and carotid artery, and CSF is released from
the basal cisterns. We seldom open the
sylvian fissure. If needed, it can be easily
performed through the LSO approach,
especially for removing larger tumors (48-
51, 100, 102, 138, 139, 198, 199).
Tumor Devascularization
The first step, after opening the basal cisterns
and achieving more space, is to reach the
dural attachments of the tumor. When
treating OGM the blood supply comes from
the AEAs and PEAs, which originate from
the  OA  and  they  are  difficult  to  close
endovascularly (67, 134, 194). We coagulate
the major arterial supply to the tumor before
further dissection to ensure minimal
intraoperative blood loss. With bipolar
coagulation we devascularize the dural
attachment of the tumor, taking care to
preserve olfactory tract function. At the
beginning of OGM removal, coagulation of
the  AEAs  and  PEAs  is  necessary  with  the
risk of ischemic damage to the olfactory tract
(47, 79). The dura of the ACP is coagulated
with bipolar forceps using high power (Malis
50) to interrupt the vascular supply to the
tumor in order to devascularize the tumor
and minimize intraoperative bleeding.
Small and Medium-Sized OGM (< 6 cm)
The olfactory tract ipsilateral to the tumor is
early identified and dissected from the tumor
in small and medium-sized tumors (< 6 cm)
(Figure 24 A). The olfactory tract is
protected by small cottonoids and the tumor
is debulked with suction and high-power
bipolar forceps (Malis® CMCIII Codman,
Synergetics™, Inc., values 50-60).
Debulking of the tumor gives more room for
manipulation and allows the dissection
between the tumor surface and the
surrounding brain along the arachnoid plane.
We routinely use the ‘water dissection’
technique, that is very effective in dissecting
meningiomas (158). Preservation of both
olfactory tracts depends on the tumor's size,
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consistency, and attachments (Figure 24 B).
Usually the ipsilateral olfactory tract is
identified at the beginning of the dissection
and it is easier to dissect than the
contralateral one. After tumor debulking the
dissection should be directed to the posterior
aspect  of  the  tumor  to  identify  and  save  the
contralateral olfactory tract. Usually one
olfactory tract is compromised by the tumor,
and a slight manipulation can abolish its
function.
Figure 24: Intraoperative view showing involvement of the tumor with the olfactory tract. A, right olfactory tract
(arrow) is preserved in a small meningioma; B, both olfactory tracts (arrows) are preserved after removal of a small
OGM; C, large (> 6 cm) OGM and extremely atrophic olfactory tract (arrow) compressed by the tumor.
Small and Medium-Sized ACM and TSM (< 4 cm)
A classic LSO approach allows a complete
removal of small and medium-sized ACMs
and TSMs (< 4 cm). The dura is opened and
slack brain is achieved by modern
neuroanesthesia (191). The first step is to
devascularize the tumor pay attention not to
coagulate the dura too close to the optic
canal; high power coagulation of the dura
close  to  the  optic  canal  could  damage  the
optic nerve. For this purpose low-power
coagulation (Malis 20-25) should be used in
the proximity of the optic nerve. Water
dissection technique is used to dissect the
tumor  from the surrounding brain (158). The
dissection can be safely performed, in soft
tumor, along the arachnoid plane by using
sharp bipolar forceps and water dissection
technique (158). In our experience ACMs
and  TSMs   meningiomas  smaller  that  2  cm
can be safely removed en-bloc. Medium-
sized ACMs and TSMs (2-4 cm) can be
attached to the ICA, the optic nerve, the
oculomotor nerve, the MCA, and the ACA.
After tumor devascularization we debulk it to
gain adequate space to reach the basal
cisterns and ensure safe dissection. A micro-
Doppler can be used to find the ICA and
prevent its accidental injury when the tumor
envelops the ICA. In hard meningioma
without an arachnoidal plane, the tumor
detachment should proceed by using sharp
bipolar forceps, low-power coagulation
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(Malis 20-25), microdissector, and
microscissors. Based on the severity of
preoperative visual deficit, the optic nerve
and optic chiasm can be manipulate and
dissected avoiding postoperative visual
deficits.
Large OGM (> 6 cm)
Both olfactory tracts can be compressed or
destroyed by a large OGM (> 6 cm) (Fig. 24
C). An attempt is made to enter the basal
cisterns and to release CSF and if this is not
possible the tumor is partially debulked. We
use high power bipolar forceps coagulation,
high-power suction and/or microscissors. We
rarely  use  an  ultrasonic  aspirator,  as  the
combined repetitive movement of suction
and bipolar forceps gives the same result
with less bleeding. ACA’s branches can give
some feeders to a large OGM (Figure 25).
Preservation of ACA’s branches is
mandatory to avoid ischemic lesions on the
medial  aspect  of  the  frontal  lobe.  We  avoid
the use of mechanical retractors that can
increase edema in the frontal lobe. The tumor
is debulked and it is carefully dissected from
the surrounding brain and neurovascular
structures by using water dissection (158).
Figure 25: Surgical view. (A) Small branches of the ACA supplying the OGM (arrows). (B) OGM attached to right
optic nerve and right ICA (arrows).
Large ACM and TSM (> 4 cm)
The LSO approach can be extended 1-cm to
the temporal side in large ACMs (> 4 cm)
(Figures 22 and 23) and this allows a better
visualization  of  the  temporal  portion  of  the
medial sphenoid wing. The dura is opened
and the sylvian fissure is visualized. The first
step is to debulk a large ACMs and TSMs by
using suction and high-power (Malis 50)
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coagulation with bipolar forceps. After this
step the basal cisterns can be entered for CSF
removal. The vascular support to the tumor
coagulated and with water dissection
technique (158) the lesion is dissected from
the brain. Also for large tumor ultrasonic
aspirator is never used and we prefer the
combined use of suction and bipolar forceps.
In case of hard tumor without arachnoidal
plane, a micro-Doppler is used to find the
ICA  and  other  vessels.  The  ICA  is  gently
freed from the tumor by using sharp bipolar
forceps and suction. The attachment of the
tumor to the ICA is coagulated (Malis 20)
and cut. The perforators coming from the
ICA and ACA (Figures 26 and  27 C) should
be preserved; they are often inside the tumor
and they can be confused with the tumor's
vascular supply. The ICA 3-5 mm proximal
to its bifurcation (253) gives branches to the
dura of the ACP and these can be coagulated
and cut. ICA, ACA, MCA, optic nerve, and
optic chiasm can be enveloped or dislocated
from a large ACMs or TSMs and sometimes
small pieces of the tumor may need to be left
attached to the vessels or to the optic
nerve(s), preventing postoperative visual
deficits or ischemia.
Figure 26: (A) Small
branches of MCA. (B)
After complete removal
of a left large ACM,
the dura of the ACP is
coagulated (*) and all
vessels are preserved.
Figure 27: Intraoperative view of a medium-sized TSM and the right optic nerve (A); atrophic optic nerve
compressed by a large TSM (B); and perforators from the ACA attached to a large TSM (C).
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Attachment to Surrounding Vascular Structures
The tumor vascular supply comes from the
ethmoidal arteries and small branches of the
ACA and ICA that can be coagulated and
cut. The recurrent artery of Heubner has to
be preserved and not confused with these
branches. Small perforators coming from the
ACA,  in  the  region  of  the  AComA,  run
above the optic chiasm and courses anterior
to the ACA and they should be preserved
(102, 252). ICA in its intradural C1 and C2
segments may be attached to or encased by
the tumor. Small veins can be attached to the
tumor and these also should be preserved
whenever possible. They can be coagulated,
if necessary. If these veins are torn
accidentally they tend to contract backwards
and unless previously coagulated, keep
oozing, often from behind a corner, and are
much more difficult to deal with later.
OGMs, ACMs, and TSMs, can be attached to
the supraclinoid carotid arteries and the optic
nerves or chiasm (Figure 27 A and B). We
use high magnification, sharp bipolar forceps
(Malis +20, +25), and sharp dissection to
preserve  all  of  the  small  perforators,
including the blood supply of the optic
chiasm.
The dura of the ASB is carefully coagulated
(Simpson grade 2) after tumor removal. We
remove  the  dura  of  the  origin  of  the
meningioma in patients with long life
expectancy. The hyperostotic bone (Figure
28) is drilled away (Simpson grade 1) by
using a high-speed diamond drill sometimes
resulting in opening of the ethmoid sinuses;
care  should  be  paid  to  seal  the  sinuses  with
muscle, TachoSil (Human Fibrinogen,
4.8 x 4.8 cm, NYCOMED, Austria
GmbH, Linz) and fibrin glue to prevent
postoperative CSF leakage.
Figure 28: Sagittal MRI scan showing
hyperostosis (arrows) of the ethmoidal bone in
a large OGM.
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Intraorbital Extension of ACM-TSM and Anterior Clinoidectomy (Publications
I-III and V)
ACMs and TSMs can sometimes grow inside
the optic canal and an anterior clinoidectomy
is necessary to remove the tumor. We usually
perform anterior clinoidectomy when there is
tumor-related hyperostosis of the ACP and
encasement of the ICA by the tumor (Figures
29 and 30). The policy of the senior author
(J.H.)  is  to  perform  an  intradural  anterior
clinoidectomy (see Discussion). The
technique consists in cutting and removing
the dura of the ACP 1 cm from the medial
border. High-speed diamond drill and
ultrasonic bone curette (Sonopet Omni,
Model UST-2001 Ultrasonic surgical system,
Synergetics™, Inc., Miwatec Co., LTD,
Kawasaki, Japan) are both used to remove
the ACP. Sometimes the senior author uses
a microrongeur (Mizuho Rongeurs Series 16
cm curved, Japan). The bone of the ACP  is
formed by a surface of cortical bone and
diploe of cancellous bone, which sometimes
communicate with the cavernous sinus (209),
and fibrin glue can be used to control the
bleeding coming from the cavernous sinus
through these venous channels. The
unroofing of the medial portion of the orbital
roof allows the exposure of the optic nerve
and laterally the C3 segment of the ICA. The
intraorbital portion of the meningiomas is
removed in small pieces, taking care not to
damage the optic nerve. Extradural anterior
clinoidectomy is seldom used in ACMs and
TSMs surgery. After performing a LSO
approach the dura is gently detached from.
The orbital roof is removed 1 cm distal to the
medial border of the ACP by using an
ultrasonic bone curette or high-speed drill, or
a microrongeur.
Figure 29: Left large meningioma in a 58-year-old man. (A) Anterior view of DSA showing vascular support to the
meningioma from the ICA (arrow). (B) Coronal 2D reformatted image from Dyna CT during left carotid arteriogram
showing  small  branches  (arrow)  of  the  anterior  clinoid  process  to  the  ACM.  (C)  Preoperative  coronal  contrast-
enhanced T1-weighted MRI showing the large ACM. (D) Postoperative coronal contrast-enhanced T1-weighted MRI
showing the complete removal of the tumor.
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Figure  30:  Coronal  2D  CTA  of  a  right  large  ACM  in  a  39-
year-old woman. Vascular support comes from small vessels
of the ACP (arrow), which appears hyperostotic (*).
Tailored Anterior Clinoidectomy (Publications V and VI)
We prefer to perform a tailored
clinoidectomy, i.e. to remove only the
necessary amount of bone for the treatment
of  the  aneurysm  or  the  tumor.  Figure  31
shows the classification of a tailored
clinoidectomy: A) minimal clinoidectomy
refers to resection of the tip of the ACP,
usually less than 1/3 of  total ACP; B) partial
clinoidectomy  refers  to  removal  of  the  tip
and head of the ACP, i.e. approximately 1/3
of total ACP; C) subtotal clinoidectomy
refers  to  removal  of  the  tip,  head,  and  body
of the ACP, i.e. approximately 2/3 of total
ACP;  and  D)  total  clinoidectomy  refers  to
removal  of  the  tip,  head,  body,  and  base  of
the ACP.
Figure 31: A  3D  CT  skull  base  reconstruction  (left)  and  a  schematic  drawing  (right)  showing  a  right  ACP  and  a
tailored clinoidectomy through an LSO approach (grid). A) minimal clinoidectomy with removal of the tip of the
ACP (less than 1/3 of total ACP); B) partial clinoidectomy with removal of the tip and head of ACP (1/3 of total
ACP); C) subtotal clinoidectomy with removal of the tip, head, and body of the ACP (2/3 of total ACP); and D) total
clinoidectomy with removal of the tip, head, body, and base of ACP (whole ACP).
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Characteristics of Meningiomas (Publications I-III)
Tumor Size
The average OGM tumor size was 47 (range
20-85) mm. Twenty-five (38%) of 66 OGMs
were large (> 6 cm), 27 (41%) medium (3–6
cm), and 14 (21%) small (< 3 cm) (Figure
32). Tumors were located in the midline in
45 patients (68%), extended to the right in 11
patients (17%), and extended to the left in 10
patients (15%).
Figure 32: Sagittal contrast-enhanced T1-weighted MRI. Examples of (A) small (with ethmoidal infiltration), (B)
medium, and (C) large OGMs, which presented also with sellar involvement (arrows).
The mean ACM tumor size was 32 (range 4-
72) mm. We considered ACMs and TSMs >
4 cm to be large and distinct from OGMs
because the close relationship with the
neurovascular structures makes the surgery
challenging. Twenty (27%) of 73 ACM
tumors were small  (< 2 cm), 32 (44%) were
medium-sized (2-4 cm), and 21 (29%) were
large (> 4 cm) (Figure 33).
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Figure 33: Coronal contrast-enhanced T1-weighted MRI showing right small (A), medium (B) and large (C) ACMs.
The mean TSM tumor size was 31 (range 6-
84) mm. Seven (13%) of 52 TSMs were
small (< 2 cm), 34 (66%) were medium-sized
(2-4 cm), and 11 (21%) were large (> 4 cm)
(Figure 34). Both ACMs and TSMs size
were associated with the presence of edema,
brain shift, and involvement of neurovascular
structures, but the tumor size did not predict
tumor consistency and was not related to the
existence of preoperative visual deficits.
Figure 34: Axial contrast-enhanced T1-weighted MRI showing right small (< 2 cm) (A), medium (2-4 cm) (B), and
large (> 4 cm) (C) TSMs.
Peritumoral Edema
Preoperative edema was present in medium
and large-sized OGMs, ACMs, and TSMs.
Four  small  OGMs  (<  3  cm)  presented  also
with peritumoral edema.
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Side of Approach in OGM and TSM
For midline meningiomas as OGMs and
TSMs we prefer a right (non-dominant) LSO
approach, more convenient for a right-
handed neurosurgeon. Fifty-five OGMs were
removed via right side even if the tumor
extends more to the left side; 11 OGMs
patients were approached from left because
of marked tumor extension to the left; the
other three patients were approached from
left because: in one there was a separate
posterior clinoid meningioma on the left
removed together with the OGM; in one
there was preoperative left-sided optic nerve
dysfunction; and in one there was an
extensive scarring on the right due to
previous surgery. Preoperative visual deficit
and main tumor location were the
determinant factors in the choice of the side
of the craniotomy.
Hyperostosis and Infiltration of Ethmoid Sinuses in OGM
Thirty-two OGM patients presented
preoperative hyperostosis, and it was related
to the tumor size (p0.001) (Figure 28). The
hyperostotic bone was drilled during surgery
with a high-speed diamond drill. Twenty-five
OGMs infiltrated the ethmoid sinus,
irrespective of hyperostosis or tumor size.
Four patients of 25 with OGM inside the
ethmoidal sinus were deliberately left with
extracranial tumor tissue behind.
Temporal Extension and Clinoidectomy in ACM and TSM
Twenty (27%) ACM patients (two small,
five medium-sized, and 13 large ACMs)
underwent  a  LSO  with  temporal  extension
predicted by the tumor size (p<0.001). In 53
(73%) ACM patients (eight large ACMs) a
classic LSO was enough to remove the
tumor. Twenty-one ACMs patients required
anterior  clinoidectomy,  six  of  whom  had  an
intraorbital extension of the tumor; in twelve
cases the anterior clinoidectomy was
predicted by the hyperostosis of the ACP
(p<0.05). Sixteen patients underwent
intradural clinoidectomy and five extradural.
The  LSO  approach  with  temporal  extension
was used to treat one TSM patient.
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Infiltration of the Sellar Region (OGM and ACM) and Cavernous Sinus (OGM,
ACM, and TSM)
Five OGM and 16 (12 large) (p<0.001) ACM
patients had tumors infiltrating the sellar
region. Seven ACM patients with sellar
infiltration also had the tumor attached to the
dura of the cavernous sinus (p<0.05). One
small, six medium, and 10 large ACMs
(p<0.05) and four TSMs (two large and two
medium-sized), presented attachment to the
dura of the cavernous sinus.
Intraorbital Tumor Extension and Attachment to the Optic Chiasm and Nerve
Thirty patients presented with OGM which
was attached to the optic chiasm, 14 of
whom had preoperative visual deficit. Ten
ACMs had an intraorbital extension and six
of which required an anterior clinoidectomy.
The size of ACM predicted optic nerve and
chiasmatic compression (p<0.001).
Chiasmatic compression was observed in 12
large, two medium-sized, and one small
ACM. In 11 ACMs (10 large and one small),
sellar involvement was also observed.
Chiasmatic compression was associated with
preoperative visual deficit in 12 of 15 cases
(p<0.05). An intraorbital extension of TSM
was seen in one large TSM.
Meningioma Attachment to the Vessels
Attachment of ICA to ACM and TSM
ACM and TSM size predicted tumor
attachment to the ICA (p<0.05). ICA
attachment was found in 60 ACM and 49
TSM  cases.  In  seven  ACMs  (four  large  and
three medium-sized), and two TSMs (one
large and one medium-sized) the ICA was
dislocated by the tumor. Encasement of ICA
inside  the  tumor,  present  in  27  ACM  and
nine TSM cases, was also related to tumor
size (p<0.001). In 33 TSM cases, both ICAs
were involved. The ICA was narrowed in
only one medium-sized TSM. In one large
and one medium-sized ACM the ICA was
closed.
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Attachment of ACA to ACM and TSM
ACA was attached to 41 ACM and 38 TSM
cases, and it was related to tumor size
(p<0.001). In 12 ACMs and four TSMs ACA
was encased by the tumor (p<0.05). The
ACA was dislocated by the ACM in 17
patients but remained patent in all of them.
In 30 TSM cases, both A1s were involved. In
14 cases, the ACA was dislocated by the
TSM;  this  was  related  to  tumor  size
(p<0.05).  In  10  cases,  both  A1s  were
dislocated; in four cases, only one.
Attachment of AComA to TSM
Forty-one meningiomas were attached to
AComA  and  it  was  related  to  tumor  size
(p<0.05). In 15 cases, the vessel was also
dislocated, and in three cases only encased
by  the  tumor.  In  no  case  was  the  vessel
closed or narrowed by the tumor (Figure 35).
Figure 35: A 3D-CTA reconstruction showing a
large TSM and its vascular relationship.
Attachment of A2 to OGM and TSM
In 33 OGM and 36 TSM patients the
A2s were involved, and it was related to
tumor size (p<0.001). Postoperative
ischemic complications in OGM
surgery were not predicted by the
attachment to A2s.
In  31  TSMs  both  pericallosal  were
involved (Figure 35). Both pericallosal
arteries were dislocated by the TSM in
13 cases.
Attachment of M1 to ACM and TSM
Attachment to M1 was found in 48 ACMs,
and tumor size again predicted this
(p<0.001). In 19 of these ACMs, the vessel
was also dislocated (p<0.001). In 14 ACMs,
the vessel was encased by the tumor, but had
remained patent. Seven TSMs were attached
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to M1 predicted by tumor size (p<0.05).
Attachment of BA to TSM
Two TSMs (one medium and one large)
were attached to the BA.
Pituitary Stalk Involvement in TSM
The pituitary stalk was involved in 42 TSM
patients  and  was  associated  with  tumor  size
(p<0.05). In 20 cases, it was encased, in four
cases dislocated by the tumor and in 18 cases
only attached to the tumor. Three patients
with pituitary stalk involvement had
preoperative endocrinological deficits. The
pituitary stalk was preserved in all cases.
Tumor Consistency
Tumor consistency was not predicted by
tumor size, patient’s age, or preoperative
neurological deficits, nor was it related to
postoperative clinical or surgical
complications. Twenty-eight OGM, 30
ACM,  and  24  TSM  patients  had  a  soft
(suckable) tumor. Twenty-four OGM and
ACM,  and  14  TSM  patients  had  a  tumor  of
medium consistency (some parts can be
removed with suction).
Fourteen OGM patients had a hard (not
suckable) tumor; 18 ACM and 14 TSM
patients also had hard tumors.
Tumor Calcifications
Tumor calcifications presented in 13 ACMs
(seven medium- and six-large- sized) and 11
TSMs (nine medium- and two large-sized)
did not affect the time meningioma removal
and was not related to postoperative surgical
complications, but eight ACM patients
presented with postoperative clinical
complications (p<0.05).
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Operative Time
The mean OGM operative time from skin to
skin was 158 (range, 60-350) min: 84 (range,
60-120) min for small, 142 (range, 73-255)
min for medium-sized, and 217 (range, 115-
350) min for large OGMs (p<0.001).
The mean ACM duration of operation from
skin to skin closure was 120 (range, 35-285)
min: 87 (range, 35-235) min for small, 98
(range, 50-190) min for medium-sized, and
186 (range, 111-285) min for large tumors.
Interestingly, the duration of surgery was
affected by tumor size (p<0.001), attachment
to M1 (p<0.05), ICA (p<0.05), and ACA
(p<0.001), and encasement of M1 (p<0.001),
ICA (p<0.001), and A1 (p<0.05).
The mean duration of all TSM operations
from skin to skin closure was 116 (range, 43-
442) min: 62 (range, 43-75) min for small,
107 (range, 53-180) min for medium, and
182 (range, 83-442) min for large tumors.
Duration  of  surgery  was  affected  by  TSM
size (p<0.05). Duration of surgery also
depended on attachment to the optic chiasm
(p<0.05), A1 attachment or encasement, and
AComA and A2 attachment (p<0.05).
Interestingly, tumor consistency did not
affect operation time in any meningioma
group.
Histological Grading of Tumors
All meningiomas were grade 1, except for 10
(two OGMs, seven ACMs, and one TSM)
patients with atypical grade 2 meningiomas.
Surgical Complications
CSF Leakage
Six OGM patients (9%) developed CSF
leakage from the nose; three of them had
tumor infiltration into the ethmoid sinuses.
Four of the six patients were treated with
lumbar  drainage  for  a  few  days.  The  other
two patients required a fascia lata graft.
Three  ACM  and  three  TSM  patients  had
cranionasal CSF leakage. All three ACM
patients underwent clinoidectomy during the
operation. All six patients were treated using
an external spinal drainage for a few days.
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Postoperative Hematoma and Infection
One OGM patient had a postoperative
hematoma in the resection cavity requiring
evacuation.
Two ACM postoperative hematomas in the
resection cavity were observed; only one
required evacuation. One TSM patient had a
subdural hematoma that did not require
evacuation. Postoperative infection occurred
in four OGM and one ACM patient.
one ACM patient.
Anosmia, Frontal Syndrome, and Visual Outcome
New postoperative anosmia appeared in six
OGM patients and was unrelated to tumor
size. All six tumors were of either hard (three
cases) or medium consistency. Three of these
six patients had tumor infiltration into the
ethmoid sinuses. Olfactory function
improved in two patients, both of whom had
a medium-sized tumor extending more to the
right side.
Three OGM patients had postoperative
frontal syndrome. One ACM patient had
anosmia and one frontal syndrome. No TSM
patients had postoperative hypo- or anosmia
or frontal syndrome.
Fourteen  of  30  OGM  patients  with  optic
chiasm attachment, had preoperative visual
deficits. Of the 16 patients with normal
preoperative vision, five developed new
deficits (two were large and soft; one was
small, one was medium, and one was large;
all were of medium consistency). No patients
with a hard tumor developed new
postoperative visual deficits. Of the 14 OGM
patients with a preoperative visual deficit,
three improved after surgery and 11
remained unchanged. Neither tumor size nor
tumor consistency predicted occurrence of
new postoperative visual deficits.
Three ACM patients had new visual deficits:
one transitory decline of visual acuity
ipsilateral to the tumor, one unilateral
quadrantopsia, and one temporal
hemianopsia.
Eleven of 39 ACM patients experienced an
improvement to pre-existing visual deficits
after the operation. Improvement was
unrelated to tumor size (two large, four
medium, and five small) and tumor
consistency (three soft, five medium, and
three hard).
One TSM patient had a de novo visual deficit
with right-sided eye blindness and left
temporal quadrantopsia. Pre-existing visual
deficits improved because of the operation in
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22 (52%) of 42 TSM patients. This was
related to tumor size (two large, 18 medium,
and two small), but not tumor consistency
(12 soft, six medium, and four hard).
Improvement of visual outcome was
predicted by duration of the preoperative
visual deficit (p<0.05). A preoperative visual
deficit that had lasted for less than six
months improved in 13 of 20 patients, a
deficit lasting between 6 and 12 months
improved in seven of 11 patients, and a
deficit lasting over 12 months improved in
only two of 11 patients.
Outcome
Early Outcome
Clinical outcome at discharge was good in
43 OGM (65%), in 54 ACM (74%) and in 45
TSM patients (87%). Fifteen OGM (23%)
and ACM (21%) and six TSM patients
(12%) had moderate disability. Eight OGM
(12%), one ACM (1%) and one TSM (2%)
had severe disability. Three ACM patients
died for surgery.
Residual Tumor
Six OGM patients (9%) showed a residual
tumor  in  the  early  postoperative  MRI.  Five
were benign meningiomas (G1) and one was
atypical (G2). Five of the residuals were
attached to the ACAs. Four of the six tumors
infiltrated the ethmoid sinuses on
preoperative images and were deliberately
left behind, but two were unexpected
findings. Three of the tumors were large, two
were  medium,  and  one  was  small.  Three  of
the six patients underwent redo surgery for
the tumor remnant, and one had
radiosurgery. One of these three patients was
reoperated on one month after the first
surgery because some tumor had been left
behind a corner in the operative field, as
documented by the postoperative CT scan
and  MRI.  Two  of  the  six  patients  were
followed up only with MRI, receiving no
additional treatment.
Sixteen ACM patients had residual tumor; all
were benign, but one was atypical (G2); this
patient was treated in 1997 by another
neurosurgeon, underwent reoperation of the
residual tumor in 2004 and 2006, followed
by radiosurgery (20 Gy). Two other patients
were previously operated on by another
surgeon. One patient had been operated on
twice, in 1977 and 1992, and presented again
with a residual tumor (benign, medium-
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sized, medium consistency) and an intraoptic
component with documented growth, and
therefore underwent a right LSO approach
with subtotal removal in 2003. Since then,
the residual has been stable and the patient
has had a good recovery. The second patient
was treated in 1994. There was a residual
tumor attached to the optic nerve that was
growing and was reoperated in 2000 (the
tumor was small, medium consistency, and
benign). After the operation, the residual was
treated with radiotherapy (50.4 GY) and has
been stable since (last MRI performed in
January 2008). In two patients, an
intraoperative laceration of the vessel
interrupted tumor removal and some tumor
was left behind. Both patients had good
recovery. In the remaining 11 patients, the
residual tumor was attached to the optic
nerve (five patients), located at the medial
sphenoid wing (three patients), located at the
cavernous sinus (two patients) and one was
intraorbital.
Seven TSM patients had residual tumor. Two
were reoperated on by the senior author
(J.H.), one was treated by radiosurgery, and
four were only followed up. All tumors were
benign (G1), but the one patient who
underwent radiosurgery presented with
multiple meningiomas.
Tumor Recurrence during Follow-up
Four OGM cases (7%) recurred during a
median follow-up of 45 (range, 2-128)
months. All of these G1 tumors infiltrated
the ethmoid sinuses and had a hard
consistency. Their initial diameters were 61
mm, 53 mm, 43 mm, and 20 mm (redo case).
Tumor recurrence was observed in three
ACM patients during a median follow-up of
36 months (range, 3-146). One patient had a
small, soft, benign tumor (maximum
diameter 10 mm) operated on in 2001. The
recurrence of about 4 mm, attached to the
medial side of the optic nerve, was
discovered in an MRI performed in
September 2009. One patient presented with
a medium-sized ACM, which recurred two
years after surgery at the medial sphenoid
wing and was reoperated on. One patient
presented a small recurrent tumor at the
medial sphenoid wing five years after the
first operation for a large-sized ACM; the
residual was stable during a six-year follow-
up.
Tumor recurrence affected only one TSM
during the follow-up. This patient had a
medium-sized (maximum diameter 24 mm)
soft tumor attached to both optic nerves, the
optic chiasm, both A1s and ACAs, the
AComA, and the right ICA. After the first
operation in 2001, the patient’s preoperative
visual deficit (bilateral visual deficit and
bitemporal hemianopsia) improved, but in
2005 and 2009 a sudden decrease in visual
acuity led to the discovery of a recurrent
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tumor that was reoperated twice, in 2006 and
2009.
Long-term Clinical Outcome and Mortality
The median follow-up of OGM patients was
45 (range, 2-128) months. During the follow-
up 53 patients (80%) had a good recovery,
five patients (8%) moderate disability and
eight patients severe disability (12%); the
median Karnofsky score was 90. Of the 13
patients with moderate or severe disability,
all but one had a medium (seven patients) or
large (five patients) tumor. Multivariate
analysis showed that only the preoperative
Karnofsky score significantly (p<0.001)
predicted good outcome (OR 2.8, 95% CI
1.6–5.0, per 10 points of Karnofsky score).
Age, tumor size, and tumor consistency were
not independent risk factors.
The median follow-up of ACM patients was
36 (range, 3-146) months. The median
Karnofsky score was 90. At the three-month
outpatient visit, 60 patients (82%) had good
recovery, nine patients (12%) had moderate
disability and three patients (4%) died for
surgery-related reasons. One patient with a
medium-sized hard tumor attached to the
ICA,  MCA,  and  ACA  developed  a  severe
vasospasm with hemispheric infarction and
died 19 days after surgery. One patient died
on the second postoperative day because of
acute myocardial infarction after a good
initial recovery from the operation. One
patient with a large, medium consistency
tumor attached to the ACA and MCA and
encasing the ICA developed hemiparesis and
died because of severe lung infection one
month after the operation.
The  median  follow-up  of  TSM  patients  was
59 (range, 1-133) months. At the outpatient
clinic 47 patients (90%) with good recovery
and four patients (8%) with moderate
disability. One patient (2%), already in poor
condition preoperatively, died 40 days after
surgery due to cardiac arrest. The median
Karnofsky score was 80.
Method of Anesthesia for OGM, ACM, and TSM Surgery
(Publication IV)
Data analysis includes surgical data for 191
patients and anesthesiological records for
187 patients. Anesthesiological charts were
not available for two OGM patients and two
ACM patients.
The surgical conditions were classified as
good (slack brain achieved) for 154 patients
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(82%), as satisfactory for 18 patients (10%), and as poor for 15 patients (8%).
Induction of Anesthesia
Diazepam (5-15 mg) was given orally to all
patients one hour before surgery. Tiopenthal
(median dose 377 mg, range 300-500 mg)
was used in 186 (99%) patients to induce
anesthesia. Etomidate (14 mg) was used in
an 80-year-old patient with congestive heart
disease and a medium-sized TSM. The mean
(range) total intraoperative amount of
fentanyl was 0.56 (0.150-3) mg, mainly
given as a single bolus at the induction of
anesthesia.
Table 7. Method of anesthesia.
Method Number of
patients
Intravenous anesthesia
 Propofol infusion  46 (25%)
Volatile agents
 Sevoflurane  74 (40%)
 Isoflurane  33 (17%)
Combined anesthesia
 Sevoflurane/Isoflurane +
    propofol infusion
 34 (18%)
Maintenance of Anesthesia and Tumor Size
Propofol infusion (46 patients/25%),
sevoflurane (74/40%), or isoflurane
(33/17%), or a combination of propofol
infusion and sevoflurane/isoflurane (34/18%)
were used for anesthesia (Table 7).
Anesthesia was maintained with Nitrous
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oxide (N2O) in 140 patients (75%). N2O was
most often combined with sevoflurane or
isoflurane (95/51%) (p<0.05).
Twenty-one medium and 21 large
meningioma received propofol anesthesia.
Only four patients anesthetized with propofol
had a small meningioma. Twenty-four
patients anesthetized with propofol presented
with peritumoral edema.
Sevoflurane or isoflurane anesthesia was
given to 37 large-, 45 medium-, and 25
small-sized meningioma patients received,
and 40 of them (10 medium and 30 large
meningiomas) presented with peritumoral
edema. Univariate analysis disclosed no
correlation between tumor size and method
of anesthesia.
One-hundred sixty-six patients (89%)
received remifentanil infusion. A
combination of remifentanil with sevoflurane
(71  cases)  or  isoflurane  (20  cases)  was  used
in 91 patients (49%) or with propofol in 41
patients (22%).
Neuromuscular block was achieved by non-
depolarizing muscle relaxants (rocuronium
or vecuronium) in all study patients. In 33
patients neostigmine was necessary to
reverse the neuromuscular block at the end
of surgery.
Brain Relaxation and Anesthesia
Brain relaxation was good in 154 patients
(82%). In 18 patients, brain relaxation was
classified as satisfactory (10%) and optimal
slack brain was achieved by opening the
basal cisterns during surgery.
In 15 patients (8%), the brain swelled
intraoperatively. Thirteen of these patients
had large tumors (p<0.001). The median
Karnofsky score was 80 (range 50-90), and
14 of the 15 patients had peritumoral edema.
Nine patients with brain swelling had either
sevoflurane (six cases) or isoflurane (three
cases) anesthesia. In multivariate analysis,
swelling of brain was associated with
medium- to large-sized meningiomas,
peritumoral edema, volatile or combined
anesthesia, and poor preoperative clinical
condition (Karnofsky score <70) (p<0.01).
Osmotic Agents
The administration of 15% mannitol
according to meningioma size is presented in
Table 8. The use and amount of mannitol
were significantly associated with
meningioma size and preoperative cerebral
edema (p<0.05). However, in two small-
meningioma patients without peritumoral
edema, 500 ml of mannitol was administered
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before surgery because they had been
operated on before the year 2000, when
mannitol began to be given routinely.
Hypertonic saline was not administered to
any patient.
The median cumulative amount of urine
during surgery was 350 (range 0-348) ml for
177 patients (95%); for 25 of these patients,
it was recorded as 0 ml.
Table 8. Size of tumor and amount of mannitol used (p=0.01).
Small Medium Large Total of patients
< 2cm 2-4 cm >4cm
Mannitol ML
100 0 1 3 4
200 0 1 1 2
250 0 0 1 1
270 0 0 1 1
350 0 0 1 1
400 0 2 2 4
500 2 12 35 49
Total of Patients 2 16 44 62
Hemodynamics and Vasoactive and Antiepileptic Drugs
Systolic and diastolic arterial pressures and
heart rate are shown in Figure 36. The mean
systolic blood pressures ranged between 95
and 110 mmHg during surgery. Heart rate
remained stable. Extreme hemodynamic
changes were not observed. Hemodynamic
data on the size and type of tumor were
similar. The mean preoperative systolic and
diastolic blood pressure was 125 and 70
mmHg, respectively. The majority of the
patients (157/84%) had a systolic blood
pressure of less than 160 mmHg for the first
six hours after the operation. Intraoperative
phenylephrine infusion was given to 60
(32%) patients and dopamine to four (2%)
patients. Sixty-nine patients were also
administered a bolus of phenylephrine. A
bolus of ephedrine (mean 3.9; range, 5-75
mg) was given to 52 (28%) patients.
Labetalol (mean 14 mg; range, 9-120 mg)
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was given to 68 (36%) patients. Other
vasoactive agents used in 29 (16%) patients
were dihydralazine sulfate (15 cases),
clonidine (six cases), metoprolol succinate
(three cases), and atropine (two cases).
Droperidol was administered to three (2%)
patients. The use of any vasoactive agent was
unrelated to type or size of tumor.
Figure 36: A graphic illustration showing the
mean pre-, intra-, and post-operative arterial
pressure.
One-hundred-four (56%) patients
received antiepileptic drugs
perioperatively. These drugs comprised
fosfenytoin (95 cases), carbamazepine
(six cases), fenytoin (two cases), and
lorazepam (one case). The administration
of antiepileptic drugs was not related to
tumor location, but was related to tumor
size (p<0.05).
Intraoperative Bleeding and Blood Transfusion
Blood loss was related to tumor size
(p<0.001). The median cumulative
intraoperative blood loss was 200 (0-2000)
ml. In 44 patients (23%), the estimated
intraoperative blood loss was less than 50 ml.
Two patients had blood loss above 1500 ml.
In one patient (blood loss of 1800 ml) the
internal carotid artery lacerated accidentally
during the removal of a small ACM; and the
laceration was repaired with microsuture.
The other patient (blood loss of 2000 ml),
had a very large vascularized (maximum
diameter > 8 cm) OGM meningioma. Red
blood cell transfusions were administered to
17 patients (9%) (Table 9). Interestingly, 170
patients (91%) did not require a red blood
cell transfusion. Fresh frozen plasma and
platelet concentrates were given to two
patients each.
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Table 9. Size of tumor and red blood cell transfusion (p<0.05).
Small Medium Large Total of patients
< 2cm 2-4 cm >4cm
Red blood cells
unit (ml)
0 29 80 61 170
100 1 1 0 2
200 1 0 1 2
250 0                       1 0                        1
400 0                       0 1 1
500 0                       0 6 6
600 1 0 0 1
750 0 0 2 2
800 0 0 1 1
1000 0 0 1 1
Extubation Time
One-hundred and fifty-seven patients (84%)
were extubated on the day of the surgery.
The median (25th/75th percentiles)  time  to
extubation after surgery was 18 (8/105) min.
Fifty-three patients (28%) were extubated
within 10 min of completion of surgery (14
small, 33 medium, and six large
meningiomas). Forty-five patients (24%)
were extubated within 30 min of surgery (13
small, 24 medium, and eight large
meningiomas). Fifty-nine patients (32%)
were extubated within 1 h (10 cases), 5 h (36
cases), or more than 5 h postsurgically,  but
nevertheless on the same day of the surgery
(13 cases).
Twenty-nine patients (16%) were extubated
during the following days after surgery: 21
patients on the first postoperative day, three
patients on the second postoperative day, one
patient on the third postoperative day, two
patients on the fourth postoperative day, and
one patient on the fifth or sixth postoperative
day (one case each). In univariate and
multivariate analyses, preoperative clinical
status (Karnofsky score < 70) (p<0.001),
tumor size and location (OGM) (p<0.001),
peritumoral edema (p<0.001), and brain
swelling at surgery (p<0.05) were predicting
factors  for  prolonged  extubation  time  after
surgery (days after surgery).
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Surgical Complications and Outcome after Anterior Clinoidectomy
(Publications V and VI)
Tailored Anterior Clinoidectomy
We performed a tailored clinoidectomy in 82
patients (Table 10). We removed only the
necessary amount of bone for the treatment
of the aneurysm or the tumor. We classify
this removal as follows 1) the tip of ACP
(less than 1/3 of all clinoid); 2) the tip and
the head of the ACP (around 1/3 of ACP); 3)
the tip, the head and the body of the ACP
(around 2/3  of  ACP);  4)  the  whole  ACP.  In
eight patients (three vascular and five tumor
cases) the anterior clinoidectomy was
extended laterally to open the SOF.
Table 10. Site of the lesions and tailored anterior clinoidectomy.
Tailored clinoidectomy Minimal  Partial Subtotal  Total
 Clinoidectomy
Total number of
cases
Vascular cases
Carotid-ophthalmic aneurysm 1 0 8 12 21
Other carotid aneurysms 1 3 3 16 23
Basilar bifurcation aneurysm 1 0 0   0   1
Carotid-cavernous fistula 0 0 1   1   2
Tumor cases
Meningioma 2 4 5 15# 26
Other lesions 0 1 1   7   9
Total
(vascular + tumor cases)
5 8 18 51 82
          # In one case orbital roof was also removed.
Visual Outcome
Preoperative visual deficits were present in
27 patients (33%) and worsened after surgery
in three patients (4%). One patient with
bilateral carotid-cavernous fistula had
previously undergone two sessions of
endovascular treatment and radiosurgery.
After  these  the  patient  had  right  oculomotor
palsy,  chemosis  and  bilateral  decrease  of
visual acuity. Extradural anterior
clinoidectomy was performed with Sonopet
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and drill and the fistula was successfully
closed. The visual deficit improved in the left
eye but worsened in the right. One patient
had preoperative bilateral visual acuity
deficit due to anterior clinoidal meningioma
and developed a unilateral blindness after
surgery. One patient presented with
intraorbital fibrous dysplasia and both visual
acuity and visual field deficit, which
worsened after surgery.
Four patients (5%) with preoperatively intact
vision had new visual deficits
postoperatively. One patient with a small
unruptured carotid-ophthalmic aneurysm
developed unilateral blindness. One patient
with a medium-sized unruptured carotid-
ophthalmic aneurysm developed temporal
hemianopsia. One patient with a ruptured
blister-like ICA aneurysm and HH Grade 5
subarachnoid hemorrhage had a unilateral
decrease of the visual acuity. One patient
with intraorbital cavernoma developed
unilateral blindness after surgery (Table 11).
Sonopet was used in five out of these seven
cases that experienced postoperative visual
complications. The whole ACP was removed
in five cases. However, univariate or
multivariate statistical analyses did not
reveal any factors that would statistically
significantly associate with the occurrence of
postoperative visual deficits.
Twelve patients (15%) with preoperatively
existing visual deficits improved after
surgery (the patient with bilateral carotid-
cavernous fistula and an improvement of the
left but worsening of the right eye visual
acuity not included). Again, statistical
analysis did not reveal factors associating
with improvement of visual deficits.
Interestingly, however, intradural
clinoidectomy was performed in all patients
with improvement in visual deficits.
Table 11.
Postoperative complications
in 82 patients who underwent
tailored anterior clinoidectomy.
CSF leakage 5
Wound infection 1
ICA rupture 1
Meningitis 1
Oculomotor palsy
(transient)
16
Oculomotor palsy
(permanent)
1
Visual deficits 7
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Ophthalmoplegic Complications
Seventeen patients (21%; ten aneurysm and
seven tumor cases) developed oculomotor
palsy after surgery and they were not related
to anterior clinoidectomy. Thirteen of them
had recovered completely at three months,
three had improved significantly, and
symptoms persisted in only one patient. This
patient was operated on for an unruptured
giant basilar bifurcation aneurysm, and the
oculomotor palsy was not related to the
anterior clinoidectomy itself (only the medial
tip of the ACP was removed). In only one of
these patients was the SOF opened; this
patient had an anterior clinoid–cavernous
sinus  meningioma,  and  the  whole  ACP  was
removed extradurally. This patient also
developed a transient abducent nerve palsy.
CSF Leakage
Five patients (6%; three aneurysm and two
tumor cases) had postoperative CSF
rhinorrhea (Table 11). Three of them
required a reoperation and duraplasty to
occlude the cranionasal fistula, and in two an
external lumbar drainage for a few days was
sufficient.
Other Surgical Complications
One patient presented with unruptured
carotid-ophthalmic and intracavernous
carotid aneurysms, and the operation was
planned to treat only the ophthalmic
aneurysm.  During  the  extradural  removal  of
the ACP with microrongeur, the
intracavernous aneurysm attached to the
ACP ruptured together with the parent
vessel.  The  rupture  site  was  repaired  with
AnastoClip (AnastoClip Vessel Closure
System 1.4 mm; LeMaitre Vascular,
Burlington, MA, USA) (Figures 37 and 38).
This case has previously been published as a
technical case report (197). One patient had
meningitis and one patient severe wound
infection (Table 11).
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Figure 37: Sagittal view of a 2D reconstruction CT showing the relationship between the anterior clinoid process
(arrows) and the intracavernous aneurysm.
Figure 38: 3D-DSA, intraoperative view and schematic drawing of left ICA aneurysms showing the tear of the ICA
repaired by using AnastoClips.
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Clinical Outcome at Discharge and
at Three Months
At discharge, 66 patients (80%) had good
recovery, seven patients (9%) had moderate
disability, seven patients (9%) had severe
disability, and two patients (2%) were
unconscious. These two patients were
admitted because of Hunt-Hess grade 5
subarachnoid hemorrhage. Disability was not
related to the anterior clinoidectomy itself in
any of the patients. At three months, 71
patients (87%) had good recovery, six
patients (7%) had moderate disability, four
patients (5%) had severe disability, and one
patient (1%) remained in a vegetative state.
Three patients experienced a worsening of
neurological condition that did not improve
in  three  months:  one  patient  with  a  giant
unruptured basilar bifurcation aneurysm had
hemiparesis and severe disability; one patient
with kidney failure who underwent clipping
for giant carotid-ophthalmic aneurysm had a
slow recovery and severe disability still at
three months; one patient with a spheno-
orbital meningioma suffered from severe
wound infection at one week from surgery
and had moderate disability at three months.
There was no surgical mortality in the series.
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6  Discussion
This series of 273 patients treated through
the LSO approach and by a single-surgeon is
the largest series published to date. The LSO
approach is simpler, faster, and less
extensive than the previously advocated
pterional, bifrontal and orbitozygomatic
approaches, while producing comparable
results in terms of safety and extent of tumor
removal. The LSO approach can be
performed in 10 minutes, allows the
neurosurgeon to remove the tumor with
minimal blood loss, and avoids brain damage
or contusion with most of the patients
extubated the same day of surgery.
Lateral Supraorbital Approach versus Pterional, Bifrontal, and
Fronto-Orbital Approaches
LSO Approach versus Pterional Approach (Publications I-III)
Both pterional or minipterional approach
were used by the senior author (J.H.) to treat
39 OGM patients since 1979. The pterional
or minipterional approaches have the sylvian
fissure in the center of the craniotomy, with
partial exposure of the frontal and temporal
lobes (70, 254). During the years, with
experience the senior author noted that the
middle fossa extension was unnecessary and
only the frontolateral part of the approach
was needed during the surgery. This
subsequently led to the development and use
of the LSO approach for vascular and
neoplastic lesions (101). The sylvian fissure
remains at the border after a LSO approach
and can easily be opened if necessary, as our
experience with MCA and other anterior
circulation and even posterior circulation
aneurysms shows (48-51, 100, 102, 138, 139,
198, 199).
The most widely described approach for
OGM,  ACM,  and  TSM  surgery  in  the
literature has been the pterional one (14, 59,
68, 188, 238, 255, 260, 261). This approach,
described by Dandy in 1942 (46) and later
perfected and popularized by Yaargil (254),
is  commonly  used  for  vascular  and
neoplastic lesions of the anterior and medial
cranial fossa. When treating OGMs, ACMs,
and  TSMs  the  pterional  approach  allows  to
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visualize the anterior circulation, the basal
feeders, and the optic nerve and chiasm.
In larger tumors with more temporal
extension, the LSO may be modified with a
1-cm temporal extension to fully visualize
the temporal portion of the sylvian fissure.
This modified approach was applied in 20
ACM patients. However, for small or
medium-sized meningiomas, the classic LSO
approach is generally sufficient to safely and
completely  remove  the  tumor.  The  LSO
approach gives the same advantages as the
classic pterional approach, but is less
traumatic and faster. The LSO approach can
be performed in 10 minutes, allows the
neurosurgeon to remove the tumor with
minimal blood loss (median cumulative
blood loss in meningioma patients was 200
ml), and avoids brain damage or contusion
with most of the patients extubated the same
day of surgery (157 meningioma patients).
Modern neuroanesthesia (191) and CSF
release after opening the basal cisterns give
space to visualize the necessary
neurovascular structures. A recent cadaveric
study demonstrates that the LSO approach
gives the same advantages than the pterional
one (204).
LSO Approach versus Bifrontal Approach (Publications I and III)
OGMs and TSMs can be treated by using a
bifrontal transbasal interhemispheric
approach. This approach  provides an easier
anatomical orientation to both optic nerves,
the optic chiasm, and vascular structures, and
allows the surgeon to devascularize the
tumor. LSO approach gives less exposure of
the frontal lobes than the bifrontal approach,
with minimal surgical manipulation.
Bilateral retraction of the frontal lobe and the
sacrifice of the anterior third of the SSS and
of the frontal draining veins are not needed
when using the LSO approach with minimal
risk of postoperative infarction or increased
edema. The frontal sinus is always opened
when performing the bifrontal approach with
the risk of postoperative CSF leakage and
infections. In our experience the frontal sinus
is seldom opened during the LSO approach.
In a recent study comparing a simple
frontolateral approach (very similar to our
LSO approach) with the bifrontal approach
in microsurgery of OGMs, three patients in
the bifrontal group died due to postoperative
brain edema. No deaths occurred in the
frontolateral group. The authors concluded
that the anterior third of the SSS should be
preserved during OGM surgery, and this is
better achieved with the frontolateral
approach (159). These authors also compared
the frontolateral and the bifrontal approach
for TSM surgery, the incidence of
postoperative brain edema and venous
infarction being higher in patients
undergoing bifrontal craniotomy. The
authors concluded that the anterior third of
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the SSS should be preserved because its
closure is not safe, often resulting in
complications or death (161).
LSO Approach versus Orbitozygomatic Approach (Publications I-III)
Frazier in 1913 first described the
orbitozygomatic approach to reach the
pituitary gland (74). This approach was later
refined by Jane (114) and it is recommended
by many authors to remove OGMs, ACMs,
and TSMs (3, 5, 149, 209, 216).
For  OGM  surgery,  Al-Mefty  and  Babu
recommended a unilateral frontal craniotomy
with orbital osteotomy to prevent bifrontal
retraction, leading to possible mental
changes (3, 5, 149, 209, 216). The
orbitozygomatic approach is recommended
by  Al-Mefty  and  Sekhar  when  treating
ACMs and TSMs (3, 5, 209). When
performing the orbitozygomatic approach
there is a minimal brain retraction;  there is
possibility to access to the tumor via
different routes (subfrontal, subtemporal,
transsylvian); the cavernous sinus can be
entered if needed; the vascular support to the
tumor can be easily reached (4, 5). Haddad
and Al-Mefty recommend using a spinal
drainage to achieve a slack brain (91). The
LSO approach provides the same advantages
as the orbitozygomatic approach, especially
if the operator enters from the side of the
head to have a better angle, but is by far
simpler, less traumatic, and faster. A slack
brain can be achieved by modern
neuroanesthesia (191) without spinal
drainage. In small and medium-sized
meningiomas additional space and brain
relaxation is achieved by opening the basal
cisterns. In large tumor debulking with high
power bipolar and suction is one of the first
steps of the operation, followed by the
opening of the basal cisterns. When using the
LSO approach, the tumor can be reached
subfrontally, but the sylvian fissure can also
be easily opened. The subtemporal route is
not  needed  when  treating  ACMs  or  TSMs
because the main vascular support comes
from the dura of the anterior clinoid, planum
sphenoidale, and orbital roof via the AEA
and PEA.
Pterional, orbitozygomatic, and
minisupraorbital approaches were compared
in a recent cadaveric study (71). The
minisupraorbital approach with removal of
the orbital rim gives a similar surgical view
as the pterional and orbitozygomatic
approaches. In our experience, inclusion of
orbital osteotomy is not necessary or
beneficial when the LSO approach is used to
remove OGMs, ACMs, and TSMs.
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Neuroanesthesia in LSO Approach for a Slack Brain  (Publication IV)
Based on our review on 187 neuroanesthesia
procedures in patients who underwent LSO
approach, we found that patient position,
method of anesthesia, osmotherapy, and
adequate cerebral perfusion pressure, all
together gives a slack brain. One-hundred
and fifty-four patients (82%) had slack brain,
17 (10%) had a satisfactory neurosurgical
conditions and 15 (8%) had brain swelling
after craniotomy. Volatile anesthesia was
given to nine (5%) patients with brain
swelling. The LSO approach with a bone flap
about 3-4 cm in diameter is not traumatic
(100, 101, 103, 104) and intraoperative
bleeding was high in only two patients due to
accidental ICA lesion or a well-vascularized
tumor.
The head of the patient should be elevated
30° and should be as neutral as possible to
facilitate the venous return (153). The senior
author (J.H.) used in all patients a round firm
pillow under the shoulders of the patient and
the position of teh head is adjusted so that
the operating table was usually 20 cm over
the cardiac level.
Brain relaxation can be achieved during
craniotomy by regulating cerebral blood flow
(CBF) and cerebral perfusion pressure
(CPP). Physiological pressure-flow
autoregulation, ventilation (CO2 reactivity),
method of anesthesia regulate CBF.
An arterial transducer set at zero at the level
of the foramen of Monroe optimized the CPP
according to the systemic blood pressure
measurement  .  The  safe  lower  limit  of  CPP
was determined individually by assessing the
overall hemodynamic profile. The systolic
blood pressure varied on average between 95
and 110 mmHg, providing a CPP of above
60 mmHg. The targeted CPP was achieved
by use of relatively small doses of vasoactive
drugs, i.e. phenylephrine or ephedrine,
without excessive intravenous fluid
administration. During removal of a brain
tumor  it  is  also  essential  to  avoid  peak
increases in systolic arterial blood pressure to
minimize bleeding. Clinical assessment of
CPP was optimal in all patients since none of
the patients had ischemic brain lesions
postoperatively and blood loss was minimal
intraoperatively.
Adequate depth of anesthesia and analgesia
gave hemodynamic stability. A bolus of
fentanyl (5-7 microg/kg) following infusion
of remifentanil blunts sympathetic activity
during craniotomy. Inhaled anesthetics were
used in patients with all tumor sizes. Our
observations confirm the results of previous
studies showing that inhaled anesthetics are
suitable in patients undergoing resection of a
brain tumor (25, 37).
In patients with high intracranial pressure
(ICP) (large tumor) inhaled anesthetics are
contraindicated. To counteract the
vasodilatory effect of inhaled anesthetics on
cerebral arteries, the patient must be slightly
6  Discussion
110
hyperventilated. Propofol anesthesia was
given to 43% of study patients, most often
patients with medium or large tumors,
supporting the capacity of propofol to
decrease ICP. Mannitol before opening of
the dura increases brain relaxation especially
in large tumor or in presence of brain edema.
The use of Mannitol should be reserved in
selected cases because it may induce
unfavorable side-effects such as disturbances
in electrolyte concentrations, renal
dysfunction, or coagulation disorder (143,
144).
Careful microsurgical technique, optimal
brain relaxation, and cerebral hemodynamics
all minimize blood loss during brain tumor
surgery. Furthermore, the duration of surgery
was  short,  even  in  patients  with  a  large
tumor. Indeed, the intraoperative blood loss
was on average only 200 ml, and very few
patients received red blood cell transfusion.
No previous report has described
intraoperative bleeding after OGM, ACM,
and TSM. The uneventful intraoperative
phase is also reflected in the immediate
postoperative period. Most of the patients
were extubated on the day of surgery, and
the median early Karnofsky score was 80.
LSO and Anterior Clinoidectomy (Publications II-VI)
The choice of intradural or extradural
anterior clinoidectomy and the extent of ACP
removal are related to the size and location
of the lesion. The policy of the senior author
(J.H.) for all surgeries is to minimize the
procedure and its risks, and when performing
skull base approaches to remove just enough
bone to treat the lesion. In aneurysm surgery,
the goal of anterior clinoidectomy is to
achieve proximal control of the ICA.
Sometimes the ACP is not at all removed,
but merely coagulate the dura over the ACP
to gain a few millimeters of space, sufficient
for  the  proximal  control  of  the  ICA.  Based
on the senior author’s (J.H.'s) experience, we
perform anterior clinoidectomy in all
vascular cases intradurally.
Intradural anterior clinoidectomy is choosen
when needed in ACM or TSM surgery which
conforms to the opinion and technique of
many other authors (68, 81, 149). The ACP
is  removed  after  the  tumor  resection  unless
the tumor is completely intraorbital or inside
the optic canal.
Extradural anterior clinoidectomy is
preferred by other author (165) who
emphasized the role of the opening of the
SOF through the orbitozygomatic approach
for the treatment of both aneurysms and
tumors. Opening of the SOF allows a better
exposure of the cavernous sinus and
mobilization of the cranial nerves inside
(165). We have also performed extradural
anterior clinoidectomies and we nowadays
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use the intradural-extradural approach for
neoplastic lesions, i.e. after orienting
ourselves carefully with the anatomy using
the intradural approach, we switch to the
extradural route for actual ACP removal.
Similarly, Dolenc in 1985 advised opening
the dura before complete unroofing of the
optic canal in giant carotid-ophthalmic
aneurysms or aneurysms extending over the
ACP or into the cavernous sinus (60).
Many authors (29, 52, 105, 151, 261)
consider the extradural route safer because
the dura protects the neurovascular
structures, whereas other authors (68, 141,
149, 170) prefer the intradural route.
Intradural  visualization  of  the  ICA  and  the
optic nerve is mandatory for exact
anatomical orientation and safe anterior
clinoidectomy. We recommend intradural
anterior clinoidectomy for all vascular and
most neoplastic lesions.
Operative Time with the LSO Approach (Publications I-III)
LSO approach can be performed in only 10
min from skin incision to opening of the
dura,  which  is  far  less  than  the  time  and
workload needed for either the bifrontal
approach or the fronto-orbital approach, not
to mention one of the more extensive skull
base approaches. Skin-to-skin operative time
includes the approach, tumor removal,
hemostasis, and wound closure. Closing time
is  usually  three  times  longer  than  opening
time. Opening and closure are shorter in the
LSO approach than in the pterional,
bifrontal, or other skull base approaches. In
our  OGM  series,  the  mean  operative  time
from skin to skin was 158 min, which was
less than a previous OGM series of 18
consecutive patients operated on by using a
bifrontal approach (230 min) (154). In all
191 patients the operative time was related to
the size of the meningiomas, but,
surprisingly, unrelated to tumor consistency.
From the economic viewpoint, the relatively
short operating times with the LSO approach
allow more efficient use of the operating
room, as more surgeries can be performed in
the same room over the course of a single
working day and also shorter operation times
are presumably beneficial for patients.
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Surgical Complications
Olfactory Function Preservation (Publications I-III)
Olfactory function preservation is one of the
key factors driving the development and
improvement of different surgical
approaches for OGMs. Excessive retraction
and manipulation or excessive coagulation
around the base of the tumor near the
vascular supply to the olfactory tract can
easily harm the olfactory function (79).
Cribriform plate osteotomy through bifrontal
craniotomy for extradural lesions of the ACF
has been reported to preserve or even
improve olfactory function (218). Dare
stresses the need to know the exact distance
below the cribriform plate to transect the
ethmoidal bone in order to preserve olfactory
function; skull base approaches to the
anterior cranial base often involve the
transection of olfactory nerves (47). We
believe that preservation of olfactory
function is only possible in small and some
medium-sized OGMs. Large OGMs
presenting with anosmia showed no
improvement  after  surgery.  In  small  and
medium-sized tumors, preoperative anosmia
was less frequent, and it was often possible
to preserve the function of the contralateral
olfactory tract. Welge-Luessen reported
potential preservation of the olfactory tract
contralateral to the tumor in OGMs of less
than 3 cm (244). Although the function of
the ipsilateral olfactory tract is often lost, the
surgical technique should aim at preservation
of both olfactory tracts by delicate dissection
in all areas, as this improves the general level
of the surgery even in large tumors. In
patients with good olfactory function,
coagulation  of  the  dura  of  the  cribriform
plate (Simpson grade II) should be limited to
preserve blood supply to the olfactory tracts
(79). Our considerable experience with
anterior circulation aneurysms indicates that
olfactory lesions may be caused by the
slightest  retraction  and  are  often  difficult  to
avoid (102). Six OGM patients had new
postoperative anosmia; only one ACM
patient had postoperative anosmia, and no
TSM patients had hypo- or anosmia.
CSF Leakage (Publications I-VI)
Other surgical series with OGM surgery have
reported CSF leakage in 3-16% of patients
operated on via the frontolateral or bifrontal
approach (14, 65, 159, 236). This high rate of
CSF leakage in OGM surgery is due to
infiltration of the tumor of the ethmoid bone
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and also to its drilling to prevent recurrences;
leakage in OGM surgery can occur
irrespective of the approach used. CSF
leakage was a postoperative complications in
six  OGM  patients;  two  patients  required  a
reoperation and three patients had infiltration
into the ethmoid sinuses.
In previous ACM reports, CSF leakage
incidence rates have ranged between 4% and
9% (4, 196). Three ACM patients had
cranionasal CSF leakage, which was
successfully treated with temporary lumbar
drainage in all cases. Clinoidectomy was
performed on all three patients, probably
leading to opening of the ethmoid sinus.
In TSM surgery, CSF leakage ranges from
4% to 33% (10, 76, 161, 207, 224, 230).
Three TSM patients in our series experienced
postoperative cranionasal CSF leakage,
which was successfully treated with
temporary lumbar drainage in all cases.
Incidence of CSF leakage after anterior
clinoidectomy has ranged between 0% and
6% (112, 178, 210, 215, 226, 261). The
anatomical continuity between the ACP and
the  ethmoid  sinuses  can  lead  to  CSF  fistula
with leakage from the nose. Five patients
(6%) in our series experienced postoperative
cranionasal  CSF  leakage;  two  of  them  were
treated with temporary lumbar drainage for a
few days and three required new operations
for  plastic  repair  of  the  skull  base.  All  of
these patients had good recovery at
discharge.
Visual Outcome (Publications I-III)
Especially in large OGM tumors visual
deterioration is a known complication. The
range of visual complications has ranged
between 7-12% in patients operated on via a
bifrontal or unilateral/subfrontal approach
(65, 169, 214). In our series, five OGM
patients had new postoperative visual
deficits;  in  four  of  these,  the  OGM  was
attached to the chiasm and the ACAs. Two
of these five patients improved.
Eleven of 39 ACM patients with
preoperative visual deficit experienced
improvement of their pre-existing visual
deficits. Five of these patients underwent
anterior clinoidectomy (four intradurally and
one extradurally). In our series, 22 of 42
TSM patients with preoperative visual
deficits experienced improvement in these
deficits. Improvement was related to the
preoperative duration of the deficit. Vision in
10  of  these  TSM  patients  was  restored
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completely after the operation; the deficit
had lasted less than six months in six cases
and between 6 and 12 months in four cases.
Seven TSM patients experienced a
worsening of the preoperative visual deficit,
and one patient presented a new visual
deficit. The visual deficit remained stable in
13 of 42 patients with pre-existing visual
deficits. The range of visual improvement in
previous TSM series has been between 19%
and 91%, and the range of visual
deterioration between 3% and 39% (15, 68,
76, 151, 160, 178, 180, 181, 202, 207, 222,
224, 230).
Pamir and colleagues recently reported a
series of 43 ACMs, noting that during the
extradural clinoidectomy when the dura is
retracted the tumor is also retracted, leading
to additional pressure to the optic nerve and
possible damage. The authors believed that
the intradural procedure is safer in preserving
the optic nerve (179). Lee and coworkers
published a series of 15 patients with ACMs
(including one patient with
hemangiopericytoma), with improvement of
the preoperative visual deficits in six patients
and no change in two patients. Otani et al.
published a series of 32 patients with TSMs;
20 patients received a selective extradural
anterior clinoidectomy (178). The
preoperative visual deficit improved in 15
(90%) of these patients, compared with 83%
in patients without a clinoidectomy. The
authors attributed this good outcome to the
extradural clinoidectomy, to opening of the
SOF, to sectioning of the falciform ligament,
and to decompression of the optic nerve
(136, 178). Mathiesen and Kihlström
reported on a series of 23 TSM patients
treated by a pterional and extradural
clinoidectomy approach, hypothesizing that
early optic nerve release can improve visual
outcome (151). The senior author (J.H.)
prefers to remove the ACP intradurally in
ACM and TSM surgery to maintain good
control  of  all  neurovascular  structures.  We
also recommend use of low-power
coagulation on the dura in the proximity of
the optic nerve to avoid nerve damage.
All  patients  with  new  visual  deficits
presented with an ACM where the ICA and
its branches were attached to or encased by
the tumor. During surgery the vascular
support to the optic nerve, mainly from the
superior hypophyseal arteries, may be
damaged, with subsequent optic nerve
ischemia and visual deficits (241). Al-Mefty
and Smith state that direct compression of
the tumor on the vascular support to the optic
chiasm and optic nerve is the main cause of
visual impairment (3).
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Visual Outcome after Anterior Clinoidectomy  (Publications V and VI)
Worsening of the visual acuity affected
seven (9%) of the 82 patients and pre-
existing visual deficits improved after
surgery in almost half of cases (12/27) who
underwent anterior clinoidectomy. Intradural
route was used in all patients in whom vision
improved. Visual worsening after anterior
clinoidectomy has ranged from 0% to 13%
(29, 128, 149, 151, 178, 202, 215, 261).
Yonekawa reported in 1997 thirty-two
patients who underwent a pterional and
extradural anterior clinoidectomy for  supra-
and parasellar lesions and three had visual
worsening after surgery (261). The “no drill”
technique to remove ACP extradurally was
reported by Chang in 2009, and two of 45
patients had postoperative visual deficits
(29). The role of the extradural anterior
clinoidectomy, sectioning of the falciform
ligament and opening of the SOF to improve
postoperative visual outcome in ACM and
TSM surgery, is emphasized by some
authors (151, 178, 202). However, we do not
routinely perform anterior clinoidectomy for
all ACM and TSM in accordance with some
other authors (15, 17, 68, 81, 112, 117, 126,
141, 207). When anterior clinoidectomy is
required for complete tumor removal, we
prefer a tailored clinoidectomy and remove
only  as  much  of  the  ACP  as  required.  No
statistically significant factors were found in
our series when analyzed the critical factors
affecting visual outcome, such as opening of
the SOF, extra- or intradural route, duration
of pre-existing visual deficits, and
instruments used to perform the
clinoidectomy. This is probably due to the
rather small number of patients with visual
complications and the subsequent lack of
statistical  power.  However,  after  scrutiny  of
the operative videos, we consider that usage
of the ultrasonic bone dissector (Sonopet in
our case) too close to the optic nerve may
have a role in optic nerve injury.
The most widely used technique to remove
the ACP is high-speed drilling. Chang
scrutinized 45 consecutive cases undergoing
anterior clinoidectomy through a
frontotemporal craniotomy, and assumed that
high-speed drilling can injury the
surrounding neurovascular structures directly
(mechanical) or indirectly (thermal damage)
(29). The ultrasonic bone aspirator has been
introduced to avoid the risks of drilling and
few reports exist regarding its use in anterior
clinoidectomy (29, 92). Chang supposes the
possibility of ultrasound-related cranial nerve
damage. Furthermore, the ultrasonic bone
dissector is a very expensive piece of
instrument with additional accessory device
costs. Recently has been published a report
about the use of the ultrasonic bone dissector
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in spinal surgery (123) and the authors report
six cases of dural injury and one case of
spinal cord injury attributable to the use of
the device. In our series, in the patient with
no pre-existing visual deficits and a small
carotid-ophthalmic aneurysm, the ultrasonic
bone dissector was used close to the optic
nerve, and this may have caused the
postoperative blindness of the eye. Also, in
one patient with a carotid-cavernous fistula
and another patient with intraorbital fibrosis,
both of whom experienced postoperative
visual deficits, ultrasonic bone dissector was
used close to the optic nerve. We therefore
believe that ultrasonic bone dissectors are
certainly not harmless and may cause optic
nerve injuries.
Surgical Mortality (Publications I-III)
The closure of the SSS and frontal cortical
veins and compression of both frontal lobes
after bifrontal craniotomy had a high
mortality (65). The advantage of the LSO
approach is to preserve the SSS and the
frontal cortical veins, avoiding bifrontal
compression.  No  OGM  patient  in  our  series
had increased edema postoperatively and no
immediate deaths occurred after the surgery.
Surgical mortality in OGM surgery had
ranged between 0% and 28% in previous
series (13, 39, 65, 94, 157, 159, 169, 228,
236, 244).
Mortality in ACM and TSM surgery has
been relatively high in published patient
series (4-6, 76, 81, 82, 112, 149, 161, 188,
196, 214, 224). This is explained by the close
proximity of important neurovascular
structures.
In previously published ACM series, the
mortality has ranged between 2% and 15%
when orbitozygomatic and pterional
approaches were applied (4, 5, 82, 188, 196).
In our ACM series, three patients (4%) died.
One had severe vasospasm and died 19 days
after the operation; one developed
hemiparesis and died of severe pneumonia
one month after surgery; one patient had a
good initial recovery, but died two days after
the operation of myocardial ischemia.
Nakamura et al. report the surgical results of
72 TSMs removed via the bifrontal,
pterional, and frontolateral approaches (161).
Two patients died in the bifrontal group. No
patients  died  with  the  pterional  or
frontolateral craniotomy (161). In our series,
one  patient  with  severe  disability
preoperatively and a large tumor (diameter
60 mm) died 40 days after surgery due to
cardiac arrest. She had slowly recovered and
was able to walk one month after the
operation. Surgical mortality reported in all
TSM series has ranged from 0% to 44%
when using pterional, bifrontal, supraorbital,
and orbitozygomatic approaches (6, 76, 81,
112, 149, 161, 214, 224).
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Tumor Recurrence during Follow-up (Publications I-III)
In our OGM series, with a median follow-up
of 45 months, tumor recurrences was 6%.
The tumor recurrence rate for OGMs varies
between 5% and 41%, depending on the
extent of the initial resection, but more
importantly, on the duration of follow-up (2,
19, 111, 152, 156, 159, 212, 214, 250).
Ethmoid sinus infiltration predisposes to
tumor recurrence, and a radical resection of
the tumor tissue from these sinuses leads to
lower recurrence rates (169). In older
patients, we do not advocate (overly) radical
surgeries because of the associated higher
risk of complications and only the
intracranial tumor mass should be removed.
In young patients with preoperative anosmia,
we perform a radical resection of the tumor
with extensive ethmoidal bone drilling.
Previously reported tumor recurrence of
ACMs has varied from 9% to 15% (250). In
the present report, with a mean follow-up of
36 (range, 3-146) months, three patients
(4%) had a recurrence.
Published tumor recurrence rates in TSMs
have varied from 0% to 8% using different
approaches (9, 68, 76, 81, 149, 161, 202,
207, 214). One patient (2%) of our TSM
series had a recurrence five years from the
first operation. Mahmoud et al. reported 58
TSMs with total resection in 88%, and a
recurrence rate of 2% over a mean follow-up
of 23 months (149). Nakamura et al.
compared the incidence of recurrence in 72
TSM patients treated using frontolateral,
bifrontal, and pterional approaches and
observed no differences during a mean long-
term follow-up of 45 months (161).
A previous series of 657 meningioma
patients treated at our department was
carefully reviewed, and the overall
recurrence rate over 20 years was estimated
to be close to 20% (111). Risk factors for
recurrence were coagulation without removal
of the dural insertion, invasion of bone, and
soft consistency of the tumor (111). With a
longer follow-up, the recurrence rate would
certainly have been higher in our series, but
in  general  the  OGM,  ACM,  and  TSM
recurrence rates do not seem to be higher
with the LSO approach than with other
approaches.
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“Il n’y a rien comme un rêve pour créer l'avenir. L'utopie d'aujourd'hui réalité de demain.”
Victor Hugo (1802-1885)
Future Perspectives
Near Future
Preoperative Imaging
Preoperative high-field magnetic resonance
imaging may provide a better view of the
anatomical relationship between the lesion
and the surrounding neural and vascular
structures. The location of the optic nerve
and chiasm relative to the tumor or aneurysm
and to the anterior skull base may be
visualized by novel MR diffusion tensor
imaging techniques in the future, whereas the
anatomy of small perforators may be better
imaged by advanced MRA techniques. A
careful preoperative anatomical study will
reduce surgical complications. It may be
possible to localize the ethmoid sinus and
prevent its opening during anterior
clinoidectomy, thereby avoiding
postoperative CSF leakage. Predicting the
exact consistency of the tumor and its dural
origin may also be possible. A
neuronavigator system will be used routinely
to specify the tumor or aneurysm relationship
to the skull base. The progress in the
endovascular field will make possible to
close preoperatively all the vascular support
to  the  tumor  even  if  coming  from  small
arteries challenges to reach.
Skull Base Simulators
Virtual  reality  may  be  used  to  improve
technical skills. An operation performed in
virtual  reality  before  the  real  one  will
provide skull base visualization and elucidate
the relationship between neurovascular
structures and the tumor or aneurysm,
allowing  a  precise  operative  plan  to  be
formulated that specifies all potential
difficulties and complications. Virtual reality
will enable the surgeon to perform
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increasingly more challenging procedures on
the anterior skull base through small
approaches.
Microsurgical Techniques
Refinement of neurosurgical instruments will
allow the neurosurgeon to perform simple,
elegant, and definitive procedures. Smaller
instruments must be designed. A higher
magnification microscope with different
devices for visualization of the vascular
anatomy of the tumor, for instance, will
allow devascularization of the lesion without
intraoperative bleeding or a risk of ischemia.
A new computerized device in the
microscope together with preoperative
imaging will facilitate total removal of
lesions, avoiding residual tumors. The
microsurgical instrument of the future as a
bone removal device will be lighter, stable,
and without a risk of lesions in the
surrounding vascular or neural structures.
Smaller and flexible endoscope will be used
routinely  to  visualize  the  tumor  behind  the
corner of bone and neurovascular structures.
The microscope will be replaced by simple
glasses connected to a fiber optic devices
which will allows the neurosurgeon to have
huge magnification avoiding the
encumbrance of the microscope.
Robot-assisted surgery can physically
replace the presence of the neurosurgeon in
the operative field as nowadays the daVinci
robot does in urology field.
Neuroanesthesia
Advancements in neuroanesthesia will
enable a slack brain to be achieved, avoiding
diuretic osmosis, especially in large tumors.
An optimal surgical condition may be
accomplished by using only one drug,
eliminating anesthetic drug interactions. The
procedures  will  be  shorter,  as  will  also  the
postoperative intensive care period of the
patient.
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Far Future
A better understanding of brain function will
improve the prevention and cure of vascular
and neoplastic lesions of the brain. Medical
treatments may in the distant future reduce
the need for invasive treatments, such as
surgery or radiotherapy, but this will require
accurate non-invasive diagnosis of brain
diseases and considerable developments in
specially targeted minimally invasive
treatment methods.
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7 Conclusions
The simple and fast LSO approach can be
used for OGMs, ACMs, and TSMs of all
sizes and has a relatively low morbidity and
low mortality.
Surgical results and tumor recurrence during
follow-up with this fast and simple method
were similar to those obtained with more
extensive, time-consuming approaches.
High-power coagulation should be avoided
in  the  proximity  of  the  optic  nerve  and
chiasm, taking special care to preserve the
vascular support coming from the ICA.
The anterior clinoid process can be removed
through the LSO approach without mortality
and with low morbility. The ultrasonic bone
device carries the risk of a postoperative
visual deficit. We recommend the intradural
approach for anterior clinoidectomy in all
vascular and most tumor cases.
The LSO approach requires good operating
site conditions and a slack brain. The latter is
achieved by correct patient positioning and
neuroanesthesia. In small or medium-sized
lesions, both intravenous and volatile
anesthesia can achieved a slack brain. In
large meningiomas, we prefer propofol
anesthesia and mannitol. Early
devascularization of the tumor and
intraoperative hypotension reduce
intraoperative bleeding. Postoperative
ventilator therapy is related to tumor size and
the patient's preoperative clinical condition.
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List of 15 Supplementary  Videos on
Microneurosurgery of OGMs, ACMs, TSMs and
Anterior Clinoidectomy through Lateral
Supraorbital Approach
The supplementary CD includes 15 videos on microneurosurgery of OGMs, ACMs, TSMs, and
anterior clinoidectomy through LSO approach:
1.   Lateral supraorbital approach (right side)
2.   Microneurosurgical treatment of a small (30 mm) OGM through a right LSO
3.   Microneurosurgical treatment of a medium-sized (50 mm) OGM through a right LSO
4.   Microneurosurgical treatment of a large (> 60 mm) OGM through a right LSO
5.   Microneurosurgical treatment of a large (> 60 mm) OGM through a right LSO
6.   Microneurosurgical treatment of a small (13 mm) ACM through a right LSO
7.   Microneurosurgical treatment of a medium-sized (28 mm) ACM through a right LSO
8.   Microneurosurgical treatment of a large (59 mm) ACM through a right LSO
9.   Microneurosurgical treatment of a large (60 mm) ACM through a right LSO
10. Microneurosurgical treatment of a medium-sized (24 mm) TSM through a right LSO
11. Microneurosurgical treatment of a medium-sized (25 mm) TSM through a right LSO
12. Microneurosurgical treatment of a large (60 mm) TSM through a right LSO
13. Microneurosurgical treatment of  intra-extradural ICA junction aneurysm through a left
      LSO and intradural anterior clinoidectomy
14. Microneurosurgical treatment of an ACM through a right LSO and intradural anterior clinoide
      ctomy
15. Microneurosurgical treatment of a spheno-orbital meningioma through a right LSO and
      extradural anterior clinoidectomy
Eleven videos are selected reviewing all operations on microneurosurgical treatment of OGMs,
ACMs, and TSMs, performed by Professor Hernesniemi at the Department of Neurosurgery,
Helsinki University Hospital, between September 1997 and August 2010. Three videos are
selected from all operations in which anterior clinoidectomy, through LSO approach, was
performed by Professor Hernesniemi between June 2007 and January 2011.
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“A l'alta fantasia qui mancò possa; ma già volgeva il mio disio e 'l velle, sì come rota
ch'igualmente è mossa,  l'amor che move il sole e l'altre stelle.”
Dante, The Divine Comedy, Paradiso, Canto XXX:  vv.142-145
Acknowledgments
This study was carried out at the Department of Neurosurgery, Helsinki University Central
Hospital, in 2008-2011. I wish to thank the following professors, colleagues, friends and relatives
for their teaching, help, and support during the past years.
I owe my deepest gratitude to my mentor Professor Juha Hernesniemi for his invaluable
guidance, daily support, and encouragement. Without his constant forward thrust, I would not
have been able to finish this work. He is a genius and an innovator in the neurosurgical field. If I
had to compare him to a great Italian artist I would certainly choose Michelangelo.
I feel very lucky to have assisted him in close to two thousand neurosurgical operations, and my
heartfelt thanks go to him for sharing his immense experience in neurosurgery with me.
I am also indebted to Docent Aki Laakso for his efficient supervision of my work. I am grateful
for his teaching in the OR and in scientific writing. Beside his neurosurgical skills, he is a great
experimental neuroscientist. His constructive criticism has been essential for the success of this
work.
I am grateful to my third supervisor Docent Marko Kangasniemi for his patience in helping with
this thesis and for his insightful ideas for improving the manuscript. He is always enthusiastic
about new projects and makes pleasant the most boring work. It is a great pleasure to work with
him.
I thank the official reviewers of this thesis, Docent Esa Heikkinen and Docent Esa Kotilainen,
for their excellent comments and corrections.
I warmly thank Dr. Leena Kivipelto and Professor Fady Charbel, the informal reviewers of this
thesis. Their corrections and comments improved the manuscript significatively.
124
I am indebted to Docent Tomi Niemi and Dr. Marja Silvasti-Lundell for their teaching and help
in preparing the anesthesia paper.
I thank Docent Mika Niemelä for his support in scientific writing.
I am grateful to Professor Juha Jääskeläinen and Dr. Martin Leheka for their assistance at the
beginning of this work. Their teaching influenced and noticeably improved my scientific thinking.
I deeply thank my coauthors Drs. Matti Porras, Stefano Toninelli, Emilia Gaal, Özgür Çelik,
and Ahmed Elsharkawy. Their contributions have been substantial.
I am grateful to Professor Henry Troupp for sharing some important old details of Finnish
Neurosurgery with me.
I thank Professor Lars Kihlström for his unique contribution in the history of Olivecrona.
 I am grateful to Dr. Roberto Crosa for his invaluable and beautiful drawings.
I thank Dr. Asem Salma for the cadaveric work of this thesis.
This work has been supported by an Ehrnrooth Fellowship, which I deeply appreciate.
I am indebted to my neurosurgical, neuroanesthesiological, and neuroradiological colleagues
for their vast experience and invaluable teaching as well as for always being ready to help and
discuss cases during my clinical work.
I thank Virpi Hakala and Eveliina Salminen for solving all technical problems and for generous
help over the years.
I thank all nurses at the neurosurgical department for their expertise and patience when working
with me. They have provided great support.
 I thank Carol Ann Pelli for editing the English language of this manuscript.
125
 I  am  grateful  to  my  former  chairman  of  the  Department  of  Neurosurgery  of  the  Catholic
University of Sacred Heart in Rome, Professor Gianfranco Rossi, for giving me the opportunity
to enter the neurosurgical world.
I warmly thank all of my friends and sisters in Rome with whom I shared the most carefree time
of my life. They helped me in many different ways and have taught me that attitudes to life can be
very different and colorful.
I thank Lode, Elina, Uschi, Joseph, and the entire Focolarini clan for their love and support.
I am deeply grateful to Kaija, Pekka, Anna, Kaisu, and Ulpu for being my Finnish family. Their
support, advice, and affection have helped me through many difficulties and homesickness. They
helped me appreciate and enjoy the Finnish culture and beautiful landscape. I thank them for
putting up with me in my worst stressful moments.
A silent thanks goes out to my late father, Francesco, who greatly influenced my interest in
medical art. I am sure that he protects me.
My heartfelt thanks go to Vincenzo for his help, support and affection.
I thank my elder sister Romina for being the most wonderful of sisters and for always being there
for me. She is a cornerstone in my life.
Alessio and Francesco I thank for being the light of my life, for their love, and for always waiting
for me in Italy. Their genuine happiness adds energy and optimism to my life.
Finally, I dedicate this work to my mother Carolina.  I  appreciate  all  of  the  sacrifices  that  she
made. She is the most hard-working and honest person I know and at the same time is the sweet
and wonderful mom that anyone would wish for. My deepest gratitude for everything she did for
me cannot be expressed in words.
This study was financially supported by the Helsinki University Central Hospital and an
Ehrnrooth Fellowship.
In Helsinki, October 2011
126
References
1 .  A l b i n  M S ,  C a r r o l l  R G ,  M a r o on  J C :  C l i n i c a l  c o n s i d e r a t i on s  c on c e r n i n g  d e t e c t i on
o f  v e n o u s  a i r  e m b o l i s m .  N e u r o s u r g e r y  3 : 3 8 0 - 3 8 4 ,  1 9 7 8 .
2 .  A l - M e f t y  O :  T u b e r c u l u m  S e l l a e  a n d  O l f a c t o r y  G r o o v e  M e n i n g i o m a s .  S ek h a r  L N
J I  ( e d ) :  S u r g e r y  o f  C r a n i a l  B a s e  T u m or s .  N e w  Y o r k :  R a v e n  P r e s s ,  1 9 9 3 ,  p p   5 0 7 -
5 1 9 .
3 .  A l - M e f t y  O  S R :  T u b e r c u l u m  S e l l a e  M e n i n g i o m a s .  A l - M e f t y  O  ( e d ) :
M e n i n g i om a s .  N e w  Y o r k :  R a v e n  P r e s s ,  1 9 9 1 ,  p p .   3 9 5 - 4 1 1 .
4 .  A l - M e f t y  O :  C l i n o i d a l  m e n i n g i o m a s .  J  N e u r o s u r g  7 3 : 8 4 0 - 8 4 9 ,  1 9 9 0 .
5 .  A l - M e f t y  O , A y o u b i  S :  C l i n o i d a l  m e n i n g i o m a s .  A c t a  N e u r o c h i r  S u p p l  ( W i e n )
5 3 : 9 2 - 9 7 ,  1 9 9 1 .
6 .  A l - M e f t y  O ,  H o l o u b i  A ,  R i f a i  A ,  F o x  J L :  M i c r o s u r g i c a l  r e m o v a l  o f  s u p r a s e l l a r
m e n i n g i o m a s .  N e u r o s u r g e r y  1 6 : 3 6 4 - 3 7 2 ,  1 9 8 5 .
7 .  A l - R o d h a n  N . R . F .  L E R , :  T h e  h i s t o r y  o f  i n t r a c r a n i a l  m e n i n g i om a s .  A l - M e f t y  O .
( e d ) :  M e n i n g i om a s .  N e w  Y o r k :  R a v e n  P r e s s ,  1 9 9 1 ,  p p   1 - 7 .
8 .  A n d a l u z  N ,  B e r e t t a  F ,  B e r n u c c i  C ,  K e l l e r  J T ,  Z u c c a r e l l o  M :  E v i d e n c e  f o r  t h e
i m p r o v e d  e x p o s u r e  o f  t h e  o p h t h a l m i c  s e g m e n t  o f  t h e  i n t e r n a l  c a r o t i d  a r t e r y  a f t e r
a n t e r i o r  c l i n o i d e c t o m y :  m or p h om e t r i c  a n a l ys i s .  A c t a  N e u r o c h i r  ( W i e n )  1 4 8 : 9 7 1 -
5 ,  2 0 0 6 .
9 .  A n d r e w s  B T , W i l s on  C B :  S u p r a s e l l a r  m e n i n g i om a s :  t h e  e f f e c t  o f  t u m or  l o c a t i on
o n  p o s t o p e r a t i v e  v i s u a l  o u t c o m e .  J  N e u r o s u r g  6 9 : 5 2 3 - 5 2 8 ,  1 9 8 8 .
1 0 .  A r a i  H ,  S a t o  K ,  O k u d a ,  M i ya j i m a  M ,  H i s h i i  M ,  N a k a n i s h i  H ,  I s h i i  H :
T r a n s c r a n i a l  t r a n s s p h e n o i d a l  a p p r o a c h  f o r  t u b e r c u l u m  s e l l a e  m e n i n g i o m a s .  A c t a
N e u r o c h i r  ( W i e n )  1 4 2 : 7 5 1 - 6 ,  2 0 0 0 .
1 1 .  A v c i  E ,  Ba d e m c i  G ,  O z t u r k  A :  M i c r o s u r g i c a l  l a n d m a r k s  f o r  s a f e  r e m o v a l  o f
a n t e r i o r  c l i n o i d  p r o c e s s .  M i n i m  I n va s i v e  N e u r o s u r g  4 8 : 2 6 8 - 2 7 2 ,  2 0 0 5 .
1 2 .  B a b u  R ,  B a r t on  A ,  K a s o f f  S S :  R e s e c t i on  o f  o l f a c t o r y  g r o o v e  m e n i n g i o m a s :
t e c h n i c a l  n o t e  r e v i s i t e d .  S u r g  N e u r o l  4 4 : 5 6 7 - 5 7 2 ,  1 9 9 5 .
1 3 .  B a k a y  L , C a r e s  H L :  O l f a c t o r y  m e n i n g i om a s . R e p or t  on  a  s e r i e s  o f  t w e n t y- f i v e
c a s e s .  A c t a  N e u r o c h i r  2 6 : 1 - 1 2 ,  1 9 7 2 .
1 4 .  B a s s i o u n i  H ,  A s g a r i  S ,  S t o l k e  D :  O l f a c t o r y  g r o o v e  m e n i n g i om a s :  f u n c t i on a l
o u t c o m e  i n  a  s e r i e s  t r e a t e d  m i c r o s u r g i c a l l y .  A c t a  N e u r o c h i r  ( W i e n )  1 4 9 : 1 0 9 -
1 2 1 ,  2 0 0 7 .
1 5 .  B a s s i o u n i  H ,  A s g a r i  S ,  S t o l k e  D :  T u b e r c u l u m  s e l l a e  m e n i n g i o m a s :  f u n c t i on a l
o u t c o m e  i n  a  c o n s e c u t i v e  s e r i e s  t r e a t e d  m i c r o s u r g i c a l l y .  S u r g  N e u r o l  6 6 : 3 7 - 4 4 ,
2 0 0 6 .
1 6 .  B a s s i o u n i  H ,  A s g a r i  S ,  S a n d a l c i o g l u  I E ,  S e i f e r t  V ,  S t o l k e  D ,  M a r q u a r d t  G :
A n t e r i or  c l i n o i d a l  m en i n g i o m a s :  f u n c t i o n a l  o u t c o m e  a f t e r  m i c r o s u r g i c a l
r e s e c t i on  i n  a  c on s e c u t i v e  s e r i e s  o f  1 0 6  p a t i e n t s .  C l i n i c a l  a r t i c l e .  J  N e u r o s u r g
1 1 1 : 1 0 7 8 - 1 0 9 0 ,  2 0 0 9 .
1 7 .  B e n j a m i n  V , R u s s e l l  S M :  T h e  m i c r o s u r g i c a l  n u a n c e s  o f  r e s e c t i n g  t u b e r c u l u m
s e l l a e  m e n i n g i o m a s .  N e u r o s u r g e r y  5 6 : 4 1 1 - 7 ,  2 0 0 5 .
1 8 .  B e n j a m i n  V ,   M c C or m a c k  B . :  S u r g i c a l  m a n a g e m e n t  o f  t u b e r c u l u m  s e l l a e  a n d
s p h e n o i d  r i d g e  m en i n g i o m a s .  S c h m i d e k  H H ,  S w e e t  W H  ( e d s ) :  O p e r a t i v e
N e u r o s u r g i c a l  T e ch n i q u e s .  P h i l a d e l p h i a ,  P en n s yl v a n i a :  W . B .  Sa u n d e r s ,  1 9 9 5 ,  p p
4 0 3 - 4 1 3 .
1 9 .  B l a c k  P M :  M e n i n g i o m a s .  N e u r o s u r g e r y  3 2 : 6 4 3 - 6 5 7 ,  1 9 9 3 .
127
2 0 .  B o n n a b e a u  R C :  T h e  E d w i n  S m i t h  P a p y r u s  f r om  a n c i e n t  E g yp t .  T h e  w o r l d ' s  f i r s t
s u r g i c a l  t r e a t i s e .  M i n n  M e d  6 8 : 2 7 7 ,  2 7 9 - 8 0 ,  1 9 8 5 .
2 1 .  B o n n a l  J ,  T h i ba u t  A ,  Br o t c h i  J ,  B or n  J :  I n v a d i n g  m e n i n g i om a s  o f  t h e  s p h e n o i d
r i d g e .  J  N e u r o s u r g  5 3 : 5 8 7 - 5 9 9 ,  1 9 8 0 .
2 2 .  B o w e r s  C A ,  A l t a y  T ,  C o u l d w e l l  W T :  S u r g i c a l  d e c i s i on - m a k i n g  s t r a t e g i e s  i n
t u b e r c u l u m  s e l l a e  m e n i n g i om a  r e s e c t i on .  N e u r o s u r g  F o c u s  3 0 : E 1 ,  2 0 1 1 .
2 3 .  B u c h f e l d e r  M :  F r om  t r e p h i n a t i on  t o  t a i l o r e d  r e s e c t i o n :  n e u r o s u r g e r y  i n  G e r m a n y
b e f o r e  W o r l d  W a r  I I .  N e u r o s u r g e r y  5 6 : 6 0 5 - 1 3 ,  2 0 0 5 .
2 4 .  B u c h f e l d e r  M , L j u n g g r e n  B :  W i l h e l m  W a g n e r  ( 1 8 4 8 - 1 9 0 0 ) .  P a r t  2 :  T h e
o s t e o p l a s t i c  f l a p .  S u r g  N e u r o l  3 0 : 4 2 8 - 4 3 3 ,  1 9 8 8 .
2 5 .  B u r n s t e i n  R .  B A :  A n e s t h e s i a  f o r  S u p r a t e n t o r i a l  S u r g e r y .  G u p t a  A K ,  G e l b  A W
( e d s ) :  E s s e n t i a l s  o f  N e u r o a n e s t h e s i a  a n d  Ne u r o i n t e n s i v e  C a r e .  C h i n a :  S a u n d e r s ,
E l s e v i e r ,  2 0 0 8 ,  p p   1 0 6 - 1 1 0 .
2 6 .  C a r d a l i  S ,  R o m a n o  A ,  A n g i l e r i  F F ,  C on t i  A ,  L a  T or r e  D ,  d e  D i v i t i i s  O ,  d ' A v e l l a
D ,  T s c h a bi t s c h e r  M ,  T o m a s e l l o  F :  M i c r o s u r g i c a l  a n a t om i c  f e a t u r e s  o f  t h e
o l f a c t o r y  n e r v e :  r e l e v a n c e  t o  o l f a c t i on  p r e s e r va t i on  i n  t h e  p t e r i on a l  a p p r oa c h .
N e u r o s u r g e r y  5 7 : 1 7 - 2 1 ,  2 0 0 5 .
2 7 .  C a s t e l l a n o  F ,  G u i d e t t i  B ,  O l i v e c r on a  H :  P t e r i on a l  m e n i n g i om a s  e n  p l a q u e .  J
N e u r o s u r g  9 : 1 8 8 - 1 9 6 ,  1 9 5 2 .
2 8 .  C h a n  R C , T h om p s on  G B:  I n t r a c r a n i a l  m e n i n g i o m a s  i n  c h i l d h o o d .  S u r g  N e u r o l
2 1 : 3 1 9 - 3 2 2 ,  1 9 8 4 .
2 9 .  C h a n g  D J :  T h e  " n o - d r i l l "  t e c h n i q u e  o f  a n t e r i o r  c l i n o i d e c t o m y :  a  c r a n i a l  b a s e
a p p r oa c h  t o  t h e  p a r a c l i n o i d  a n d  p a r a s e l l a r  r e g i on .  N e u r o s u r g e r y  6 4 : 9 6 - 1 0 5 ,
2 0 0 9 .
3 0 .  C h a n g  H S ,  J o k o  M ,  S on g  J S ,  I t o  K ,  I n ou e  T ,  N a k a g a w a  H :  U l t r a s on i c  b o n e
c u r e t t a g e  f o r  o p t i c  c a n a l  u n r o o f i n g  a n d  a n t e r i o r  c l i n o i d e c t o m y .  T e c h n i c a l  n o t e .
J  N e u r o s u r g  1 0 4 : 6 2 1 - 6 2 4 ,  2 0 0 6 .
3 1 .  C h a t t e r j e e  P R ,  C h a t t e r j e e  D ,  C h a k r a b or t y  K S ,  C h a t t o p a d h ya y  S :  A n  u n u s u a l
p r e s en t a t i on  o f  m e d i a l  s p h e n o i d  w i n g  m e n i n g i o m a .  J  I n d i a n  M ed  A s s o c  1 0 2 : 1 0 5 -
1 0 6 ,  2 0 0 4 .
3 2 .  C h i  J H , M c D e r m ot t  M W :  T u b e r c u l u m  s e l l a e  m e n i n g i om a s .  N e u r o s u r g  F o c u s
1 4 : e 6 ,  2 0 0 3 .
3 3 .  C i r i c  I , R o s e n b l a t t  S :  S u p r a s e l l a r  m e n i n g i o m a s .  N e u r o s u r g e r y  4 9 : 1 3 7 2 - 1 3 7 7 ,
2 0 0 1 .
3 4 .  C o l l i  B O ,  C a r l o t t i  C G , J r ,  A s s i r a t i  J A , J r ,  S a n t o s  M B ,  N e d e r  L ,  S a n t o s  A C ,
B a t a g i n i  N C :  O l f a c t o r y  g r o o v e  m e n i n g i o m a s :  s u r g i c a l  t e c h n i q u e  a n d  f o l l o w - u p
r e v i e w .  A r q  N e u r op s i q u i a t r  6 5 : 7 9 5 - 7 9 9 ,  2 0 0 7 .
3 5 .  C o o k  A W :  T o t a l  r e m o v a l  o f  l a r g e  g l o b a l  m e n i n g i o m a s  a t  t h e  m e d i a l  a s p e c t  o f
t h e  s p h e n o i d  r i d g e .  T e c h n i c a l  n o t e .  J  N e u r os u r g  3 4 : 1 0 7 - 1 1 3 ,  1 9 7 1 .
3 6 .  C o p h i g n on  J ,  L u c e n a  J ,  C l a y  C ,  M a r c h a c  D :  L i m i t s  t o  r a d i c a l  t r e a t m e n t  o f
s p h e n o - o r b i t a l  m e n i n g i o m a s .  A c t a  N e u r o c h i r  S u p p l  ( W i e n )  2 8 : 3 7 5 - 3 8 0 ,  1 9 7 9 .
3 7 .  C o u l d w e l l  W T ,   W e i s s  M H :  O l f a c t o r y  G r o o v e  M e n i n g i o m a s .  K a ye  A H ,  B l a c k  P M
( e d s ) :  O p e r a t i v e  N e u r o s u r g e r y .  L o n d on :  C h u r c h i l l  L i v i n g s t on e ,  2 0 0 0 ,  p p   5 2 3 -
5 3 2 .
3 8 .  C u i  H ,  W a n g  Y ,  Y i n  Y H ,  F e i  Z M ,  L u o  Q Z ,  J i a n g  J Y :  S u r g i c a l  m a n a g e m e n t  o f
a n t e r i o r  c l i n o i d a l  m e n i n g i o m a s :  a  2 6 - c a s e  r e p o r t .  S u r g  N e u r o l  6 8 : S 6 - S 1 0 ,  2 0 0 7 .
3 9 .  C u s h i n g   H , E i s e n h a r d t  L :  M e n i n g i o m a s :  T h e i r  c l a s s i f i c a t i o n ,  r e g i o n a l  b e h a v i o u r ,
l i f e  h ys t o r y ,  a n d  s u r g i c a l  e n d  r e s u l t s .  C h a p t e r  X V :  M e n i n g i o m a s  o f  t h e
s p h e n o i d a l  r i d g e .  A .  T h o s e  o f  t h e  d e e p  o r  c l i n o i d a l  t h i r d .  S p r i n g f i e l d ,  I L ,
C h a r l e s  C  T h om a s  2 9 8 - 3 1 9 ,  1 9 3 8 .
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4 0 .  C u s h i n g  H ,  E i s e n h a r d t  L :  M en i n g i o m a s :  T h e i r  C l a s s i f i c a t i on ,  R e g i o n a l
B e h a v i o u r ,  L i f e  H ys t o r y ,  a n d  S u r g i c a l  E n d  R e s u l t s .  i n  I l l i n o i s ,  S p r i n g f i e l d ,  I L ,
C h a r l e s  C  T h om a s ,  1 9 3 8 ,
4 1 .  C u s h i n g  H :  T h e  m e n i n g i o m a s  ( d u r a l  e n d o t h e l i om a s ) :  t h e i r  s o u r c e ,  a n d  f a v o u r e d
s e a t s  o f  o r i g i n .  Br a i n  2 8 2 - 3 1 6 ,  1 9 2 2 .
4 2 .  C u s h i n g  H :  T h e  s p e c i a l  f i e l d  o f  n e u r o l o g i c a l  s u r g e r y :  f i v e  ye a r s  l a t e r .  B u l l e t t i n
o f  t h e  J oh n s  H o p k i n s  H o s p i t a l  3 2 5 - 3 3 9 ,  1 9 1 0 .
4 3 .  C u s h i n g  H :  T h e  S p e c i a l  F i e l d  o f  N e u r o l o g i c a l  S u r g e r y .  B u l l e t t i n  o f  t h e  J oh n s
H o p k i n s  H o s p i t a l  X V I . : 7 7 - 8 7 ,  1 9 0 5 .
4 4 .  D a n d y  W :  H i r n c h i r u r g i e  i n  H e i d e l b e r g ,  G e r m a n y ,  J oh a n n  A m b r o s i u s ,  L e i p z i g ,
S p r i n g e r ,  1 9 3 8 ,
4 5 .  D a n d y  W E :  I n t r a c r a n i a l  a n e u r ys m  o f  t h e  i n t e r n a l  c a r o t i d  a r t e r y .  C u r e d  b y
o p e r a t i o n .  A n n  S u r g  6 5 4 - 6 5 9 ,  1 9 3 8 .
4 6 .  D a n d y  W e :  A n e u r ys m s  o f  t h e  a n t e r i o r  c e r e b r a l  a r t e r y .  J A M A  1 1 9 : 1 2 5 3 ,  1 9 4 2 .
4 7 .  D a r e  A O ,  B a l o s  L L ,  G r a n d  W :  O l fa c t i on  p r e s e r va t i on  i n  a n t e r i o r  c r a n i a l  b a s e
a p p r oa c h e s :  a n  a n a t om i c  s t u d y .  N e u r o s u r g e r y  4 8 : 1 1 4 2 - 5 ,  2 0 0 1 .
4 8 .  D a s h t i  R ,  H e r n e s n i e m i  J ,  L e h t o  H,  N i e m e l ä  M ,  L e h e c k a  M ,  R i n n e  J ,  P or r a s  M ,
R o n k a i n e n  A ,  P h or n s u w a n n a p h a  S ,  K o i v i s t o  T ,  J ä ä s k e l ä i n e n  J E :
M i c r on e u r o s u r g i c a l  m a n a g em e n t  o f  p r ox i m a l  a n t e r i or  c e r e b r a l  a r t e r y  a n e u r ys m s .
S u r g  N e u r o l  6 8 : 3 6 6 - 3 7 7 ,  2 0 0 7 .
4 9 .  D a s h t i  R ,  H e r n e s n i e m i  J ,  N i e m e l ä  M ,  R i n n e  J ,  L e h e c k a  M ,  S h e n  H,  L e h t o  H ,
A l b a yr a k  B S ,  R o n k a i n e n  A ,  K o i v i s t o  T ,  J ä ä s k e l ä i n e n  J E :  M i c r on e u r o s u r g i c a l
m a n a g e m e n t  o f  d i s t a l  m i d d l e  c e r e b r a l  a r t e r y  a n e u r ys m s .  S u r g  N e u r o l  6 7 : 5 5 3 -
5 6 3 ,  2 0 0 7 .
5 0 .  D a s h t i  R ,  H e r n e s n i e m i  J ,  N i e m e l ä  M ,  R i n n e  J ,  P o r r a s  M ,  L e h e c k a  M ,  S h e n  H ,
A l b a yr a k  B S ,  L e h t o  H ,  K or o k n a y- P a l  P ,  d e  O l i v e i r a  R S ,  P e r r a  G ,  R on k a i n e n  A ,
K o i v i s t o  T ,  J ä ä s k e l ä i n e n  J E :  M i c r on e u r o s u r g i c a l  m a n a g em e n t  o f  m i d d l e  c e r e b r a l
a r t e r y  b i f u r c a t i on  a n e u r ys m s .  S u r g  N e u r o l  6 7 : 4 4 1 - 4 5 6 ,  2 0 0 7 .
5 1 .  D a s h t i  R ,  R i n n e  J ,  H e r n e s n i e m i  J ,  N i e m e l ä  M ,  K i v i p e l t o  L ,  L e h e c k a  M ,  K a r a t a s
A ,  A v c i  E ,  I s h i i  K ,  S h e n  H ,  P e l a e z  J G ,  A l b a yr a k  B S ,  R o n k a i n e n  A ,  K o i v i s t o  T ,
J ä ä s k e l ä i n e n  J E :  M i c r on e u r os u r g i c a l  m a n a g e m e n t  o f  p r o x i m a l  m i d d l e  c e r e b r a l
a r t e r y  a n e u r ys m s .  S u r g  N e u r o l  6 7 : 6 - 1 4 ,  2 0 0 7 .
5 2 .  D a y  A L :  A n e u r ys m s  o f  t h e  o p h t h a l m i c  s e g m e n t .  A  c l i n i c a l  a n d  a n a t o m i c a l
a n a l ys i s .  J  N e u r o s u r g  7 2 : 6 7 7 - 6 9 1 ,  1 9 9 0 .
5 3 .  D a y  J D ,  G i a n n o t t a  S L ,  F u k u s h i m a  T :  E x t r a d u r a l  t e m p o r o p o l a r  a p p r o a c h  t o
l e s i o n s  o f  t h e  u p p e r  b a s i l a r  a r t e r y  a n d  i n f r a c h i a s m a t i c  r e g i o n .  J  N e u r o s u r g
8 1 : 2 3 0 - 2 3 5 ,  1 9 9 4 .
5 4 .  d e  D i v i t i i s  E ,  E s p o s i t o  F ,  C a p p a b i a n c a  P ,  C a va l l o  L M ,  d e  D i v i t i i s  O :
T u b e r c u l u m  s e l l a e  m e n i n g i o m a s :  h i g h  r o u t e  o r  l o w  r o u t e ?  A  s e r i e s  o f  5 1
c o n s e c u t i v e  c a s e s .  N e u r o s u r g e r y  6 2 : 5 5 6 - 6 3 ,  2 0 0 8 .
5 5 .  D e M o n t e  F :  S u r g i c a l  t r e a t m e n t  o f  a n t e r i o r  b a s a l  m e n i n g i o m a s .  J  N e u r o on c o l
2 9 : 2 3 9 - 2 4 8 ,  1 9 9 6 .
5 6 .  D e r o m e  P :  L e s  t u m e u r s  s p h é n o - e t h m o i d a l e s .  P o s s i b i l i t é s  d ' e x é r è s e  e t  d e
r é p a r a t i on  c h i r u r g i c a l e s .  N e u r o c h i r u r g i e  1 8  ( s u p p l  1 ) : 1 - 1 6 4 ,  1 9 7 2 .
5 7 .  d ’ A v e l l a  D ,  S a l p i e t r o  F M ,  A l a f a c i  C ,  T om a s e l l o  F :  G i a n t  o l f a c t o r y
m e n i n g i o m a s :  t h e  p t e r i on a l  a p p r oa c h  a n d  i t s  r e l e v a n c e  f o r  m i n i m i z i n g  s u r g i c a l
m or b i d i t y .  S k u l l  Ba s e  S u r g  9 : 2 3 - 3 1 ,  1 9 9 9 .
5 8 .  D o l e n c  V V :  C en t r a l  s k u l l  ba s e  m e n i n g i om a s .  D o l e n c  V V  ( e d ) :  M i c r o s u r g i c a l
A n a t om y  a n d  S u r g e r y  o f  t h e  C e n t r a l  S k u l l  B a s e .  W i e n :  S p r i n g e r - V er l a g ,  2 0 0 3 ,
p p   1 4 0 - 2 3 5 .
5 9 .  D o l e n c  V V :  S k u l l  a n d  S k u l l  B a s e  T u m or s :  O v e r v i e w .  W i n n  R W  ( e d ) :  Y o u m a n s
N e u r o l o g i c a l  S u r g e r y .  P h i l a d e l p h i a :  S a u n d e r s ,  2 0 0 3 ,  p p   1 2 6 5 - 1 2 8 1 .
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6 0 .  D o l e n c  V V :  A  c o m b i n e d  e p i -  a n d  s u b d u r a l  d i r e c t  a p p r oa c h  t o  c a r o t i d - o p h t h a l m i c
a r t e r y  a n e u r ys m s .  J  N e u r o s u r g  6 2 : 6 6 7 - 6 7 2 ,  1 9 8 5 .
6 1 .  D o n a g h y  R . M . P . :  H i s t o r y  o f  M i c r on e u r o s u r g e r y .  W i l k i n s  R . H . ,  R e n g a c h a r y  S . S .
( e d s ) :  N e u r o s u r g e r y .  U S A :  M c G r a w - H i l l ,  1 9 9 6 ,  p p   3 7 - 4 2 .
6 2 .  D r a k e  C G ,  V a n d e r l i n d e n  R G ,  A m a c h e r  A L :  C a r o t i d - o p h t h a l m i c  a n e u r ys m s .  J
N e u r o s u r g  2 9 : 2 4 - 3 1 ,  1 9 6 8 .
6 3 .  D u r a n t e  F :  E s t i r p a z i on e  d i  u n  t u m or e  e n d o c r a n i o  ( f o r m a  m or b o s a  p r i m a  e  d o p o
l ' o p e r a z i on e ) .  B o l l  R  A c c a d  M e d  R o m a  1 1 : 2 4 7 - 2 5 2 ,  1 8 8 5 .
6 4 .  D u r a n t e  F :  C on t r i b u t i on  t o  e n d o c r a n i a l  s u r g e r y .  L a n c e t  2 : 6 5 4 ,  1 8 8 7 .
6 5 .  E l  G i n d i  S :  O l f a c t o r y  g r o o v e  m e n i n g i o m a :  s u r g i c a l  t e c h n i q u e s  a n d  p i t f a l l s .  S u r g
N e u r o l  5 4 : 4 1 5 - 4 1 7 ,  2 0 0 0 .
6 6 .  E l - B a h y  K:  V a l i d i t y  o f  t h e  f r on t o l a t e r a l  a p p r oa c h  a s  a  m i n i m a l l y  i n va s i v e
c o r r i d o r  f o r  o l f a c t o r y  g r o o v e  m e n i n g i om a s .  A c t a  N e u r o c h i r  ( W i e n )  1 5 1 : 1 1 9 7 -
1 2 0 5 ,  2 0 0 9 .
6 7 .  E r d o g m u s  S , G o v s a  F :  T h e  a n a t o m i c  l a n d m a r k s  o f  e t h m oi d a l  a r t e r i e s  f or  t h e
s u r g i c a l  a p p r o a c h e s .  J  C r a n i o f a c  S u r g  1 7 : 2 8 0 - 2 8 5 ,  2 0 0 6 .
6 8 .  F a h l b u s c h  R , S c h o t t  W :  P t e r i on a l  s u r g e r y  o f  m e n i n g i o m a s  o f  t h e  t u b e r c u l u m
s e l l a e  a n d  p l a n u m  s p h e n o i d a l e :  s u r g i c a l  r e s u l t s  w i t h  s p e c i a l  c o n s i d e r a t i on  o f
o p h t h a l m ol o g i c a l  a n d  e n d o c r i n o l o g i c a l  o u t c o m e s .  J  N e u r o s u r g  9 6 : 2 3 5 - 2 4 3 ,  2 0 0 2 .
6 9 .  F a t e m i  N ,  D u s i c k  J R ,  d e  P a i va  N e t o  M A ,  M a l k a s i a n  D ,  K e l l y  D F :  E n d on a s a l
v e r s u s  s u p r a or b i t a l  k e y h o l e  r e m o v a l  o f  c r a n i o p h a r yn g i om a s  a n d  t u b e r c u l u m
s e l l a e  m e n i n g i o m a s .  N e u r o s u r g e r y  6 4 : 2 6 9 - 8 4 ,  2 0 0 9 .
7 0 .  F i g u e i r e d o  E G ,  D e s h m u k h  P ,  N a k a j i  P ,  C r u s i u s  M U ,  C r a w f o r d  N ,  S p e t z l e r  R F ,
P r e u l  M C :  T h e  m i n i p t e r i on a l  c r a n i o t om y:  t e ch n i c a l  d e s c r i p t i on  a n d  a n a t om i c
a s s e s s m e n t .  N e u r o s u r g e r y  6 1 : 2 5 6 - 6 4 ,  2 0 0 7 .
7 1 .  F i g u e i r e d o  E G ,  D e s h m u k h  V ,  N a k a j i  P ,  D e s h m u k h  P ,  C r u s i u s  M U ,  C r a w f o r d  N ,
S p e t z l e r  R F ,  P r e u l  M C :  A n  a n a t o m i c a l  e v a l u a t i on  o f  t h e  m i n i - s u p r a or b i t a l
a p p r oa c h  a n d  c o m p a r i s on  w i t h  s t a n d a r d  c r a n i o t o m i e s .  N e u r o s u r g e r y  5 9 : O N S 2 1 2 -
2 0 ,  2 0 0 6 .
7 2 .  F i s c h e r  G ,  F i s c h e r  C ,  M a n s u y  L :  S u r g i c a l  p r o g n o s i s  o f  m e n i n g i om a s  o f  t h e
s p h e n o i d a l  r i d g e .  N e u r o c h i r u r g i e  1 9 : 3 2 3 - 3 4 6 ,  1 9 7 3 .
7 3 .  F l a m m  E .  S . :  H i s t o r y  o f  N e u r o v a s c u l a r  S u r g e r y .  I .  C e r e b r a l  A n e u r ys m s  a n d
S u b a f a c h n o i d  H e m o r r h a g e .  G r e e n b l a t t  S . H . ,  D a g i  T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A
H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,  1 9 9 7 ,  p p   2 5 9 - 2 7 0 .
7 4 .  F r a z i e r  C H :  A n  a p p r oa c h  t o  t h e  h yp o p h ys i s  t h r o u g h  t h e  a n t e r i o r  c r a n i a l  f o s s a .
A n n  S u r g  5 7 : 1 4 5 ,  1 9 1 3 .
7 5 .  F r o t s c h e r  B B C :  Z u r  K a s u i s t i k  d e r  D u r a e n d o t h e l i o m e .  A r c h  P s yc h i a t r  N e r v e n k r
4 7 : 1 9 6 – 1 9 9 ,  1 9 1 0 .
7 6 .  G a l a l  A ,  F a i s a l  A ,  A l - W e r d a n y  M ,  E l  S h e h a b y  A ,  L o t f y  T ,  M oh a r r a m  H :
D e t e r m i n a n t s  o f  p o s t o p e r a t i v e  v i s u a l  r e c o v e r y  i n  s u p r a s e l l a r  m e n i n g i o m a s .  A c t a
N e u r o c h i r  ( W i e n )  1 5 2 : 6 9 - 7 7 ,  2 0 1 0 .
7 7 .  G a n n a  A ,  D eh d a s h t i  A R ,  K a r a b a t s o u  K ,  G e n t i l i  F :  F r on t o - b a s a l  i n t e r h e m i s p h e r i c
a p p r oa c h  f o r  t u b e r c u l u m  s e l l a e  m e n i n g i o m a s ;  l on g - t e r m  v i s u a l  o u t c o m e .  Br  J
N e u r o s u r g  2 3 : 4 2 2 - 4 3 0 ,  2 0 0 9 .
7 8 .  G a z z e r i  R ,  G a l a r z a  M ,  G a z z e r i  G :  G i a n t  o l f a c t o r y  g r o o v e  m e n i n g i o m a :
o p h t h a l m ol o g i c a l  a n d  c o g n i t i v e  o u t c o m e  a f t e r  b i f r on t a l  m i c r o s u r g i c a l  a p p r oa c h .
A c t a  N e u r o c h i r  ( Wi e n )  1 5 0 : 1 1 1 7 - 2 5 ,  2 0 0 8 .
7 9 .  G e r b e r  M ,  V i s h t eh  A G ,  S p e t z l e r  R F :  R e t u r n  o f  o l f a c t i on  a f t e r  g r o s s  t o t a l
r e s e c t i on  o f  a n  o l f a c t o r y  g r o o v e  m e n i n g i o m a :  c a s e  r e p or t .  S k u l l  Ba s e  S u r g
8 : 2 2 9 - 2 3 1 ,  1 9 9 8 .
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8 0 .  G i u f f r é  R :  S u c c e s s f u l  r a d i c a l  r e m o v a l  o f  a n  i n t r a c r a n i a l  m e n i n g i o m a  i n  1 8 3 5  b y
P r o f e s s o r  P e c c h i o l i  o f  S i e n a .  J  N e u r o s u r g  6 0 : 4 7 ,  1 9 8 4 .
8 1 .  G o e l  A ,  M u z u m d a r  D ,  D e s a i  K I :  T u b e r c u l u m  s e l l a e  m e n i n g i om a :  a  r e p or t  on
m a n a g e m e n t  o n  t h e  b a s i s  o f  a  s u r g i c a l  e x p e r i e n c e  w i t h  7 0  p a t i e n t s .  N eu r o s u r g e r y
5 1 : 1 3 5 8 - 6 3 ,  2 0 0 2 .
8 2 .  G o e l  A ,  G u p t a  S ,  D e s a i  K :  N e w  g r a d i n g  s ys t e m  t o  p r e d i c t  r e s e c t a b i l i t y  o f
a n t e r i o r  c l i n o i d  m e n i n g i o m a s .  N e u r o l  M ed  C h i r  ( T o k yo )  4 0 : 6 1 0 - 6 ,  2 0 0 0 .
8 3 .  G o l s h a n i  K ,  F e r r e l l  A ,  Z o m or o d i  A ,  S m i t h  T P ,  Br i t z  G W :  A  r e v i e w  o f  t h e
m a n a g e m e n t  o f  p o s t e r i o r  c om m u n i c a t i n g  a r t e r y  a n e u r ys m s  i n  t h e  m o d e r n  e r a .
S u r g  N e u r o l  I n t  1 : 8 8 ,  2 0 1 0 .
8 4 .  G o n z a l e z - D a r d e r  J M :  I n t r a d u r a l  a n t e r i o r  c l i n o i d e c t om y.  A n a t m o c l i n i c a l  s t u d y
a n d  i t s  u s e f u l n e s s  i n  t h e  t r e a t m e n t  o f  t r a n s - s e g m e n t a r y  C 5 - C 6  t r a n s - s e g m e n t a r y
p a r a c l i n o i d  a n e u r ys m s ] .  N e u r o c i r u g i a  ( A s t u r )  1 8 : 2 0 1 - 2 0 8 ,  2 0 0 7 .
8 5 .  G o o d r i c h  J .  T . :  N e u r o s u r g e r y  i n  t h e  A n c i e n t  a n d  M e d i e v a l  W o r l d s .  G r e e n b l a t t
S . H . ,  D a g i  T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,
1 9 9 7 ,  p p   3 7 - 6 4 .
8 6 .  G r e e n b l a t t  S . H .  S D C :  T h e  E m er g e n c e  o f  C u s h i n g ' s  L e a d e r s h i p :  1 9 0 1  t o  1 9 2 0 .
G r e e n b l a t t  S . H . ,  D a g i  T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .
U S A :  A A N S ,  1 9 9 7 ,  p p   1 6 7 - 1 9 0 .
8 7 .  G r i s o l i  F ,  D i a z - V a s q u e z  P ,  R i s s  M ,  V i n c e n t e l l i  F ,  L e c l e r c q  T A ,  H a s s o u n  J ,
S a l a m on  G :  M i c r o s u r g i c a l  m a n a g em e n t  o f  t u b e r c u l u m  s e l l a e  m e n i n g i o m a s .
R e s u l t s  i n  2 8  c on s e c u t i v e  c a s e s .  S u r g  N e u r o l  2 6 : 3 7 - 4 4 ,  1 9 8 6 .
8 8 .  G u i d e t t i  B :  F r a n c e s c o  D u r a n t e .  J u n e  2 9 ,  1 8 4 4  t o  O c t o b e r  2 ,  1 9 3 4 .  S u r g  N e u r o l
2 0 : 1 - 3 ,  1 9 8 3 .
8 9 .  G u i d e t t i  B , L a  T o r r e  E :  M a n a g e m e n t  o f  c a r o t i d - o p h t h a l m i c  a n e u r ys m s .  J
N e u r o s u r g  4 2 : 4 3 8 - 4 4 2 ,  1 9 7 5 .
9 0 .  G u yo t  J F ,  V o u yo u k l a k i s  D ,  P e r t u i s e t  B :  M e n i n g i o m a s  o f  t h e  s p h e n o i d a l  r i d g e :
a p r op o s  o f  5 0  c a s e s .  N e u r o c h i r u r g i e  1 3 : 5 7 1 - 5 8 4 ,  1 9 6 7 .
9 1 .  H a d d a d  G F ,  A l - M e f t y  O ,   A b d u l r a u f  S I :  M e n i n g i om a s .  Y o u m a n s  N e u r o l o g i c a l
S u r g e r y  V o l    I .  W i n n ,  R . H . . ( E d . ) 5  t h  e d . S a u n d e r s , P h i l a d e l p h i a ,  P e n n s yl v a n i a .
1 9 9 6 ,  p p   1 0 9 9 - 1 1 3 1 .
9 2 .  H a d e i s h i  H ,  S u z u k i  A ,  Y a s u i  N ,  S a t o u  Y :  A n t e r i o r  c l i n o i d e c t o m y  a n d  o p en i n g  o f
t h e  i n t e r n a l  a u d i t o r y  c a n a l  u s i n g  a n  u l t r a s o n i c  b on e  c u r e t t e .  N e u r o s u r g e r y
5 2 : 8 6 7 - 7 0 ,  2 0 0 3 .
9 3 .  H a k u b a  A ,  L i u  S ,  N i s h i m u r a  S :  T h e  or b i t oz yg o m a t i c  i n f r a t e m p or a l  a p p r oa c h :  a
n e w  s u r g i c a l  t e c h n i q u e .  S u r g  N e u r o l  2 6 : 2 7 1 - 2 7 6 ,  1 9 8 6 .
9 4 .  H a l l a c q  P ,  M or e a u  J J ,  F i s ch e r  G ,  B e z i a t  J L :  T r a n s - s i n u s a l  f r on t a l  a p p r oa c h  f o r
o l f a c t o r y  g r o o v e  m e n i n g i o m a s .  S k u l l  Ba s e  1 1 : 3 5 - 4 6 ,  2 0 0 1 .
9 5 .  H ä n s e l  G , S e e g e r  W :  T h e  m i c r o s u r g i c a l  t r e a t m e n t  o f  t h e  s o - c a l l e d  t u b er c u l u m -
s e l l a e - m e n i n g i o m a s  ( a u t h or ' s  t r a n s l ) .  A c t a  N e u r o c h i r  ( W i e n )  3 7 : 1 1 1 - 1 2 3 ,  1 9 7 7 .
9 6 .  H a s s l e r  W , Z en t n e r  J :  S u r g i c a l  t r e a t m e n t  o f  o l f a c t o r y  g r o o v e  m e n i n g i o m a s  u s i n g
t h e  p t e r i o n a l  a p p r oa c h .  A c t a  N e u r o c h i r  S u p p l  ( W i e n )  5 3 : 1 4 - 1 8 ,  1 9 9 1 .
9 7 .  H a s s l e r  W , Z e n t n e r  J :  P t e r i on a l  a p p r o a c h  f o r  s u r g i c a l  t r e a t m e n t  o f  o l f a c t o r y
g r o o v e  m e n i n g i o m a s .  N e u r o s u r g e r y  2 5 : 9 4 2 - 5 ,  1 9 8 9 .
9 8 .  H e i s k a n e n  O . :  K i i l a l u u n  s i i v e n  m e n i n g e o o m i e n  o i r e i s t a .  D u o d e c i m  6 7 9 - 6 8 4 ,
1 9 5 9 .
9 9 .  H e n t s c h e l  S J , D e M on t e  F :  O l fa c t o r y  g r o o v e  m e n i n g i o m a s .  N e u r o s u r g  F o c u s
1 4 : e 4 ,  2 0 0 3 .
1 0 0 . H e r n e s n i e m i  J ,  R o m a n i  R,  N i e m e l ä  M :  S k u l l  b a s e  a n d  a n e u r ys m  s u r g e r y .  S u r g
       N e u r o l  3 0 - 3 1 ,  2 0 0 9 .
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1 0 1 . H e r n e s n i e m i  J ,  I s h i i  K ,  N i e m e l ä  M ,  S m r c k a  M ,  K i v i p e l t o  L ,  F u j i k i  M ,  S h e n  H :
L a t e r a l  s u p r a o r b i t a l  a p p r oa c h  a s  a n  a l t e r n a t i v e  t o  t h e  c l a s s i c a l  p t e r i on a l
a p p r oa c h .  A c t a  N e u r o c h i r  S u p p l  9 4 : 1 7 - 2 1 ,  2 0 0 5 .
1 0 2 . H e r n e s n i e m i  J ,  D a s h t i  R ,  L e h e c k a  M ,  N i e m e l ä  M ,  R i n n e  J ,  L e h t o  H ,  R on k a i n e n
A ,  K o i v i s t o   T ,  J ä ä s k e l ä i n e n  J E :  M i c r on e u r o s u r g i c a l  m a n a g em e n t  o f  a n t e r i or
c o m m u n i c a t i n g  a r t e r y  a n e u r ys m s .  S u r g  N e u r o l  7 0 : 8 - 2 8 ,  2 0 0 8 .
1 0 3 . He r n e s n i e m i  J ,  N i em e l ä  M ,  K a r a t a s  A ,  K i v i p e l t o  L ,  I sh i i  K ,  R i n n e  J ,  R on k a i n e n
A ,  K o i v i s t o  T ,  K i v i s a a r i  R ,  S h e n  H ,  L e h e c k a  M ,  F r ö s e n  J ,  P i i p p o  A ,
J ä ä s k e l ä i n e n  J E :  S o m e  c o l l e c t e d  p r i n c i p l e s  o f  m i c r on e u r o s u r g e r y :  s i m p l e  a n d
f a s t ,  wh i l e  p r e s e r v i n g  n or m a l  a n a t om y:  a  r e v i e w .  S u r g  N e u r o l  6 4 : 1 9 5 - 2 0 0 ,  2 0 0 5 .
1 0 4 . H e r n e s n i e m i  J ,  N i e m e l ä  M ,  D a s h t i  R ,  K a r a t a s  A ,  K i v i p e l t o  L ,  I s h i i  K ,  R i n n e  J ,
R o n k a i n en  A ,  P e l a e z  J G ,  K o i v i s t o  T ,  K i v i s a a r i  R ,  S h en  H ,  L e h e c k a  M ,  F r ö s e n  J ,
P i i p p o  A ,  A v c i  E ,  J ä ä s k e l ä i n e n  J E :  P r i n c i p l e s  o f  m i c r on e u r o s u r g e r y  f o r  s a f e  a n d
f a s t  s u r g e r y .  S u r g  T e ch n o l  I n t  1 5 : 3 0 5 - 3 1 0 ,  2 0 0 6 .
1 0 5 . H er o s  R C ,  N e l s on  P B ,  O j e m a n n  RG ,  C r o w e l l  R M ,  D e B r u n  G :  L a r g e  a n d  g i a n t
p a r a c l i n o i d  a n e u r ys m s :  s u r g i c a l  t e c h n i q u e s ,  c o m p l i c a t i on s ,  a n d  r e s u l t s .
N e u r o s u r g e r y  1 2 : 1 5 3 - 1 6 3 ,  1 9 8 3 .
1 0 6 . H o l u b  K:  I n t r a k r a n i e l l e  m e n i n g e o m e .  A c t a  N e u r o c h i r  ( W i e n )  4 : 3 5 5 - 4 0 1 ,  1 9 5 6 .
1 0 7 . H or w i t z  N H :  L i b r a r y :  h i s t o r i c a l  p e r s p e c t i v e .  H e r b e r t  O l i v e c r on a  ( 1 8 9 1 - 1 9 8 0 ) .
N e u r o s u r g e r y  4 3 : 9 7 4 - 9 7 8 ,  1 9 9 8 .
1 0 8 . H u n t  WE , H e s s  R M :  S u r g i c a l  r i s k  a s  r e l a t e d  t o  t i m e  o f  i n t e r v e n t i o n  i n  t h e  r e p a i r
o f  i n t r a c r a n i a l  a n e u r ys m s .  J  N e u r os u r g  2 8 : 1 4 - 2 0 ,  1 9 6 8 .
1 0 9 . H u yn h - L e  P ,  N a t o r i  Y ,  S a s a k i  T :  S u r g i c a l  a n a t o m y  o f  t h e  a n t e r i or  c l i n o i d
p r o c e s s .  J  C l i n  N e u r o s c i  1 1 : 2 8 3 - 2 8 7 ,  2 0 0 4 .
1 1 0 . I wa b u c h i  T ,  S u z u k i  S ,  S o b a t a  E :  I n t r a c r a n i a l  d i r e c t  o p er a t i o n  f o r  c a r o t i d -
o p h t h a l m i c  a n e u r ys m  b y  u n r o o f i n g  o f  t h e  o p t i c  c a n a l .  A c t a  N e u r o c h i r  ( W i e n )
4 3 : 1 6 3 - 1 6 9 ,  1 9 7 8 .
1 1 1 . J ä ä s k e l ä i n e n  J :  S e e m i n g l y  c o m p l e t e  r e m o v a l  o f  h i s t o l o g i ca l l y  b e n i g n
i n t r a c r a n i a l  m e n i n g i om a :  l a t e  r e c u r r e n c e  r a t e  a n d  f a c t o r s  p r e d i c t i n g  r e c u r r e n c e
i n  6 5 7  p a t i e n t s .  A  m u l t i va r i a t e  a n a l ys i s .  S u r g  N e u r o l  2 6 : 4 6 1 - 4 6 9 ,  1 9 8 6 .
1 1 2 . J a l l o  G I , B e n j a m i n  V :  T u b e r c u l u m  s e l l a e  m e n i n g i o m a s :  m i c r o s u r g i c a l  a n a t om y
a n d  s u r g i c a l  t e c h n i q u e .  N e u r o s u r g e r y  5 1 : 1 4 3 2 - 3 9 ,  2 0 0 2 .
1 1 3 . J a n  M ,  Ba z e z e  V ,  S a u d e a u  D ,  A u t r e t  A ,  B e r t r a n d  P ,  G o u a z e  A :  O u t c o m e  o f
i n t r a c r a n i a l  m e n i n g i o m a  i n  a d u l t s .  R e t r os p e c t i v e  s t u d y  o f  a  m e d i c o s u r g i c a l
s e r i e s  o f  1 6 1  m e n i n g i om a s .  N e u r o c h i r u r g i e  3 2 : 1 2 9 - 1 3 4 ,  1 9 8 6 .
1 1 4 . J a n e  JA ,  P a r k  T S ,  P o b e r e s k i n  L H,  W i n n  H R ,  B u t l e r  A B :  T h e  su p r a o r b i t a l
a p p r oa c h :  t e c h n i c a l  n o t e .  N e u r o s u r g e r y  1 1 : 5 3 7 - 5 4 2 ,  1 9 8 2 .
1 1 5 . J e f f e r s o n  A , A z z a m  N :  T h e  s u p r a s e l l a r  m e n i n g i o m a s :  a  r e v i e w  o f  1 9  ye a r s '
e x p e r i e n c e .  A c t a  N e u r o c h i r  S u p p l  ( Wi e n )  2 8 : 3 8 1 - 3 8 4 ,  1 9 7 9 .
1 1 6 . J e n n e t t  B , B on d  M :  A s s e s s m e n t  o f  o u t c o m e  a f t e r  s e v e r e  b r a i n  d a m a g e .  L a n c e t
1 : 4 8 0 - 4 8 4 ,  1 9 7 5 .
1 1 7 . J u n g  H . W . ,   P a r k  C . K . :  P a r a s e l l a r  M e n i n g i o m a  ( T u b e r c u l u m  S e l l a e
M e n i n g i om a ) .  K a t o  Y . ,  D e c h a m b en o i t  G .  ( e d s ) :  E s s e n t i a l  P r a c t i c e  o f
N e u r o s u r g e r y .  C h i k u s a k u ,  N a g o ya ,  J a p a n :  K a l a n g u  K . K . N . ,  2 0 0 9 ,  p p   1 7 4 - 1 7 8 .
1 1 8 . Ka d i s  G N ,  M o u n t  L A ,  G a n t i  S R :  T h e  i m p o r t a n c e  o f  e a r l y  d i a g n o s i s  a n d
t r e a t m e n t  o f  t h e  m e n i n g i om a s  o f  t h e  p l a n u m  s p h en o i d a l e  a n d  t u b e r c u l u m  s e l l a e :
a  r e t r o s p e c t i v e  s t u d y  o f  1 0 5  c a s e s .  S u r g  N e u r o l  1 2 : 3 6 7 - 3 7 1 ,  1 9 7 9 .
1 1 9 . Ka n n o  T :  T u b e r c u l u m  S e l l a e  M e n i n g i o m a s  S u r g i c a l  T e ch n i q u e s  i n  B r a i n  T u m o r
S u r g e r y .  H i g a s h i - G o t a n d a  S h i n a g a w a - k u ,  T o k y o ,  J a p a n :  N e u r on  P u bl i s h i n g  C o . ,
L t d . ,  2 0 0 7 ,  p p   5 7 - 6 4 .
1 2 0 . K a n n o  T :  O l f a c t o r y  G r o o v e  M e n i n g i om a s .  K a n n o  T  ( e d ) :  T o k yo ,  J a p a n ,  N e u r on ,
2 0 0 7 ,  p p   4 5 - 5 6 .
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1 2 1 . Ka r n o f s k y  D A , B u r c h e n a l  J :  T h e  c l i n i c a l  e v a l u a t i o n o f  c h e m o t h e r a p e u t i c  A g e n t s .
I n  M a c L e o d  C M  ( e d ) :  E v a l u a t i on  o f  C h e m o t h e r a p e u t i c  A g e n t s : 1 9 1 - 2 0 5 ,  1 9 4 9 .
1 2 2 . K e m p e  L G :  O l f a c t o r y  g r o o v e  m e n i n g i om a .  O p e r a t i v e  N e u r o s u r g e r y .  N e w  Y o r k :
S p r i n g e r - V er l a g ,  1 9 6 8 ,  p p   1 0 4 - 1 0 8 .
1 2 3 . K i m  K ,  I s u  T ,  M a t s u m o t o  R ,  I s o b e  M ,  K o g u r e  K :  S u r g i c a l  p i t f a l l s  o f  a n
u l t r a s on i c  b o n e  cu r e t t e  ( S O N O P E T )  i n  s p i n a l  s u r g e r y .  N e u r o s u r g e r y  5 9 : O N S 3 9 0 -
3 ;  d i s c u s s i o n  O N S 3 9 3 ,  2 0 0 6 .
1 2 4 . K i m  T W ,  J u n g  S ,  J u n g  T Y ,  K i m  I Y ,  K a n g  S S ,  K i m  S H:  P r og n o s t i c  f a c t o r s  o f
p o s t o p e r a t i v e  v i s u a l  o u t c o m e s  i n  t u b e r c u l u m  s e l l a e  m e n i n g i om a .  Br  J  N e u r o s u r g
2 2 : 2 3 1 - 2 3 4 ,  2 0 0 8 .
1 2 5 . K i n j o  T ,  a l - M e f t y  O ,  C i r i c  I :  D i a p h r a g m a  s e l l a e  m e n i n g i o m a s .  N e u r o s u r g e r y
3 6 : 1 0 8 2 - 1 0 9 2 ,  1 9 9 5 .
1 2 6 . K i t a n o  M,  T a n e d a  M ,  N a k a o  Y :  P o s t o p e r a t i v e  i m p r o v e m e n t  i n  v i s u a l  f u n c t i on  i n
p a t i e n t s  w i t h  t u b e r c u l u m  s e l l a e  m e n i n g i om a s :  r e s u l t s  o f  t h e  e x t e n d e d
t r a n s s p h e n o i d a l  a n d  t r a n s c r a n i a l  a p p r oa c h e s .  J  N e u r os u r g  1 0 7 : 3 3 7 - 3 4 6 ,  2 0 0 7 .
1 2 7 . K n o s p  E ,  M u l l e r  G ,  P e r n e c z k y  A ,  K n o s p  E ,  M u l l e r  G ,  P e r n e c z k y  A :  T h e
p a r a c l i n o i d  c a r o t i d  a r t e r y :  a n a t om i c a l  a s p ec t s  o f  a  m i cr on e u r o s u r g i c a l  a p p r oa c h ;
T h e  p a r a c l i n o i d  c a r o t i d  a r t e r y :  a n a t o m i c a l  a s p e c t s  o f  a  m i c r on e u r o s u r g i c a l
a p p r oa c h .  N e u r os u r g e r y  2 2 : 8 9 6 - 9 0 1 , 1 9 8 8 .
1 2 8 . K o b a ya s h i  S ,  K yo s h i m a  K ,  G i b o  H ,  H e g d e  S A ,  T a k e m a e  T ,  S u g i t a  K :  C a r o t i d
c a v e  a n e u r ys m s  o f  t h e  i n t e r n a l  c a r o t i d  a r t e r y .  J  N e u r o s u r g  7 0 : 2 1 6 - 2 2 1 ,  1 9 8 9 .
1 2 9 . K on o v a l o v  A N ,  F e d or o v  S N ,  F a l l e r  T O ,  S o k o l o v  A F ,  T c h e r e p a n o v  A N :
E x p e r i e n c e  i n  t h e  t r e a t m e n t  o f  t h e  p a r a s e l l a r  m e n i n g i o m a s .  A c t a  N e u r o ch i r
S u p p l  ( W i e n )  2 8 : 3 7 1 - 3 7 2 ,  1 9 7 9 .
1 3 0 . K or o s u e  K , H er o s  R C :  " S u b c l i n o i d "  c a r o t i d  a n e u r ys m  w i t h  e r o s i on  o f  t h e
a n t e r i o r  c l i n o i d  p r o c e s s  a n d  f a t a l  i n t r a op e r a t i v e  r u p t u r e .  N e u r o s u r g e r y  3 1 : 3 5 6 - 9 ,
1 9 9 2 .
1 3 1 . L a g a r e s  A ,  L o b a t o  R D ,  C a s t r o  S ,  A l d a y  R ,  D e  l a  L a m a  A ,  A l e n  J F ,  G on z a l e z  P :
M e n i n g i om a  o f  t h e  o l f a c t o r y  g r o o v e :  r e v i e w  o f  a  s e r i e s  o f  2 7  c a s e s .
N e u r o c i r u g i a  ( A s t u r )  1 2 : 1 7 - 2 2 ,  2 0 0 1 .
1 3 2 . La n d o l t  A . M . :  H i s t o r y  o f  P i t u i t a r y  S u r g e r y .  G r e e n b l a t t  S . H . ,  D a g i  T .  F . ,  E p s t e i n
M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,  1 9 9 7 ,  p p .   3 7 3 - 4 0 0 .
1 3 3 . L a n g  J :  S k u l l  ba s e  a n d  b r a i n  i n  c h i l d r e n  a n d  a d u l t s .  B i f r on t a l  a n d  f r on t o l a t e r a l
a p p r oa c h e s .  L a n g  J  ( e d ) :  S k u l l  Ba s e  a n d  R e l a t e d  S t r u c t u r e s .  S t u t t g a r t :
S ch a t t a u e r ,  2 0 0 1 ,  p p .   5 1 - 1 1 2 .
1 3 4 . L a n g  J :  C l i n i c a l  a n a t o m y  o f  a p p r oa c h e s .  B i f r on t a l  a n d  f r on t o l a t e r a l  a p p r oa c h .
L a n g  J  ( e d ) :  S k u l l  B a s e  a n d  R e l a t e d  S t r u c t u r e s .  S t u t t g a r t :  S c h a t t a u e r ,  1 9 9 5 ,  p p
9 7 - 1 1 2 .
1 3 5 . L e e  J H ,  S a d e  B ,  P a r k  B J :  A  s u r g i c a l  t e c h n i q u e  f o r  t h e  r e m o v a l  o f  c l i n o i d a l
m e n i n g i o m a s .  N e u r o s u r g e r y  5 9 : O N S 1 0 8 - 1 4 ,  2 0 0 6 .
1 3 6 . L e e  J H ,  J e u n  S S ,  E va n s  J ,  K o s m or s k y  G :  S u r g i c a l  m a n a g e m e n t  o f  c l i n o i d a l
m e n i n g i o m a s .  N e u r o s u r g e r y  4 8 : 1 0 1 2 - 9 ;  d i s c u s s i on  1 0 1 9 - 2 1 ,  2 0 0 1 .
1 3 7 . L eh e c k a  M ,  L a a k s o  A ,  H e r n e s n i e m i  J :  S p e c i f i c  t e ch n i q u e s  a n d  s t r a t e g i e s  f o r
d i f f e r e n t  p a t h o l o g i e s :  m en i n g i o m a s .  L e h e c k a  M,  L a a k s o  A ,  H e r n e s n i e m i  J  ( e d ) :
A e s c u l a p  A c a d e m y,  2 0 1 1 ,  p p   2 1 8 - 2 2 6 .
1 3 8 . L e h e c k a  M ,  D a s h t i  R ,  H e r n e s n i e m i  J ,  N i e m e l ä  M ,  K o i v i s t o  T ,  R o n k a i n e n  A ,
R i n n e  J ,  J ä ä s k e l ä i n e n  J :  M i c r o n e u r o s u r g i ca l  m a n a g em en t  o f  a n e u r y s m s  a t  t h e  A 2
s e g m e n t  o f  a n t e r i o r  c e r e b r a l  a r t e r y  ( p r o x i m a l  p e r i c a l l o s a l  a r t e r y )  a n d  i t s
f r on t o b a s a l  b r a n c h e s .  S u r g  N e u r o l  7 0 : 2 3 2 - 4 6 ,  2 0 0 8 .
1 3 9 . L e h e c k a  M ,  D a s h t i  R ,  L a a k s o  A ,  v a n  P o p t a  J S ,  R o m a n i  R ,  N a vr a t i l  O ,  K i v i p e l t o
L ,  K i v i s a a r i  R ,  F or o u g h i  M ,  K o k u z a w a  J ,  L e h t o  H ,  N i e m e l ä  M ,  R i n n e  J ,
R o n k a i n e n  A ,  K oi v i s t o  T ,  J ä ä s k e l ä i n en  J E ,  H e r n e s n i em i  J :  M i c r on e u r o s u r g i c a l
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m a n a g e m e n t  o f  a n t e r i o r  c h or o i d  a r t e r y  a n e u r ys m s .  W or l d  N e u r o s u r g  7 3 : 4 8 6 - 4 9 9 ,
2 0 1 0 .
1 4 0 . L i  X ,  L i u  M ,  L i u  Y ,  Z h u  S :  S u r g i c a l  m a n a g em e n t  o f  T u b e r c u l u m  s e l l a e
m e n i n g i o m a s .  J  C l i n  N e u r o s c i  1 4 : 1 1 5 0 - 1 1 5 4 ,  2 0 0 7 .
1 4 1 . L i - H u a  C ,  L i n g  C ,  L i - X u  L :  M i c r o s u r g i c a l  m a n a g e m e n t  o f  t u b e r c u l u m  s e l l a e
m e n i n g i o m a s  b y  t h e  f r on t o l a t e r a l  a p p r oa c h :  S u r g i c a l  t e c h n i q u e  a n d  v i s u a l
o u t c o m e .  C l i n  N e u r o l  N e u r o s u r g  2 0 1 0 .
1 4 2 . L i n d q u i s t  C , K i h l s t r om  L :  D e p a r t m e n t  o f  N e u r o s u r g e r y ,  K a r o l i n s k a  I n s t i t u t e :  6 0
y e a r s .  N e u r o s u r g e r y  3 9 : 1 0 1 6 - 1 0 2 1 ,  1 9 9 6 .
1 4 3 . L i n d r o o s  A C ,  N i i ya  T ,  R a n d e l l  T ,  R o m a n i  R ,  H e r n e s n i e m i  J ,  N i e m i  T :  S i t t i n g
p o s i t i on  f o r  r e m o v a l  o f  p i n e a l  r e g i on  l e s i o n s :  t h e  H e l s i n k i  e x p e r i en c e .  W or l d
N e u r o s u r g  7 4 : 5 0 5 - 5 1 3 ,  2 0 1 0 .
1 4 4 . L u o s t a r i n e n  T ,  T a k a l a  R S ,  N i e m i  T T ,  K a t i l a  A J ,  N i e m e l ä  M ,  H e r n e s n i e m i  J ,
R a n d e l l  T :  A d e n o s i n e - i n d u c e d  c a r d i a c  a r r e s t  d u r i n g  i n t r a o p e r a t i v e  c e r e b r a l
a n e u r ys m  r u p t u r e .  W o r l d  N e u r o s u r g  7 3 : 7 9 - 8 3 ,  2 0 1 0 .
1 4 5 . L yo n s  A . E . :  T h e  C r u c i b l e  Y ea r s  1 8 8 0  t o  1 9 0 0 :  M a c e w e n  t o  C u s h i n g .  G r e e n b l a t t
S . H . ,  D a g i  T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,
1 9 9 7 ,  p p   1 5 3 - 1 6 6 .
1 4 6 . Ma c C a r t y  C S ,  P i e p g r a s  D G ,  E b e r s o l d  M J :  M e n i n g e a l  t u m o r s  o f  t h e  br a i n . I n
Y o u m a n s  J R : N e u r o s u r g i c a l  S u r g e r y : A  C o m p r e h e n s i v e  R e f e r e n c e  G u i d e  t o  t h e
D i a g n o s i s  a n d  M a n a g e m e n t  o f  N e u r o s u r g i c a l  P r o b l e m s . 2 n d
e d . P h i l a d e l p h i a : S a u n d e r s .  1 9 8 2 .
1 4 7 . Ma c C a r t y  C S , T a y l o r  W F :  I n t r a c r a n i a l  m e n i n g i o m a s :  E x p e r i e n c e  a t  t h e  M a y o
C l i n i c .  N e u r o l  M e d  C h i r  ( T o k yo )  1 9 : 5 6 9 ,  1 9 7 9 .
1 4 8 . Ma c h i n i s  T G , F o u n t a s  K N :  O l i v e c r on a  o n  t h e  d e v e l o p m e n t  o f  n e u r os u r g e r y  i n  t h e
m i d d l e  o f  t h e  t w e n t i e t h  c e n t u r y :  r e f l e c t i on s  w i t h  t h e  w i s d om  o f  t o d a y .
N e u r o s u r g  F o c u s  2 0 : E 1 0 ,  2 0 0 6 .
1 4 9 . M a h m o u d  M ,  N a d e r  R ,  A l - M e f t y  O :  O p t i c  c a n a l  i n v o l v e m e n t  i n  t u b e r c u l u m
s e l l a e  m e n i n g i o m a s :  i n f l u e n c e  o n  a p p r oa c h ,  r e c u r r e n c e ,  a n d  v i s u a l  r e c o v e r y .
N e u r o s u r g e r y  6 7 : 1 0 8 - 1 8 ,  2 0 1 0 .
1 5 0 . M a i u r i  F ,  S a l z a n o  F A ,  M o t t a  S ,  C o l e l l a  G ,  S a r d o  L :  O l fa c t o r y  g r o o v e
m e n i n g i o m a  w i t h  p a r a n a s a l  s i n u s  a n d  n a s a l  c a v i t y  e x t e n s i o n :  r e m o v a l  b y
c o m b i n e d  s u b f r on t a l  a n d  n a s a l  a p p r oa c h .  J  C r a n i o m a x i l l o f a c  S u r g  2 6 : 3 1 4 - 3 1 7 ,
1 9 9 8 .
1 5 1 . M a t h i e s e n  T , K i h l s t r öm  L :  V i s u a l  o u t c o m e  o f  t u b e r c u l u m  s e l l a e  m e n i n g i o m a s
a f t e r  e x t r a d u r a l  o p t i c  n e r v e  d e c o m p r e s s i on .  N e u r o s u r g e r y  5 9 : 5 7 0 - 6 ,  2 0 0 6 .
1 5 2 . Ma t h i e s en  T ,  L i n d q u i s t  C ,  K i h l s t r ö m  L ,  K a r l s s on  B:  R e c u r r e n c e  o f  c r a n i a l  ba s e
m e n i n g i o m a s .  N e u r o s u r g e r y  3 9 : 2 - 7 ,  1 9 9 6 .
1 5 3 . M a vr o c o r d a t o s  P ,  B i s s on n e t t e  B ,  R a v u s s i n  P :  E f f e c t s  o f  n e c k  p o s i t i on  a n d  h e a d
e l e v a t i on  on  i n t r a c r a n i a l  p r e s s u r e  i n  a n a e s t h e t i z e d  n e u r o s u r g i c a l  p a t i e n t s :
p r e l i m i n a r y  r e s u l t s .  J  N e u r o s u r g  A n e s t h e s i o l  1 2 : 1 0 - 1 4 ,  2 0 0 0 .
1 5 4 . M a yf r a n k  L , G i l s ba c h  J M :  I n t e r h e m i s p h e r i c  a p p r oa c h  f o r  m i c r o s u r g i c a l  r e m o v a l
o f  o l f a c t o r y  g r o o v e  m e n i n g i om a s .  B r  J  N e u r o s u r g  1 0 : 5 4 1 - 5 4 5 ,  1 9 9 6 .
1 5 5 . M c A r t h u r  L . L . :  A n  a s e p t i c  s u r g i c a l  a c c e s s  t o  t h e  p i t u i t a r y  b o d y  a n d  i t s
n e i g h b or h o o d .  J A M A  5 8 : 2 0 0 9 - 2 0 1 1 ,  1 9 1 2 .
1 5 6 . M i r i m a n o f f  R O ,  D o s o r e t z  D E ,  L i n g g o o d  R M ,  O j e m a n n  R G ,  M a r t u z a  R L :
M e n i n g i om a :  a n a l ys i s  o f  r e c u r r e n c e  a n d  p r o g r e s s i on  f o l l o w i n g  n e u r o s u r g i c a l
r e s e c t i on .  J  N e u r o s u r g  6 2 : 1 8 - 2 4 ,  1 9 8 5 .
1 5 7 . M or l e y  T P :  T u m o r s  o f  t h e  c r a n i a l  m e n i n g e s .  I n  Y o u m a n s  J R : N e u r o l o g i c a l
s u r g e r y : A  C om p r e h e n s i v e  R e f e r e n c e  G u i d e  t o  t h e  D i a g n o s i s  a n d  M a n a g e m e n t  o f
N e u r o s u r g i c a l  P r o b l e m s  1 s t  e d P h i l a d e l p h i a : S a u n d e r s  1 9 7 3 .
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1 5 8 . N a g y  L ,  I s h i i  K ,  K a r a t a s  A ,  S h e n  H ,  V a j d a  J ,  N i e m e l ä  M ,  J ä ä s k e l ä i n e n  J ,
H e r n e s n i e m i  J ,  T o t h  S :  W a t e r  d i s s e c t i o n  t e c h n i q u e  o f  T o t h  f o r  o p e n i n g
n e u r o s u r g i c a l  c l e a v a g e  p l a n e s .  S u r g  N e u r o l  6 5 : 3 8 - 4 1 ;  d i s c u s s i on  4 1 ,  2 0 0 6 .
1 5 9 . N a k a m u r a  M ,  S t r u c k  M ,  R o s e r  F ,  V o r k a p i c  P ,  S a m i i  M :  O l f a c t o r y  g r o o v e
m e n i n g i o m a s :  c l i n i ca l  o u t c o m e  a n d  r e c u r r en c e  r a t e s  a f t e r  t u m or  r e m o v a l  t h r o u g h
t h e  f r on t o l a t e r a l  a n d  b i f r on t a l  a p p r o a c h .  N e u r o s u r g e r y  6 0 : 8 4 4 - 5 2 ,  2 0 0 7 .
1 6 0 . N a k a m u r a  M ,  R o s e r  F ,  J a c o b s  C ,  V or k a p i c  P ,  S a m i i  M :  M e d i a l  s p h e n o i d  w i n g
m e n i n g i o m a s :  c l i n i c a l  o u t c o m e  a n d  r e c u r r e n c e  r a t e .  N e u r o s u r g e r y  5 8 : 6 2 6 - 3 9 ,
2 0 0 6 .
1 6 1 . N a k a m u r a  M ,  R o s e r  F ,  S t r u c k  M ,  V o r k a p i c  P ,  S a m i i  M :  T u b e r c u l u m  s e l l a e
m e n i n g i o m a s :  c l i n i ca l  o u t c om e  c o n s i d e r i n g  d i f f e r e n t  s u r g i c a l  a p p r oa c h e s .
N e u r o s u r g e r y  5 9 : 1 0 1 9 - 2 8 ,  2 0 0 6 .
1 6 2 . N a k a s e  H ,  O h n i s h i  H ,  T o u h o  H ,  M i ya m o t o  S ,  M or i s a k o  T ,  W a t a b e  Y ,  I t oh  T ,
Y a m a d a  K ,  S h i ba m o t o  K ,  K a r a s a w a  J :  S u r g i c a l  e x c i s i on  o f  a  h u g e  o l f a c t o r y
g r o o v e  m e n i n g i o m a  b y  e x t e n s i v e  t r a n s f r on t a l  a p p r oa c h .  N o  S h i n k e i  G e k a  2 1 : 2 6 3 -
2 6 7 ,  1 9 9 3 .
1 6 3 . N a n d a  A , J a v a l k a r  V :  M i c r on e u r o s u r g i c a l  M a n a g e m e n t  o f  O p h t h a l m i c  S e g m e n t  o f
t h e  I C A  A n e u r ys m s :  S i n g l e  S u r g e on  O p e r a t i v e  E x p e r i e n c e  f r o m  L S U  S h r e v e p or t .
N e u r o s u r g e r y  2 0 1 0 .
1 6 4 . N e wf i e l d  P .  A M :  N e u r o a n e s t h e s i a .  W i l k i n s  R . H .  R S S  ( e d ) :  N e u r o s u r g e r y .  U S A :
M c G r a w - H i l l ,  1 9 9 6 ,  p p   3 9 9 - 4 2 4 .
1 6 5 . N o g u c h i  A ,  B a l a s i n g a m  V ,  S h i o k a w a  Y ,  M c M en om e y  S O ,  D e l a s h a w  J B , J r :
E x t r a d u r a l  a n t e r i o r  c l i n o i d e c t o m y .  T e ch n i c a l  n o t e .  J  N e u r o s u r g  1 0 2 : 9 4 5 - 9 5 0 ,
2 0 0 5 .
1 6 6 . N o z a k i  K ,  K i k u t a  K ,  T a k a g i  Y ,  M i n e h a r u  Y ,  T a k a h a s h i  J A ,  H a s h i m o t o  N :  E f f e c t
o f  e a r l y  o p t i c  c a n a l  u n r o o f i n g  on  t h e  o u t c o m e  o f  v i s u a l  f u n c t i on s  i n  s u r g e r y  f o r
m e n i n g i o m a s  o f  t h e  t u b e r c u l u m  s e l l a e  a n d  p l a n u m  s p h e n o i d a l e .  N e u r o s u r g e r y
6 2 : 8 3 9 - 4 4 ,  2 0 0 8 .
1 6 7 . N u t i k  S L :  R e m o v a l  o f  t h e  a n t e r i o r  c l i n o i d  p r o c e s s  f o r  e x p o s u r e  o f  t h e  p r o x i m a l
i n t r a c r a n i a l  c a r o t i d  a r t e r y .  J  N e u r o s u r g  6 9 : 5 2 9 - 5 3 4 ,  1 9 8 8 .
1 6 8 . O  Br i e n  D F ,  F a r r e l l  M ,  P i d g e on  C N :  C o m b i n e d  n a s a l  a n d  s k u l l  ba s e  p a t h o l o g y :
a d j a c e n t  n a s a l  s c h wa n n om a  a n d  o l f a c t o r y  g r o o v e  m e n i n g i om a .  Br  J  N e u r o s u r g
1 9 : 4 4 6 - 4 4 8 ,  2 0 0 5 .
1 6 9 . O b e i d  F , A l - M e f t y  O :  R e c u r r e n c e  o f  o l f a c t o r y  g r o o v e  m e n i n g i om a s .
N e u r o s u r g e r y  5 3 : 5 3 4 - 4 2 ,  2 0 0 3 .
1 7 0 . O h m o t o  T ,  N a g a o  S ,  M i n o  S ,  I t o  T ,  H o n m a  Y ,  F u j i w a r a  T :  E x p o s u r e  o f  t h e
i n t r a c a v e r n o u s  c a r o t i d  a r t e r y  i n  a n e u r ys m  s u r g e r y .  N e u r os u r g e r y  2 8 : 3 1 7 - 2 3 ,
1 9 9 1 .
1 7 1 . O h t a  K ,  Y a s u o  K ,  M or i k a w a  M ,  N a g a s h i m a  T ,  T a m a k i  N :  T r e a t m e n t  o f
t u b e r c u l u m  s e l l a e  m e n i n g i o m a s : a  l o n g - t e r m  f o l l o w - u p  s t u d y .  J  C l i n  N e u r o s c i  8
S u p p l  1 : 2 6 - 3 1 ,  2 0 0 1 .
1 7 2 . O j e m a n n  R G :  S u p r a t e n t o r i a l  M en i n g i o m a s :  C l i n i c a l  F e a t u r e s  a n d  S u r g i c a l
M a n a g e m e n t .  W i l k i n s  R H  R S  ( e d ) :  N e u r o s u r g e r y .  N e w  Y o r k :  M c G r a w - H i l l ,  1 9 9 6 ,
p p   8 7 3 - 8 9 0 .
1 7 3 . O j e m a n n  R G :  S u r g i c a l  M a n a g e m e n t  o f  O l f a c t o r y  G r o o v e ,  S u p r a s e l l a r ,  a n d
M e d i a l  S p h e n o i d  W i n g  M e n i n g i o m a s .  S ch m i d e k  H H  ( e d ) :  M en i n g i o m a s  a n d  t h e i r
S u r g i c a l  M a n a g e m e n t .  P h i l a d e l p h i a :  W. B .  Sa u n d e r s  C o . ,  1 9 9 1 ,  p p   2 4 2 - 2 5 9 .
1 7 4 . O l i v e c r on a  H , U r ba n  H :  U b e r  M en i n g e om e  d e r  S i e b b e i n p l a t t e .  B r u n ' s  B e i t r  K l i n
C h i r  1 6 1 : 2 2 4 - 2 5 3 ,  1 9 3 5 .
1 7 5 . O l i v e c r on a  H :  T h e  s u r g i c a l  t r e a t m e n t  o f  i n t r a c r a n i a l  t u m or s .  O l i v e c r on a  H  T W
( e d ) :  H a n d b u c h  D er  N e u r o c h i r u r g i e .  B e r l i n :  S p r i n g e r - V er l a g ,  1 9 6 7 ,  p p   1 - 3 0 1 .
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1 7 6 . O l i v e c r on a  H . :  N e u r o s u r g e r y ,  p a s t  a n d  p r e s en t .  A c t a  N eu r o c h i r  ( W i e n )  4 - 8 ,
1 9 5 1 .
1 7 7 . O s b o r n  A G :  M e n i n g i o m a .  O s b or n  A G  ( e d ) :  D i a g n os t i c  I m a g i n g  Br a i n .  S a l t  La k e
C i t y ,  U t a h :  A m i r s ys ,  2 0 0 4 ,  p p .  5 6 - 6 3 .
1 7 8 . O t a n i  N ,  M u r o i  C ,  Y a n o  H ,  K h a n  N ,  P a n g a l u  A ,  Y on e k a w a  Y :  S u r g i c a l
m a n a g e m e n t  o f  t u b e r c u l u m  s e l l a e  m e n i n g i om a :  r o l e  o f  s e l e c t i v e  e x t r a d u r a l
a n t e r i o r  c l i n o i d e c t om y.  Br  J  N e u r os u r g  2 0 : 1 2 9 - 1 3 8 ,  2 0 0 6 .
1 7 9 . P a m i r  M N ,  B e l i r g e n  M ,  O z d u m a n  K ,  K i l i c  T ,  O z e k  M :  A n t e r i o r  c l i n o i d a l
m e n i n g i o m a s :  a n a l ys i s  o f  4 3  c o n s e c u t i v e  s u r g i c a l l y  t r e a t e d  c a s e s .  A c t a
N e u r o c h i r  ( W i en )  1 5 0 : 6 2 5 - 3 5 ,  2 0 0 8 .
1 8 0 . P a m i r  M N ,  O z d u m a n  K ,  B e l i r g e n  M ,  K i l i c  T ,  O z e k  M M :  O u t c o m e  d e t e r m i n a n t s
o f  p t e r i o n a l  s u r g e r y  f o r  t u b e r c u l u m  s e l l a e  m e n i n g i o m a s .  A c t a  N e u r o c h i r  ( W i e n )
1 4 7 : 1 1 2 1 - 3 0 ,  2 0 0 5 .
1 8 1 . P a r k  C K ,  J u n g  H W ,  Y a n g  S Y ,  S e o l  HJ ,  P a e k  S H ,  K i m  D G :  S u r g i c a l l y  t r e a t e d
t u b e r c u l u m  s e l l a e  a n d  d i a p h r a g m  s e l l a e  m e n i n g i o m a s :  t h e  i m p or t a n c e  o f  s h or t -
t e r m  v i s u a l  o u t c o m e .  N e u r o s u r g e r y  5 9 : 2 3 8 - 4 3 ;  d i s c u s s i on  2 3 8 - 4 3 ,  2 0 0 6 .
1 8 2 . P a r k  S K ,  S h i n  Y S ,  L i m  Y C ,  C h u n g  J :  P r e o p e r a t i v e  p r e d i c t i v e  v a l u e  o f  t h e
n e c e s s i t y  f o r  a n t e r i o r  c l i n o i d e c t o m y  i n  p o s t e r i o r  c o m m u n i c a t i n g  a r t e r y  a n e u r ys m
c l i p p i n g .  N e u r o s u r g e r y  6 5 : 2 8 1 - 5 ,  2 0 0 9 .
1 8 3 . P a t e r n i t i  S ,  F i o r e  P ,  L e v i t a  A ,  L a  C a m e r a  A ,  C a m br i a  S :  V e n o u s  s a v i n g  i n
o l f a c t o r y  m e n i n g i om a ' s  s u r g e r y .  C l i n  N e u r o l  N e u r o s u r g  1 0 1 : 2 3 5 - 2 3 7 ,  1 9 9 9 .
1 8 4 . P a t e r n i t i  S ,  F i o r e  P ,  L e v i t a  A ,  L a  C a m e r a  A ,  C a m br i a  S :  B a s a l  m e n i n g i o m a s .  A
r e t r o s p e c t i v e  s t u d y  o f  1 3 9  s u r g i c a l  c a s e s .  J  N e u r o s u r g  S c i  4 3 : 1 0 7 - 1 3 ;  d i s c u s s i on
1 1 3 - 4 ,  1 9 9 9 .
1 8 5 . P e r n e c z k y  A ,  K n o s p  E ,  V or k a p i c  P ,  C z e ch  T :  D i r e c t  s u r g i c a l  a p p r oa c h  t o
i n f r a c l i n o i d a l  a n e u r ys m s .  A c t a  N e u r o c h i r  ( W i e n )  7 6 : 3 6 - 4 4 ,  1 9 8 5 .
1 8 6 . P o m p i l i  A ,  D e r om e  P J ,  V i s o t  A ,  G u i o t  G :  H yp e r o s t o s i n g  m e n i n g i om a s  o f  t h e
s p h e n o i d  r i d g e - - c l i n i ca l  f e a t u r e s ,  s u r g i c a l  t h e r a p y ,  a n d  l on g - t e r m  o b s e r va t i on s :
r e v i e w  o f  4 9  c a s e s .  S u r g  N e u r o l  1 7 : 4 1 1 - 4 1 6 ,  1 9 8 2 .
1 8 7 . P o p p e n  J L :  O p e r a t i v e  t e c h n i q u e s  f o r  r e m o v a l  o f  o l f a c t o r y  g r o o v e  a n d
s u p r a s e l l a r  m e n i n g i o m a s .  C l i n  N e u r o s u r g  1 1 : 1 - 7 ,  1 9 6 4 .
1 8 8 . P u z z i l l i  F ,  R u g g e r i  A ,  M a s t r on a r d i  L ,  A g r i l l o  A ,  F e r r an t e  L :  A n t e r i or  c l i n o i d a l
m e n i n g i o m a s :  r e p or t  o f  a  s e r i e s  o f  3 3  p a t i e n t s  o p e r a t e d  on  t h r o u g h  t h e  p t e r i o n a l
a p p r oa c h .  N e u r o  O n c o l  1 : 1 8 8 - 1 9 5 ,  1 9 9 9 .
1 8 9 . Ra c h l i n  J . R .  a n d  R o s e n b l u m  M . L . :  E t i o l o g y  a n d  B i o l o g y  o f  M e n i n g i o m a s .  A l -
M e f t y  O .  ( ed ) :  M en i n g i o m a s .  N e w  Y or k :  R a v e n  P r e s s ,  1 9 9 1 ,  p p   2 7 - 3 5 .
1 9 0 . Ra c o  A ,  Br i s t o t  R ,  D o m e n i c u c c i  M ,  C a n t o r e  G :  M e n i n g i om a s  o f  t h e  t u b e r c u l u m
s e l l a e .  O u r  e x p e r i e n c e  i n  6 9  c a s e s  s u r g i c a l l y  t r e a t e d  b e t w e e n  1 9 7 3  a n d  1 9 9 3 .  J
N e u r o s u r g  S c i  4 3 : 2 5 3 - 6 0 ,  1 9 9 9 .
1 9 1 . R a n d e l l  T ,  N i e m e l ä  M ,  K yt t ä  J ,  T a n s k a n e n  P ,  M ä ä t t ä n en  M ,  K a r a t a s  A ,  I s h i i  K ,
D a s h t i  R ,  S h e n  H,  H e r n e s n i e m i  J :  P r i n c i p l e s  o f  n e u r oa n e s t h e s i a  i n  a n e u r ys m a l
s u b a r a c h n o i d  h e m o r r h a g e :  T h e  H e l s i n k i  e x p e r i e n c e .  S u r g  N e u r o l  6 6 : 3 8 2 - 8 ,  2 0 0 6 .
1 9 2 . Ra u d a m  E , K a a s i k  A E :  L u d w i g  P u u s e p p  1 8 7 5 - 1 9 4 2 .  S u r g  N e u r o l  1 6 : 8 5 - 8 7 ,  1 9 8 1 .
1 9 3 . R e i s c h  R , P e r n e c z k y  A :  T e n - ye a r  e x p e r i e n c e  w i t h  t h e  s u p r a o r b i t a l  s u b f r on t a l
a p p r oa c h  t h r ou g h  a n  e ye b r o w  s k i n  i n c i s i o n .  N eu r o s u r g e r y  5 7 : 2 4 2 - 5 5 ,  2 0 0 5 .
1 9 4 . R h o t o n  A L , J r :  T h e  a n t e r i o r  a n d  m i d d l e  c r a n i a l  b a s e .  N e u r o s u r g e r y  5 1 : S 2 7 3 - 3 0 2 ,
2 0 0 2 .
1 9 5 . Rh o t on  A L , J r :  M i c r o s u r g i c a l  A n a t om y  o f  t h e  S e l l a r  R e g i on .  W i l k i n s  R H,
R e n g a c h a r y  S S  ( e d s ) :  N e u r o s u r g e r y .  U n i t e d  S t a t e s :  M c G R A W - H I L L ,  1 9 9 6 ,  p p
1 2 4 3 - 1 2 5 2 .
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1 9 6 . Ri s i  P ,  U s k e  A ,  d e  T r i b o l e t  N :  M en i n g i o m a s  i n v o l v i n g  t h e  a n t e r i or  c l i n o i d
p r o c e s s .  Br  J  N e u r o s u r g  8 : 2 9 5 - 3 0 5 ,  1 9 9 4 .
1 9 7 . R o m a n i  R ,  K i v i s a a r i  R ,  C e l i k  O ,  N i e m e l ä  M ,  P e r r a  G ,  H e r n e s n i e m i  J :  R e p a i r  o f
a n  a l a r m i n g  i n t r a op e r a t i v e  i n t r a c a v e r n o u s  c a r o t i d  a r t e r y  t e a r  w i t h  a n a s t o c l i p s :
t e ch n i c a l  c a s e  r e p or t .  N e u r o s u r g e r y  6 5 : E 9 9 8 - 9 ,  2 0 0 9 .
1 9 8 . R o m a n i  R ,  L e h t o  H ,  L a a k s o  A ,  H o r c a j a d a s  A ,  K i v i s a a r i  R ,  v on  Un d  Z u
F r a u n b e r g  M ,  N i e m e l ä  M ,  R i n n e  J ,  H e r n e s n i e m i  J :  M i c r o s u r g e r y  f o r  P r e v i o u s l y
C o i l e d  A n e u r ys m s :  E x p e r i e n c e  Wi t h  8 1  P a t i e n t s .  N eu r o s u r g e r y  6 8 : 1 4 0 - 1 5 4 ,
2 0 1 1 .
1 9 9 . R o m a n i  R ,  L a a k s o  A ,  N i e m e l ä  M ,  L e h e c k a  M ,  D a s h t i  R ,  I s a r a k u l  P ,  C e l i k  O ,
N a vr a t i l  O ,  L e h t o  H ,  K i vi s a a r i  R ,  H e r n e s n i em i  J :  M i c r o s u r g i c a l  p r i n c i p l e s  f o r
a n t e r i o r  c i r c u l a t i o n  a n e u r ys m s .  A c t a  N e u r oc h i r  S u p p l  1 0 7 : 3 - 7 ,  2 0 1 0 .
2 0 0 . R u bi n  G ,  B e n  D a v i d  U ,  G or n i s h  M ,  R a p p a p o r t  Z H :  M en i n g i o m a s  o f  t h e  a n t e r i o r
c r a n i a l  f o s s a  f l o o r .  R e v i e w  o f  6 7  c a s e s .  A c t a  N e u r o c h i r  ( W i e n )  1 2 9 : 2 6 - 3 0 ,  1 9 9 4 .
2 0 1 . R u s s e l l  S M , B e n j a m i n  V :  M e d i a l  s p h en o i d  r i d g e  m e n i n g i o m a s :  c l a s s i f i c a t i on ,
m i c r o s u r g i c a l  a n a t o m y,  o p e r a t i v e  n u a n c e s ,  a n d  l on g - t e r m  s u r g i c a l  o u t c om e  i n  3 5
c o n s e c u t i v e  p a t i e n t s .  N e u r os u r g e r y  6 2 : 3 8 - 5 0 ,  2 0 0 8 .
2 0 2 . S a d e  B , L e e  J H :  H i g h  i n c i d e n c e  o f  o p t i c  c a n a l  i n v o l v e m e n t  i n  t u b e r c u l u m  s e l l a e
m e n i n g i o m a s :  r a t i on a l e  f o r  a g g r e s s i v e  s k u l l  b a s e  a p p r o a c h .  S u r g  N e u r o l  7 2 : 1 1 8 -
2 3 ,  2 0 0 9 .
2 0 3 . S a d e  B , L e e  J H :  H i g h  i n c i d e n c e  o f  o p t i c  c a n a l  i n v o l v e m e n t  i n  c l i n o i d a l
m e n i n g i o m a s :  r a t i on a l e  f o r  a g g r e s s i v e  s k u l l  b a s e  a p p r oa c h .  A c t a  N e u r o c h i r
( W i e n )  1 5 0 : 1 1 2 7 - 3 2 ,  2 0 0 8 .
2 0 4 . S a l m a  A ,  A l k a n d a r i  A ,  S a m m e t  S ,  A m m i r a t i  M :  L a t e r a l  s u p r a or b i t a l  a p p r oa c h
v e r s u s  p t e r i on a l  a p p r oa c h :  a n  a n a t om i c a l  q u a l i t a t i v e  a n d  q u a n t i t a t i v e  e v a l u a t i on .
N e u r o s u r g e r y  2 0 1 1 .
2 0 5 . S a u l  F . P .  S J M :  T r e p a n a t i on :  O l d  W or l d  a n d  N e w  W o r l d .  G r e e n b l a t t  S . H . ,  D a g i
T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,  1 9 9 7 ,  p p   2 9 -
3 5 .
2 0 6 . S c h a l l e r  C ,  R oh d e  V ,  H a s s l e r  W :  M i c r o s u r g i c a l  R e m o v a l  o f  O l f a c t o r y  G r o o v e
M e n i n g i om a s  v i a  t h e  P t e r i on a l  A p p r oa c h .  S k u l l  Ba s e  S u r g  4 : 1 8 9 - 1 9 2 ,  1 9 9 4 .
2 0 7 . S c h i c k  U , H a s s l e r  W :  S u r g i c a l  m a n a g em e n t  o f  t u b e r c u l u m  s e l l a e  m e n i n g i o m a s :
i n v o l v e m e n t  o f  t h e  o p t i c  c a n a l  a n d  v i s u a l  o u t c o m e .  J  N e u r o l  N e u r o s u r g
P s yc h i a t r y  7 6 : 9 7 7 - 9 8 3 ,  2 0 0 5 .
2 0 8 . S e k h a r  L N :  H o w  t o  p e r f o r m  c en t r a l  s k u l l  b a s e  a p p r oa c h e s .  S i n d o u  M .  ( e d ) :
P r a c t i c a l  H a n d b o o k  o f  N e u r o s u r g e r y .  f r o m  L e a d i n g  N e u r o s u r g e o n s .  W i e n ,
G er m a n y :  S p r i n g e r - V er l a g ,  2 0 0 9 ,  p p   1 3 5 - 1 5 2 .
2 0 9 . S e k h a r  L N ,   G o e l  A :  A n t e r i o r  a n d  M i d d l e  C r a n i a l  B a s e  L e s i o n s  ( E x c l u d i n g
C a v e r n ou s  S i n u s ) .  A p u z z o  M L J  ( e d ) :  B r a i n  S u r g e r y .  C o m p l i c a t i on  A v o i d a n c e
a n d  Ma n a g e m e n t .  N e w  Y or k :  C h u r c h i l l  L i v i n g s t o n e ,  1 9 9 3 ,  p p   2 1 7 5 - 2 1 9 4 .
2 1 0 . S e k h a r  L N ,  N a n d a  A ,  S e n  C N :  T h e  e x t e n d e d  f r on t a l  a p p r oa c h  t o  t u m or s  o f  t h e
a n t e r i o r , m i d d l e ,  a n d  p o s t e r i o r  s k u l l  ba s e .  J  N e u r o s u r g  7 6 : 1 9 8 - 2 0 6 ,  1 9 9 2 .
2 1 1 . S e p e h r n i a  A , K n op p  U :  P r e s e r va t i o n  o f  t h e  o l f a c t o r y  t r a c t  i n  b i f r on t a l
c r a n i o t o m y  f o r  v a r i o u s  l e s i o n s  o f  t h e  a n t e r i o r  c r a n i a l  f o s s a .  N e u r o s u r g e r y
4 4 : 1 1 3 - 1 1 7 ,  1 9 9 9 .
2 1 2 . S i m p s on  D :  T h e  r e c u r r e n c e  o f  i n t r a c r a n i a l  m e n i n g i o m a s  a f t e r  s u r g i c a l
t r e a t m e n t .  J  N e u r o l  N e u r os u r g  P s yc h i a t r y  2 0 : 2 2 ,  1 9 5 7 .
2 1 3 . Sn yd e r  W E ,  S h a h  M V ,  W e i s b e r g e r  E C ,  C a m p b e l l  R L :  P r e s en t a t i o n  a n d  p a t t e r n s
o f  l a t e  r e c u r r e n c e  o f  o l f a c t o r y  g r o o v e  m e n i n g i o m a s .  S k u l l  B a s e  S u r g  1 0 : 1 3 1 -
1 3 9 ,  2 0 0 0 .
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2 1 4 . S o l e r o  C L,  G i om b i n i  S ,  M or e l l o  G :  S u p r a s e l l a r  a n d  o l f a c t o r y  m e n i n g i om a s .
R e p o r t  on  a  s e r i e s  o f  1 5 3  p e r s on a l  c a s e s .  A c t a  N e u r o c h i r  ( W i e n )  6 7 : 1 8 1 - 1 9 4 ,
1 9 8 3 .
2 1 5 . S on  H E ,  P a r k  M S ,  K i m  S M ,  J u n g  S S ,  P a r k  K S ,  C h u n g  S Y :  T h e  a v o i d a n c e  o f
m i c r o s u r g i c a l  c o m p l i c a t i on s  i n  t h e  e x t r a d u r a l  a n t e r i or  c l i n o i d e c t o m y  t o
p a r a c l i n o i d  a n e u r ys m s .  J  K or e a n  N e u r o s u r g  S o c  4 8 : 1 9 9 - 2 0 6 ,  2 0 1 0 .
2 1 6 .  S p e k t o r  S ,  V a l a r e z o  J ,  F l i s s  D M ,  G i l  Z ,  C oh e n  J ,  G o l d m a n  J ,  U m a n s k y  F :
O l f a c t o r y  g r o o v e  m e n i n g i o m a s  f r o m  n e u r o s u r g i c a l  a n d  e a r ,  n os e ,  a n d  t h r oa t
p e r s p e c t i v e s :  a p p r oa c h e s ,  t e ch n i q u e s ,  a n d  o u t c o m e s .  N e u r o s u r g e r y  5 7 : 2 6 8 - 8 0 ,
2 0 0 5 .
2 1 7 . S p e r a t i  G :  C r a n i o t o m y  t h r ou g h  t h e  a g e s .  A c t a  O t o r h i n o l a r yn g o l  I t a l  2 7 : 1 5 1 - 1 5 6 ,
2 0 0 7 .
2 1 8 . S p e t z l e r  R F ,  He r m a n  J M ,  B e a l s  S ,  J o g a n i c  E ,  M i l l i g a n  J :  P r e s e r va t i on  o f
o l f a c t i o n  i n  a n t e r i o r  c r a n i o f a c i a l  a p p r oa c h e s .  J  N eu r o s u r g  7 9 : 4 8 - 5 2 ,  1 9 9 3 .
2 1 9 . S t a n t on  C . A . ,   C h a l l a  V . R . :  M e n i n g i o m a s :  P a t h o l o g y .  W i l k i n s  R . H .  R S S  ( e d ) :
N e u r o s u r g e r y .  M c G r a w - H i l l ,  1 9 9 6 ,  p p   8 4 3 - 8 5 4 .
2 2 0 . S u g i t a  K :  M e n i n g i o m a .  S u g i t a  K  ( e d ) :  M i c r on e u r o s u r g i c a l  A t l a s .  W ü r z z b u r g :
S p r i n g e r - V er l a g  B e r l i n  H e i d e l b e r g ,  1 9 8 5 ,  p p   1 8 5 - 2 0 5 .
2 2 1 . S u n d t  T M , J r , P i e p g r a s  D G:  S u r g i c a l  a p p r oa c h  t o  g i a n t  i n t r a c r a n i a l  a n e u r ys m s .
O p e r a t i v e  e x p e r i e n c e  w i t h  8 0  c a s e s .  J  N e u r o s u r g  5 1 : 7 3 1 - 7 4 2 ,  1 9 7 9 .
2 2 2 . S u r i  A ,  N a r a n g  K S ,  S h a r m a  B S ,  M a h a p a t r a  A K :  V i s u a l  o u t c om e  a f t e r  s u r g e r y  i n
p a t i e n t s  w i t h  s u p r a s e l l a r  t u m or s  a n d  p r e o p e r a t i v e  b l i n d n e s s .  J  N e u r o s u r g
1 0 8 : 1 9 - 2 5 ,  2 0 0 8 .
2 2 3 . S yk e s  P :  T h e  E d w i n  S m i t h  p a p y r u s  ( ca .  1 6 t h  c e n t u r y  B C ) .  A n n  P l a s t  S u r g  6 2 : 3 -
4 ,  2 0 0 9 .
2 2 4 . S ym o n  L , R o s e n s t e i n  J :  S u r g i c a l  m a n a g e m e n t  o f  s u p r a s e l l a r  m e n i n g i om a .  P a r t  1 :
T h e  i n f l u e n c e  o f  t u m or  s i z e ,  d u r a t i on  o f  s ym p t o m s ,  a n d  m i c r o s u r g e r y  o n
s u r g i c a l  o u t c o m e  i n  1 0 1  c on s e c u t i v e  c a s e s .  J  N e u r o s u r g  6 1 : 6 3 3 - 6 4 1 ,  1 9 8 4 .
2 2 5 . S ym o n  L , J a k u b o w s k i  J :  C l i n i c a l  f e a t u r e s ,  t e c h n i c a l  p r o b l e m s ,  a n d  r e s u l t s  o f
t r e a t m e n t  o f  a n t e r i o r  p a r a s e l l a r  m e n i n g i o m a s .  A c t a  N e u r o c h i r  S u p p l  ( W i e n )
2 8 : 3 6 7 - 3 7 0 ,  1 9 7 9 .
2 2 6 . T a k a h a s h i  J A ,  K a w a r a z a k i  A ,  H a s h i m o t o  N :  I n t r a d u r a l  e n - b l o c  r e m o v a l  o f  t h e
a n t e r i o r  c l i n o i d  p r o c e s s .  A c t a  N e u r o c h i r  ( W i e n )  1 4 6 : 5 0 5 - 5 0 9 ,  2 0 0 4 .
2 2 7 . T a o  C S ,  L o u  M Q ,  L u  Y C ,  W a n g  L ,  W a n g  B X ,  L i  W ,  Z h a n g  K ,  J i a n g  J H :
E x p e r i e n c e  o f  r e s e c t i on  l a r g e  c l i n o i d a l  m e n i n g i o m a s .  Z h on g h u a  W a i  K e  Z a  Z h i
4 3 : 1 4 1 4 - 1 4 1 7 ,  2 0 0 5 .
2 2 8 . T a t t e r  S B ,  W i l s o n  C B ,   H a r s h  G R :  N e u r o e p i t h e l i a l  t u m or s  o f  t h e  a d u l t  b r a i n .
Y o u m a n s  J R  ( e d ) :  N e u r o l o g i c a l  S u r g e r y .  P h i l a d e l p h i a :  W . B.  S a u n d e r s  C o ,  1 9 9 6 ,
p p   2 6 1 2 - 2 6 8 4 .
2 2 9 . T e l l a  O I , J r ,  P a i v a  N e t o  M A ,  H e r c u l a n o  M A ,  F a e d o  N e t o  A :  O l f a c t o r y  g r o o v e
m e n i n g i o m a .  A r q  N e u r o p s i q u i a t r  6 4 : 8 3 - 8 7 ,  2 0 0 6 .
2 3 0 . T e r a s a k a  S ,  A s a o k a  K ,  K o b a y a s h i  H ,  Y a m a g u c h i  S :  A n t e r i o r  i n t e r h e m i s p h e r i c
a p p r oa c h  f o r  t u b e r c u l u m  s e l l a e  m e n i n g i o m a .  N e u r os u r g e r y  6 8 : 8 4 - 8 ,  2 0 1 1 .
2 3 1 . T o b i a s  S ,  K i m  C H ,  K o s m or s k y  G ,  L e e  J H :  M a n a g e m e n t  o f  s u r g i c a l  c l i n o i d a l
m e n i n g i o m a s .  N e u r o s u r g  F o c u s  1 4 : e 5 ,  2 0 0 3 .
2 3 2 . T ön n i s  W :  Z u r  O p e r a t i on  d e r  M en i n g e o m e  d e r  S i e b b e i n p l a t t e .  Z en t r a l b l a t t  f u r
N e u r o c h i r  1 : 1 - 7 ,  1 9 3 8 .
2 3 3 . T ör m ä  T :  A a r n o  Sn e l l m a n ,  t h e  p i o n e e r  o f  m o d e r n  n e u r o s u r g e r y  i n  F i n l a n d  a n d
t h e  f o u n d e r  o f  t h e  N e u r o s u r g i c a l  C l i n i c  o f  H e l s i n k i  U n i v e r s i t y  H o s p i t a l .
H i p p o k r a t e s  ( H e l s i n k i )  1 1 : 8 4 - 9 4 ,  1 9 9 4 .
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2 3 4 . T ör m ä  T :  P e r s p e c t i v e s  i n  i n t e r n a t i o n a l  n e u r o s u r g e r y :  n e u r o s u r g e r y  i n  F i n l a n d .
N e u r o s u r g e r y  9 : 4 7 9 - 4 8 1 ,  1 9 8 1 .
2 3 5 . T ör m ä  T :  D e v e l o p m e n t  o f  n e u r os u r g e r y  i n  F i n l a n d .  D u o d e c i m  7 9 : 1 9 6 - 1 9 9 ,  1 9 6 3 .
2 3 6 . T u n a  H,  B o z k u r t  M ,  A yt e n  M ,  E r d o g a n  A ,  D e d a  H :  O l fa c t o r y  g r o o v e
m e n i n g i o m a s .  J  C l i n  N e u r o s c i  1 2 : 6 6 4 - 6 6 8 ,  2 0 0 5 .
2 3 7 . T u n a  M,  G o c e r  A I ,  G ez e r c a n  Y ,  V u r a l  A ,  I l d a n  F ,  H a c i y a k u p o g l u  S ,  K a r a d a y i  A :
H u g e  m e n i n g i o m a s :  a  r e v i e w  o f  9 3  c a s e s .  S k u l l  Ba s e  S u r g  9 : 2 2 7 - 2 3 8 ,  1 9 9 9 .
2 3 8 . T u r a z z i  S ,  C r i s t o f o r i  L ,  G a m b i n  R ,  Br i c o l o  A :  T h e  p t e r i on a l  a p p r oa c h  f o r  t h e
m i c r o s u r g i c a l  r e m o v a l  o f  o l f a c t o r y  g r o o v e  m e n i n g i o m a s .  N e u r o s u r g e r y  4 5 : 8 2 1 - 5 ,
1 9 9 9 .
2 3 9 . U g r u m o v  V M ,  I g n a t ye v a  G E ,  O l u s h i n  V E ,  T i g l i e v  G S ,  P o l e n o v  A L :  P a r a s e l l a r
m e n i n g i o m a s :  d i a g n o s i s  a n d  p o s s i b i l i t y  o f  s u r g i c a l  t r e a t m e n t  a c c or d i n g  t o  t h e
p l a c e  o f  o r i g i n a l  g r o w t h .  A c t a  N e u r o c h i r  S u p p l  ( W i e n )  2 8 : 3 7 3 - 3 7 4 ,  1 9 7 9 .
2 4 0 . U i h l e i n  A ,  W e ya n d  R D :  M e n i n g i om a s  o f  a n t e r i o r  c l i n o i d  p r o c e s s  a s  a  c a u s e  o f
u n i l a t e r a l  l o s s  o f  v i s i on ;  s u r g i c a l  c on s i d e r a t i on s .  A M A  Ar c h  O p h t h a l m ol
4 9 : 2 6 1 - 2 7 0 ,  1 9 5 3 .
2 4 1 . va n  O v e r b e e k e  J , S e k h a r  L :  M i c r o a n a t om y  o f  t h e  b l o o d  s u p p l y  t o  t h e  o p t i c  n e r v e .
O r b i t  2 2 : 8 1 - 8 8 ,  2 0 0 3 .
2 4 2 . W a r r e n  W L , Gr a n t  G A :  T r a n s c i l i a r y  o r b i t o f r on t o z y g o m a t i c  a p p r oa c h  t o  l e s i o n s
o f  t h e  a n t e r i o r  c r a n i a l  f o s s a .  N e u r o s u r g e r y  6 4 : 3 2 4 - 9 ,  2 0 0 9 .
2 4 3 . W e i  C P ,  W a n g  A D ,  T s a i  M D :  R e s e c t i on  o f  g i a n t  o l f a c t o r y  g r o o v e  m e n i n g i o m a
w i t h  e x t r a d u r a l  d e v a s c u l a r i z a t i on .  S k u l l  B a s e  1 2 : 2 7 - 3 1 ,  2 0 0 2 .
2 4 4 . W e l g e - L u e s s e n  A ,  T em m e l  A ,  Q u i n t  C ,  M ol l  B ,  W ol f  S ,  Hu m m e l  T :  O l f a c t o r y
f u n c t i on  i n  p a t i e n t s  w i t h  o l f a c t o r y  g r o o v e  m e n i n g i o m a .  J  N e u r o l  N e u r o s u r g
P s yc h i a t r y  7 0 : 2 1 8 - 2 2 1 ,  2 0 0 1 .
2 4 5 . W i l k i n s  R . H . :  T r e a t m e n t  o f  C r a n i o c e r e br a l  I n f e c t i on  a n d  O t h e r  C o m m o n
N e u r o s u r g i c a l  O p e r a t i on s  a t  t h e  T i m e  o f  L i s t e r  a n d  M a c e w e n .  G r e e n b l a t t  S . H . ,
D a g i  T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,  1 9 9 7 ,
p p   8 3 - 9 6 .
2 4 6 . W i l k i n s  R . H . :  N e u r o s u r g i c a l  T e c h n i q u e s :  A n  O v e r v i e w .  G r e e n b l a t t  S . H . ,  D a g i
T .  F . ,  E p s t e i n  M . H .  ( e d ) :  A  H i s t o r y  o f  N e u r o s u r g e r y .  U S A :  A A N S ,  1 9 9 7 ,  p p
1 9 3 - 2 1 2 .
2 4 7 . W i l k i n s  R . H. :  H i s t o r y  o f  N e u r o s u r g e r y .  N e u r o s u r g e r y .  M c G r a w - H i l l ,  U S A :
W i l k i n s  R .  H . ;  R e n g a c h a r y  S . S . ,  1 9 9 6 ,  p p   2 5 - 3 6 .
2 4 8 . W ol f f  J :  T h e  c l a s s i c :  on  t h e  t h e o r y  o f  f r a c t u r e  h e a l i n g .  1 8 7 3 .  C l i n  O r t h op  R e l a t
R e s  4 6 8 : 1 0 5 2 - 1 0 5 5 ,  2 0 1 0 .
2 4 9 . X u  Y M ,  Q i  S T ,  P a n  J ,  L u  Y T ,  F a n  J :  Mi c r o s u r g i c a l  r e m o v a l  o f  h u g e  t u b e r c u l u m
s e l l a e  m e n i n g i o m a s  t h r o u g h  b i - s u b f r on t a l  a n t e r i o r  l on g i t u d i n a l  f i s s i o n  a p p r oa c h .
N a n  F a n g  Y i  K e  D a  X u e  X u e  Ba o  3 0 : 1 6 8 8 - 1 6 9 0 ,  2 0 1 0 .
2 5 0 . Y a m a s h i t a  J ,  H a n d a  H ,  I w a k i  K ,  A b e  M :  R e c u r r e n c e  o f  i n t r a c r a n i a l
m e n i n g i o m a s ,  w i t h  s p e c i a l  r e f e r e n c e  t o  r a d i o t h e r a p y .  S u r g  N e u r o l  1 4 : 3 3 - 4 0 ,
1 9 8 0 .
2 5 1 . Y a n g  Y M ,  J i a n g  H Z ,  S h a  C ,  Y u a n  Q G ,  X i e  H W ,  W a n g  D M :  M i c r o s u r g i c a l
m a n a g e m e n t  o f  a n t e r i o r  c l i n o i d a l  m en i n g i o m a s .  Z h on g h u a  Y i  X u e  Za  Z h i
9 0 : 1 7 6 4 - 1 7 6 6 ,  2 0 1 0 .
2 5 2 . Ya  a r g i l  M G:  C h a p t e r  1 :  O p e r a t i v e  A n a t o m y .  Y a  a r g i l  M G  ( e d ) :
M i c r on e u r o s u r g e r y .  S t u t t g a r t ,  G e r m a n y :  T h i e m e  V e r l a g ,  1 9 8 4 ,  p p   5 - 7 0 .
2 5 3 . Ya  a r g i l  M G:  C h a p t e r  2 :  I n t e r n a l  C a r o t i d  A r t e r y  A n e u r ys m s .  Y a  a r g i l  M G  ( e d ) :
M i c r on e u r o s u r g e r y :  C l i n i c a l  C on s i d e r a t i o n s ,  S u r g e r y  o f  t h e  I n t r a c r a n i a l
A n e u r ys m s  a n d  R e s u l t s .  S t u t t g a r t ;  N e w  Y o r k :  T h i e m e  S t r a t t on ,  1 9 8 4 ,  p p   3 3 -
1 2 3 .
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2 5 4 . Ya  a r g i l  M G :  C h a p t e r  3 :  S u r g i c a l  A p p r oa c h e s .  Y a  a r g i l  M G  ( e d ) :
M i c r on e u r o s u r g e r y .  Mi c r on e u r o s u r g e r y  o f  C N S  T u m or s .  S t u t t g a r t ,  G e r m a n y :
G e o r g e  T h i e m e  V e r l a g ,  1 9 9 6 ,  p p   2 9 - 6 8 .
2 5 5 . Ya  a r g i l  M G:  C h a p t e r  9  A :  M en i n g i o m a s .  Y a  a r g i l  M G  ( e d ) :  M i c r on e u r o s u r g e r y .
M i c r on e u r o s u r g e r y  o f  C N S  T u m or s .  S t u t t g a r t ,  G e r m a n y :  G e o r g  T h i e m e  V e r l a g ,
1 9 9 6 ,  p p   1 3 4 - 1 6 5 .
2 5 6 . Ya  a r g i l  M G :  C h a p t e r  3 :  G e n e r a l  O p e r a t i v e  T e c h n i q u e s .  Y a  a r g i l  M G  ( e d ) :
M i c r on e u r o s u r g e r y .  S t u t t g a r t ,  G e r m a n y :  T h i e m e - V e r l a g ,  1 9 8 4 ,  p p   2 0 8 - 2 7 1 .
2 5 7 . Ya  a r g i l  M G :  E d i t o r i a l .  P e r s on a l  c o n s i d e r a t i o n s  on  t h e  h i s t o r y  o f
m i c r on e u r o s u r g e r y .  J  N e u r o s u r g  1 1 2 : 1 3 4 7 ,  2 0 1 0 .
2 5 8 . Y a  a r g i l  M G:  A  l e g a c y  o f  m i c r on e u r os u r g e r y :  m e m o i r s ,  l e s s on s ,  a n d  a x i o m s .
N e u r o s u r g e r y  4 5 : 1 0 2 5 - 1 0 9 2 ,  1 9 9 9 .
2 5 9 . Y a  a r g i l  M G ,  G a s s e r  J C ,  H o d o s h  R M ,  R a n k i n  T V :  C a r o t i d - o p h t h a l m i c
a n e u r ys m s :  d i r e c t  m i c r o s u r g i c a l  a p p r o a c h .  S u r g  N e u r o l  8 : 1 5 5 - 1 6 5 ,  1 9 7 7 .
2 6 0 . Y on e k a w a  Y :  O p er a t i v e  n e u r o s u r g e r y :  p e r s on a l  v i e w  a n d  h i s t o r i c a l
b a c k g r ou n d s .  ( 5 )  M e n i n g i o m a .  N o  S h i n k e i  G e k a  3 7 : 7 1 - 9 0 ,  2 0 0 9 .
2 6 1 . Y o n e k a w a  Y ,  O g a t a  N ,  I m h o f  H G ,  O l i v e c r on a  M ,  S t r om m e r  K ,  K w a k  T E ,  R o t h  P ,
G r o s c u r t h  P :  S e l e c t i v e  e x t r a d u r a l  a n t e r i o r  c l i n o i d e c t om y  f o r  s u p r a -  a n d
p a r a s e l l a r  p r o c e s s e s .  T e c h n i c a l  n o t e .  J  N e u r o s u r g  8 7 : 6 3 6 - 6 4 2 ,  1 9 9 7 .
2 6 2 . Z e v g a r i d i s  D ,  M e d e l e  R J ,  M ü l l e r  A ,  H i s c h a  A C ,  S t e i g e r  H J :  M e n i n g i o m a s  o f  t h e
s e l l a r  r e g i on  p r e s e n t i n g  w i t h  v i s u a l  i m p a i r m en t :  i m p a c t  o f  v a r i o u s  p r og n o s t i c
f a c t o r s  on  s u r g i c a l  o u t c om e  i n  6 2  p a t i e n t s .  A c t a  N e u r o c h i r  ( W i e n )  1 4 3 : 4 7 1 - 4 7 6 ,
2 0 0 1 .
